ID,PubURL,Author,PubYear,Country,Site,Lon,Lat,StartYr,EndYr,MrkrType,Tested,Present,MixedPres,Drug,SiteNo,PubmedID_Title,Notes
19014684,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2613152&tool=pmcentrez&rendertype=abstract,Figueiredo P,2008,Angola,Luanda,13.2344,-8.83833,2005,2005,pfcrt 76K/T,245,1,1,Amodiaquine,0,"Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.",
19014684,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2613152&tool=pmcentrez&rendertype=abstract,Figueiredo P,2008,Angola,Luanda,13.2344,-8.83833,2005,2005,pfcrt 76T,245,230,231,Amodiaquine,0,"Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.",
19014684,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2613152&tool=pmcentrez&rendertype=abstract,Figueiredo P,2008,Angola,Luanda,13.2344,-8.83833,2005,2005,pfmdr1 86N/Y,199,20,20,Amodiaquine,0,"Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.",
19014684,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2613152&tool=pmcentrez&rendertype=abstract,Figueiredo P,2008,Angola,Luanda,13.2344,-8.83833,2005,2005,pfmdr1 86Y,199,122,142,Amodiaquine,0,"Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.",
19708897,http://www.ncbi.nlm.nih.gov/pubmed/19708897,Menegon M,2009,Angola,Uige Provincial Hospital,15.0506,-7.61383,2004,2004,pfcrt 76T,66,62,62,Amodiaquine,0,"Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.",
19708897,http://www.ncbi.nlm.nih.gov/pubmed/19708897,Menegon M,2009,Angola,Uige Provincial Hospital,15.0506,-7.61383,2004,2004,pfcrt CIET,66,62,62,Amodiaquine,0,"Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.",
19708897,http://www.ncbi.nlm.nih.gov/pubmed/19708897,Menegon M,2009,Angola,Uige Provincial Hospital,15.0506,-7.61383,2004,2004,pfmdr1 86N/Y,66,21,21,Amodiaquine,0,"Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.",In vitro data available.
19708897,http://www.ncbi.nlm.nih.gov/pubmed/19708897,Menegon M,2009,Angola,Uige Provincial Hospital,15.0506,-7.61383,2004,2004,pfmdr1 86Y,66,24,45,Amodiaquine,0,"Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.",
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt 76K/T,102,0,0,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt 76T,102,99,99,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt CIET,102,13,13,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt CINT,102,2,2,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt CMDT,102,3,3,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt CMNT,102,4,4,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfcrt SMNT,102,58,58,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfmdr1 86N/Y,28,1,1,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
20565881,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898790&tool=pmcentrez&rendertype=abstract,Gama BE,2010,Angola,Luanda,13.2344,-8.83833,2007,2007,pfmdr1 86Y,28,18,19,Amodiaquine,0,Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.,
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfcrt 76K/T,430,108,108,Amodiaquine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfcrt 76T,430,165,273,Amodiaquine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfcrt CIET,430,165,165,Amodiaquine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfmdr1 1246Y,115,0,0,Amodiaquine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",Mothers and their children
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfmdr1 184F,138,37,54,Lumefantrine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",Mothers and their children
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfmdr1 184Y/F,138,17,17,Lumefantrine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",Mothers and their children
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfmdr1 86N/Y,138,20,20,Amodiaquine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",Mothers and their children
22850519,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3457352&tool=pmcentrez&rendertype=abstract,Fançony C,2012,Angola,Dande,13.73,-8.49,2010,2010,pfmdr1 86Y,138,24,44,Amodiaquine,0,"Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.",Mothers and their children
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Uige,15.0616,-7.6102,2013,2013,pfmdr1 1246Y,6,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Uige,15.0616,-7.6102,2013,2013,pfmdr1 184F,6,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Uige,15.0616,-7.6102,2013,2013,pfmdr1 86Y,6,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Zaire,14.2338,-6.2694,2013,2013,pfmdr1 1246Y,19,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Zaire,14.2338,-6.2694,2013,2013,pfmdr1 184F,19,8,9,,,,added by HYE (study not identified in WWARN PDMS)
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Zaire,14.2338,-6.2694,2013,2013,pfmdr1 184Y/F,19,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1ANG,https://www.ncbi.nlm.nih.gov/pubmed/25367912,Plucinski,2013,Angola,Zaire,14.2338,-6.2694,2013,2013,pfmdr1 86Y,19,3,3,,,,added by HYE (study not identified in WWARN PDMS)
24581308,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3945814&tool=pmcentrez&rendertype=abstract,Aguiar ACC,2014,Angola,,,,2012,2013,pfcrt 76T,1,0,0,Amodiaquine,2,Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia,travelers
24581308,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3945814&tool=pmcentrez&rendertype=abstract,Aguiar ACC,2014,Angola,,,,2012,2013,pfmdr1 1246Y,1,0,0,Amodiaquine,2,Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia,travelers
24581308,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3945814&tool=pmcentrez&rendertype=abstract,Aguiar ACC,2014,Angola,,,,2012,2013,pfmdr1 184F,1,0,0,Lumefantrine,2,Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia,travelers
24581308,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3945814&tool=pmcentrez&rendertype=abstract,Aguiar ACC,2014,Angola,,,,2012,2013,pfmdr1 86Y,1,0,0,Amodiaquine,2,Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia,travelers
25889865,http://www.ncbi.nlm.nih.gov/pubmed/25889865,Foumane Ngane V,2015,Angola,Balombo,14.7762,-12.3537,2010,2011,pfcrt 76T,36,32,32,Amodiaquine,1,"Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.",
25889865,http://www.ncbi.nlm.nih.gov/pubmed/25889865,Foumane Ngane V,2015,Angola,Balombo,14.7762,-12.3537,2010,2011,pfcrt CIET,36,32,32,Amodiaquine,1,"Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.",
25889865,http://www.ncbi.nlm.nih.gov/pubmed/25889865,Foumane Ngane V,2015,Angola,Balombo,14.7762,-12.3537,2010,2011,pfmdr1 1246Y,54,1,1,Amodiaquine,1,"Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.",
25889865,http://www.ncbi.nlm.nih.gov/pubmed/25889865,Foumane Ngane V,2015,Angola,Balombo,14.7762,-12.3537,2010,2011,pfmdr1 184F,54,8,8,Lumefantrine,1,"Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.",
25889865,http://www.ncbi.nlm.nih.gov/pubmed/25889865,Foumane Ngane V,2015,Angola,Balombo,14.7762,-12.3537,2010,2011,pfmdr1 86Y,54,29,29,Amodiaquine,1,"Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2012,2012,pfmdr1 1246D/Y,32,0,0,Amodiaquine,2,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2011,2011,pfmdr1 1246Y,31,0,0,Amodiaquine,1,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2012,2012,pfmdr1 1246Y,32,1,1,Amodiaquine,2,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2013,2013,pfmdr1 1246Y,33,0,0,Amodiaquine,3,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2011,2011,pfmdr1 86N/Y,28,3,3,Amodiaquine,1,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2012,2012,pfmdr1 86N/Y,33,4,4,Amodiaquine,2,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2013,2013,pfmdr1 86N/Y,33,1,1,Amodiaquine,3,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2011,2011,pfmdr1 86Y,28,6,9,Amodiaquine,1,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2012,2012,pfmdr1 86Y,33,6,10,Amodiaquine,2,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2013,2013,pfmdr1 86Y,33,5,6,Amodiaquine,3,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2011,2011,pfmdr1 copy number >1,32,4,4,Lumefantrine,1,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2012,2012,pfmdr1 copy number >1,29,4,4,Lumefantrine,2,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
26670642,http://www.ncbi.nlm.nih.gov/pubmed/?term=26670642,"Kiaco K, Teixeira J, Machado M, do Rosário V, Lopes D",2015,Angola,Luanda,13.2344,-8.83833,2013,2013,pfmdr1 copy number >1,32,5,5,Lumefantrine,3,"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.",
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Angola,,,,2012,2015,pfcrt 76T,101,26,32,Amodiaquine,7,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Angola,,,,2012,2015,pfcrt CIET,101,26,32,Amodiaquine,18,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
628,https://www.ncbi.nlm.nih.gov/pubmed/?term=29458380,Dragan Ljolje,2018,Angola,Benguela,13.4165,-12.5905,2015,2015,pfmdr1 86Y,194,26,26,,1,"Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.","Participants with mixed infections were included in the numerator for each haplotype 86, 184, 1246 observed; pfmdr1 haplotypes are N86Y, Y184F, D1246Y"
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Benguela,13.4165,-12.5905,2017,2017,pfcrt 76T,6,5,1,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Benguela,13.4165,-12.5905,2017,2017,pfmdr1 1246Y,6,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Benguela,13.4165,-12.5905,2017,2017,pfmdr1 184F,6,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Benguela,13.4165,-12.5905,2017,2017,pfmdr1 86Y,6,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Benguela,13.4165,-12.5905,2017,2017,pfmdr1 copy number >1,6,0,0,,,,added by HYE (study not identified in WWARN PDMS)
628,https://www.ncbi.nlm.nih.gov/pubmed/?term=29458380,Dragan Ljolje,2018,Angola,Lunda Sul,20.4761,-9.74041,2015,2015,pfmdr1 86Y,96,7,7,,2,"Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.","Participants with mixed infections were included in the numerator for each haplotype 86, 184, 1246 observed; pfmdr1 haplotypes are N86Y, Y184F, D1246Y"
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Lunda Sul,20.4761,-9.74041,2017,2017,pfcrt 76T,9,1,2,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Lunda Sul,20.4761,-9.74041,2017,2017,pfmdr1 1246Y,9,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Lunda Sul,20.4761,-9.74041,2017,2017,pfmdr1 184F,9,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Lunda Sul,20.4761,-9.74041,2017,2017,pfmdr1 86Y,9,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Lunda Sul,20.4761,-9.74041,2017,2017,pfmdr1 copy number >1,9,0,0,,,,added by HYE (study not identified in WWARN PDMS)
628,https://www.ncbi.nlm.nih.gov/pubmed/?term=29458380,Dragan Ljolje,2018,Angola,Zaire,14.2343,-6.2649,2015,2015,pfmdr1 86Y,201,51,51,,3,"Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.","Participants with mixed infections were included in the numerator for each haplotype 86, 184, 1246 observed; pfmdr1 haplotypes are N86Y, Y184F, D1246Y"
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Zaire,14.2343,-6.2649,2017,2017,pfcrt 76T,23,17,20,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Zaire,14.2343,-6.2649,2017,2017,pfmdr1 1246Y,23,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Zaire,14.2343,-6.2649,2017,2017,pfmdr1 184F,23,7,7,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Zaire,14.2343,-6.2649,2017,2017,pfmdr1 86Y,23,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2ANG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883595/pdf/12936_2018_Article_2290.pdf,Davlantes,2018,Angola,Zaire,14.2343,-6.2649,2017,2017,pfmdr1 copy number >1,23,0,0,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Angola,,,,2012,2016,pfmdr1 86Y,145,23,23,,5,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Benin,,,,1998,2004,pfcrt 76T,1,1,1,Amodiaquine,9,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Benin,,,,2005,2009,pfmdr1 copy number >1,6,0,0,Lumefantrine,6,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Benin,,,,2005,2005,pfcrt 76T,2,2,2,Amodiaquine,5,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
21767415,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3199903&tool=pmcentrez&rendertype=abstract,Bertin G,2011,Benin,Ouidah,2.08333,6.36667,2005,2008,pfmdr1 copy number >1,113,0,0,Lumefantrine,0,Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.,Pregnant women_x000d_
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfcrt 76K/T,195,0,0,Amodiaquine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfcrt 76T,195,191,191,Amodiaquine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfmdr1 1246D/Y,195,11,11,Amodiaquine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfmdr1 1246Y,195,12,23,Amodiaquine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfmdr1 184F,195,146,155,Lumefantrine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfmdr1 184Y/F,195,9,9,Lumefantrine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfmdr1 86N/Y,195,22,22,Amodiaquine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
24100489,http://www.ncbi.nlm.nih.gov/pubmed/24100489,Dahlström S,2013,Benin,"Allada, Sekou",2.15976,6.66446,2007,2007,pfmdr1 86Y,195,137,159,Amodiaquine,0,Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.,Post treatment genotypes after ASAQ and AL tr
23634705,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3651273&tool=pmcentrez&rendertype=abstract,Ogouyèmi-Hounto A,2013,Benin,"Littoral, Ouémé",2.44417,6.35306,2011,2011,pfcrt 76T,213,200,200,Amodiaquine,0,Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.,"Sub-analyses sympt/asympt, age"
24225351,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3834525&tool=pmcentrez&rendertype=abstract,Ogouyèmi-Hounto A,2013,Benin,Parakou,2.61667,9.35,2012,2012,pfcrt 76T,193,56,56,Amodiaquine,0,Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin., 
24225351,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3834525&tool=pmcentrez&rendertype=abstract,Ogouyèmi-Hounto A,2013,Benin,Parakou,2.61667,9.35,2012,2012,pfmdr1 86Y,193,47,47,Amodiaquine,0,Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.,Pfmdr1 copy number befo
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Benin,,,,2012,2015,pfcrt 76T,5,4,4,Amodiaquine,11,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Benin,,,,2012,2015,pfcrt CIET,5,4,4,Amodiaquine,24,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Benin,,,,2012,2016,pfmdr1 86Y,6,1,1,,15,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
718,https://www.ncbi.nlm.nih.gov/pubmed/?term=30350774,,2018,Botswana,Ngamiland,22.241,-19.9547,2012,2016,pfcrt 76K/T,167,4,4,,1,Molecular Surveillance of Plasmodium Falciparum Drug Resistance Markers in Clinical Samples from Botswana,
718,https://www.ncbi.nlm.nih.gov/pubmed/?term=30350774,,2018,Botswana,Ngamiland,22.241,-19.9547,2012,2016,pfcrt 76T,167,6,10,,1,Molecular Surveillance of Plasmodium Falciparum Drug Resistance Markers in Clinical Samples from Botswana,
718,https://www.ncbi.nlm.nih.gov/pubmed/?term=30350774,,2018,Botswana,Ngamiland,22.241,-19.9547,2012,2016,pfmdr1 86N/Y,166,6,6,,1,Molecular Surveillance of Plasmodium Falciparum Drug Resistance Markers in Clinical Samples from Botswana,
718,https://www.ncbi.nlm.nih.gov/pubmed/?term=30350774,,2018,Botswana,Ngamiland,22.241,-19.9547,2012,2016,pfmdr1 86Y,166,7,13,,1,Molecular Surveillance of Plasmodium Falciparum Drug Resistance Markers in Clinical Samples from Botswana,
17292769,http://www.ncbi.nlm.nih.gov/pubmed/?term=17292769,Zongo I,2007,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2005,2005,pfcrt 76T,50,14,14,Amodiaquine,0,Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.,Prevalence of mixed or wildtype infections no
17292769,http://www.ncbi.nlm.nih.gov/pubmed/?term=17292769,Zongo I,2007,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2005,2005,pfmdr1 1246D/Y,50,7,7,Amodiaquine,0,Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.,Prevalence of mixed or wildtype infections no
17292769,http://www.ncbi.nlm.nih.gov/pubmed/?term=17292769,Zongo I,2007,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2005,2005,pfmdr1 1246Y,50,0,7,Amodiaquine,0,Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.,Prevalence of mixed or wildtype infections no
17292769,http://www.ncbi.nlm.nih.gov/pubmed/?term=17292769,Zongo I,2007,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2005,2005,pfmdr1 184F,50,14,14,Lumefantrine,0,Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.,Prevalence of mixed or wildtype infections no
17292769,http://www.ncbi.nlm.nih.gov/pubmed/?term=17292769,Zongo I,2007,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2005,2005,pfmdr1 86Y,50,7,7,Amodiaquine,0,Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.,Prevalence of mixed or wildtype infections no
17336652,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2532500&tool=pmcentrez&rendertype=abstract,"Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN.",2007,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2005,2005,pfcrt 76T,50,14,14,Amodiaquine,0,"Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.",Clinical AQ+SP and AL data and post-treatment
SR1BRF,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2358917/,Mandi,2008,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfcrt 76T,77,40,40,,,,added by HYE (study not identified in WWARN PDMS)
18304270,http://www.ncbi.nlm.nih.gov/pubmed/18304270,Tinto H,2008,Burkina Faso,,,,2005,2005,pfcrt 76T,195,120,120,Amodiaquine,0,Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso.,
18304270,http://www.ncbi.nlm.nih.gov/pubmed/18304270,Tinto H,2008,Burkina Faso,,,,2005,2005,pfmdr1 86Y,195,58,58,Amodiaquine,0,Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso.,Clinical AQ data available.
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2006,2006,pfcrt 76T,150,109,109,Amodiaquine,1,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,"Clinical data AL, DHA-PIP, AQ-SP, post-treatm"
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2007,2007,pfcrt 76T,111,74,74,Amodiaquine,2,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2006,2006,pfmdr1 1246Y,150,14,14,Amodiaquine,1,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,"Clinical data AL, DHA-PIP, AQ-SP, post-treatm"
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2007,2007,pfmdr1 1246Y,111,4,4,Amodiaquine,2,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,Post-treatment (DHA-PIP) genotypes available
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2006,2006,pfmdr1 184F,150,100,100,Lumefantrine,1,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,"Clinical data AL, DHA-PIP, AQ-SP, post-treatm"
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2007,2007,pfmdr1 184F,111,75,75,Lumefantrine,2,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,Post-treatment (DHA-PIP) genotypes available
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2006,2006,pfmdr1 86Y,150,54,54,Amodiaquine,1,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,"Clinical data AL, DHA-PIP, AQ-SP, post-treatm"
20231394,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863637&tool=pmcentrez&rendertype=abstract,Somé AF,2010,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2007,2007,pfmdr1 86Y,111,43,43,Amodiaquine,2,Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.,Post-treatment (DHA-PIP) genotypes available
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfcrt 76K/T,109,22,22,Amodiaquine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfcrt 76T,109,35,57,Amodiaquine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfmdr1 1246D/Y,111,5,5,Amodiaquine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfmdr1 1246Y,111,1,6,Amodiaquine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfmdr1 184F,111,52,97,Lumefantrine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfmdr1 184Y/F,111,45,45,Lumefantrine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfmdr1 86N/Y,111,17,17,Amodiaquine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20060374,http://www.ncbi.nlm.nih.gov/pubmed/20060374,Danquah I,2010,Burkina Faso,Nouna,-3.86667,12.7333,2005,2005,pfmdr1 86Y,111,18,35,Amodiaquine,0,Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.,"Clinical data AQ, post-treatment genotypes"
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Burkina Faso,,,,2005,2009,pfmdr1 copy number = 2,18,1,1,Lumefantrine,2,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Burkina Faso,,,,2005,2006,pfcrt 76T,4,2,2,Amodiaquine,14,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Burkina Faso,,,,2012,2012,pfcrt 76K/T,1,0,0,Amodiaquine,5,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Burkina Faso,,,,2012,2012,pfcrt 76T,1,0,0,Amodiaquine,5,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Burkina Faso,,,,2012,2012,pfcrt CIET,1,0,0,Amodiaquine,5,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Burkina Faso,,,,2012,2012,pfmdr1 86Y,1,0,0,Amodiaquine,5,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Burkina Faso,,,,2012,2012,pfmdr1 copy number >1,1,0,0,Lumefantrine,5,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24733476,http://www.ncbi.nlm.nih.gov/pubmed/24733476,Somé F,2014,Burkina Faso,"Satiri, Balla, Kadomba",-4.03778,11.4347,2009,2009,pfcrt 76T,261,179,179,Amodiaquine,0,Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso.,Publication presents genotype prevalence pre-
24733476,http://www.ncbi.nlm.nih.gov/pubmed/24733476,Somé F,2014,Burkina Faso,"Satiri, Balla, Kadomba",-4.03778,11.4347,2009,2009,pfmdr1 1246Y,261,20,20,Amodiaquine,0,Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso.,
24733476,http://www.ncbi.nlm.nih.gov/pubmed/24733476,Somé F,2014,Burkina Faso,"Satiri, Balla, Kadomba",-4.03778,11.4347,2009,2009,pfmdr1 184F,261,153,153,Lumefantrine,0,Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso.,Publication presents genotype prevalence pre-
24733476,http://www.ncbi.nlm.nih.gov/pubmed/24733476,Somé F,2014,Burkina Faso,"Satiri, Balla, Kadomba",-4.03778,11.4347,2009,2009,pfmdr1 86Y,261,76,76,Amodiaquine,0,Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso.,Publication presents genotype prevalence pre-
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Burkina Faso,,,,2006,2007,pfcrt 76K/T,26,0,0,Amodiaquine,8,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Burkina Faso,,,,2006,2007,pfcrt 76T,26,7,7,Amodiaquine,8,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
532,http://www.ncbi.nlm.nih.gov/pubmed/?term=25918149,"Zongo I, Milligan P, Compaore YD, Some AF, Greenwood B, Tarning J, Rosenthal PJ, Sutherland C, Nosten F, Ouedraogo JB",2015,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2009,2010,pfcrt 76T,39,24,24,Amodiaquine,1,Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.,SMC (control group displayed in Surveyor). dhps 108 not added due to wt/mut unclarity
532,http://www.ncbi.nlm.nih.gov/pubmed/?term=25918149,"Zongo I, Milligan P, Compaore YD, Some AF, Greenwood B, Tarning J, Rosenthal PJ, Sutherland C, Nosten F, Ouedraogo JB",2015,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2009,2010,pfcrt CIET,39,24,24,Amodiaquine,1,Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.,SMC (control group displayed in Surveyor). dhps 108 not added due to wt/mut unclarity
532,http://www.ncbi.nlm.nih.gov/pubmed/?term=25918149,"Zongo I, Milligan P, Compaore YD, Some AF, Greenwood B, Tarning J, Rosenthal PJ, Sutherland C, Nosten F, Ouedraogo JB",2015,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2009,2010,pfmdr1 184F,79,48,48,Lumefantrine,1,Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.,SMC (control group displayed in Surveyor). dhps 108 not added due to wt/mut unclarity
532,http://www.ncbi.nlm.nih.gov/pubmed/?term=25918149,"Zongo I, Milligan P, Compaore YD, Some AF, Greenwood B, Tarning J, Rosenthal PJ, Sutherland C, Nosten F, Ouedraogo JB",2015,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2009,2010,pfmdr1 86Y,79,24,24,Amodiaquine,1,Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.,SMC (control group displayed in Surveyor). dhps 108 not added due to wt/mut unclarity
26516402,http://www.ncbi.nlm.nih.gov/pubmed/?term=26516402,"Sondo P, Derra K, Tarnagda Z, Nakanabo SD, Zampa O, Kazienga A, Valea I, Sorgho H, Ouedraogo JB, Guiguemde TR, Tinto H",2015,Burkina Faso,Nanoro,-2.18869,12.6842,2010,2012,pfcrt 76K/T,675,91,91,Amodiaquine,1,Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso.,
26516402,http://www.ncbi.nlm.nih.gov/pubmed/?term=26516402,"Sondo P, Derra K, Tarnagda Z, Nakanabo SD, Zampa O, Kazienga A, Valea I, Sorgho H, Ouedraogo JB, Guiguemde TR, Tinto H",2015,Burkina Faso,Nanoro,-2.18869,12.6842,2010,2012,pfcrt 76T,675,120,211,Amodiaquine,1,Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso.,
25403659,http://www.ncbi.nlm.nih.gov/pubmed/?term=25403659,"Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A",2015,Burkina Faso,,,,2005,2005,pfcrt 76K/T,267,58,58,Amodiaquine,1,In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.,
25403659,http://www.ncbi.nlm.nih.gov/pubmed/?term=25403659,"Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A",2015,Burkina Faso,,,,2005,2005,pfcrt 76T,267,130,188,Amodiaquine,1,In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.,
25403659,http://www.ncbi.nlm.nih.gov/pubmed/?term=25403659,"Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A",2015,Burkina Faso,,,,2005,2005,pfmdr1 86N/Y,272,53,53,Amodiaquine,1,In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.,
25403659,http://www.ncbi.nlm.nih.gov/pubmed/?term=25403659,"Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A",2015,Burkina Faso,,,,2005,2005,pfmdr1 86Y,272,49,102,Amodiaquine,1,In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.,
497,http://www.ncbi.nlm.nih.gov/pubmed/?term=28004634,"Somé AF, Sorgho H, Zongo I, Bazié T, Nikiéma F, Sawadogo A, Zongo M, Compaoré YD, Ouédraogo JB",2016,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2012,2012,pfcrt 76T,236,58,58,Amodiaquine,1,"Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.",
497,http://www.ncbi.nlm.nih.gov/pubmed/?term=28004634,"Somé AF, Sorgho H, Zongo I, Bazié T, Nikiéma F, Sawadogo A, Zongo M, Compaoré YD, Ouédraogo JB",2016,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2012,2012,pfmdr1 184F,236,167,167,Lumefantrine,1,"Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.",
497,http://www.ncbi.nlm.nih.gov/pubmed/?term=28004634,"Somé AF, Sorgho H, Zongo I, Bazié T, Nikiéma F, Sawadogo A, Zongo M, Compaoré YD, Ouédraogo JB",2016,Burkina Faso,Bobo-Dioulasso,-4.29177,11.1781,2012,2012,pfmdr1 86Y,238,46,46,Amodiaquine,1,"Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.",
27031231,http://www.ncbi.nlm.nih.gov/pubmed/?term=27031231,"Sondo P, Derra K, Diallo Nakanabo S, Tarnagda Z, Kazienga A, Zampa O, Valéa I, Sorgho H, Owusu-Dabo E, Ouédraogo JB, Guiguemdé TR, Tinto H",2016,Burkina Faso,Nanoro,-2.18869,12.6842,2013,2013,pfcrt 76T,571,120,120,Amodiaquine,1,"Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.",
27031231,http://www.ncbi.nlm.nih.gov/pubmed/?term=27031231,"Sondo P, Derra K, Diallo Nakanabo S, Tarnagda Z, Kazienga A, Zampa O, Valéa I, Sorgho H, Owusu-Dabo E, Ouédraogo JB, Guiguemdé TR, Tinto H",2016,Burkina Faso,Nanoro,-2.18869,12.6842,2013,2013,pfmdr1 184F,570,294,294,Lumefantrine,1,"Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.",Mixed infections excluded
27031231,http://www.ncbi.nlm.nih.gov/pubmed/?term=27031231,"Sondo P, Derra K, Diallo Nakanabo S, Tarnagda Z, Kazienga A, Zampa O, Valéa I, Sorgho H, Owusu-Dabo E, Ouédraogo JB, Guiguemdé TR, Tinto H",2016,Burkina Faso,Nanoro,-2.18869,12.6842,2013,2013,pfmdr1 86Y,592,49,49,Amodiaquine,1,"Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.",Mixed infections excluded
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Burkina Faso,,,,2012,2015,pfcrt 76T,1,0,0,Amodiaquine,20,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Burkina Faso,,,,2012,2016,pfmdr1 86Y,1,0,0,,12,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Cameroon,,,,1998,2004,pfcrt 76T,3,2,2,Amodiaquine,2,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
20105282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2831903&tool=pmcentrez&rendertype=abstract,Mbacham WF,2010,Cameroon,Garoua,13.4,9.3,2004,2006,pfcrt 76T,240,76,76,Amodiaquine,1,"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.","Clinical data AQ, AQSP, SP, mixes removed or "
20105282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2831903&tool=pmcentrez&rendertype=abstract,Mbacham WF,2010,Cameroon,Garoua,13.4,9.3,2004,2006,pfmdr1 86Y,240,53,53,Amodiaquine,1,"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.","Clinical data AQ, AQSP, SP, mixes removed or "
20105282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2831903&tool=pmcentrez&rendertype=abstract,Mbacham WF,2010,Cameroon,Mutengene,9.3146,4.08925,2004,2006,pfcrt 76T,260,226,226,Amodiaquine,2,"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.","Clinical data AQ, AQSP, SP, mixes removed or "
20105282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2831903&tool=pmcentrez&rendertype=abstract,Mbacham WF,2010,Cameroon,Mutengene,9.3146,4.08925,2004,2006,pfmdr1 86Y,260,192,192,Amodiaquine,2,"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.","Clinical data AQ, AQSP, SP, mixes removed or "
20105282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2831903&tool=pmcentrez&rendertype=abstract,Mbacham WF,2010,Cameroon,Yaoundé,11.5167,3.86667,2004,2006,pfcrt 76T,260,200,200,Amodiaquine,3,"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.","Clinical data AQ, AQSP, SP, mixes removed or "
20105282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2831903&tool=pmcentrez&rendertype=abstract,Mbacham WF,2010,Cameroon,Yaoundé,11.5167,3.86667,2004,2006,pfmdr1 86Y,260,198,198,Amodiaquine,3,"Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.",
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Cameroon,,,,2005,2009,pfmdr1 copy number >1,17,0,0,Lumefantrine,11,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Cameroon,,,,2003,2005,pfcrt 76T,2,2,2,Amodiaquine,8,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Mfou,11.9333,3.96667,2005,2009,pfcrt 76K/T,229,69,69,Amodiaquine,2,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Mfou,11.9333,3.96667,2005,2009,pfcrt 76T,229,125,194,Amodiaquine,2,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Mfou,11.9333,3.96667,2005,2009,pfmdr1 86N/Y,209,25,25,Amodiaquine,2,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Mfou,11.9333,3.96667,2005,2009,pfmdr1 86Y,209,175,200,Amodiaquine,2,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Yaoundé,11.5167,3.86667,2005,2009,pfcrt 76K/T,203,20,20,Amodiaquine,1,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Yaoundé,11.5167,3.86667,2005,2009,pfcrt 76T,203,145,165,Amodiaquine,1,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Yaoundé,11.5167,3.86667,2005,2009,pfmdr1 86N/Y,201,28,28,Amodiaquine,1,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",In vitro CQ
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Yaoundé,11.5167,3.86667,2005,2009,pfmdr1 86Y,201,153,181,Amodiaquine,1,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.",
22498364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3368752&tool=pmcentrez&rendertype=abstract,Menard S,2012,Cameroon,Yaoundé,11.5167,3.86667,2005,2009,pfmdr1 copy number >1,215,0,0,Lumefantrine,1,"Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.","Clinical data AQ, AQSP, SP, mixes removed or "
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt 76T,180,65,65,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt CIET,180,100,100,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt CMDT,180,4,4,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt CMET,180,1,1,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt CMNT,180,2,2,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt SMET,180,2,2,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
24092656,http://www.ncbi.nlm.nih.gov/pubmed/24092656,Ngassa Mbenda HG,2014,Cameroon,"Yaoundé, Douala, Ebolowa, Kyeossi, Bertoua", ,,2010,2010,pfcrt SMNT,180,6,6,Amodiaquine,0,Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum.,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Cameroon,,,,2012,2015,pfcrt 76T,23,6,9,Amodiaquine,24,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
1CAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368939/,Ndam,2017,Cameroon,Messok,14.0624,3.0853,2012,2012,pfcrt 76K/T,95,20,20,NA,,,added by HYE (study not identified in WWARN PDMS)
1CAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368939/,Ndam,2017,Cameroon,Messok,14.0624,3.0853,2012,2012,pfcrt 76T,95,24,44,NA,,,added by HYE (study not identified in WWARN PDMS)
1CAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368939/,Ndam,2017,Cameroon,Messok,14.0624,3.0853,2012,2012,pfcrt CIET,95,24,44,NA,,,added by HYE (study not identified in WWARN PDMS)
604,http://www.ncbi.nlm.nih.gov/pubmed/?term=29110722,"Apinjoh TO, Mugri RN, Miotto O, Chi HF, Tata RB, Anchang-Kimbi JK, Fon EM, Tangoh DA, Nyingchu RV, Jacob C, Amato R, Djimde A, Kwiatkowski D, Achidi EA, Amambua-Ngwa A",2017,Cameroon,Mutengene,9.3146,4.08925,2013,2014,pfcrt 76T,233,116,116,Amodiaquine,1,Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.,"Age was not specified, mixed infections were excluded, prevalence data was not presented by site"
604,http://www.ncbi.nlm.nih.gov/pubmed/?term=29110722,"Apinjoh TO, Mugri RN, Miotto O, Chi HF, Tata RB, Anchang-Kimbi JK, Fon EM, Tangoh DA, Nyingchu RV, Jacob C, Amato R, Djimde A, Kwiatkowski D, Achidi EA, Amambua-Ngwa A",2017,Cameroon,Mutengene,9.3146,4.08925,2013,2014,pfmdr1 184F,233,121,121,Lumefantrine,1,Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.,"Age was not specified, mixed infections were excluded, prevalence data was not presented by site"
604,http://www.ncbi.nlm.nih.gov/pubmed/?term=29110722,"Apinjoh TO, Mugri RN, Miotto O, Chi HF, Tata RB, Anchang-Kimbi JK, Fon EM, Tangoh DA, Nyingchu RV, Jacob C, Amato R, Djimde A, Kwiatkowski D, Achidi EA, Amambua-Ngwa A",2017,Cameroon,Mutengene,9.3146,4.08925,2013,2014,pfmdr1 86Y,233,25,25,Amodiaquine,1,Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.,"Age was not specified, mixed infections were excluded, prevalence data was not presented by site"
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2003,2005,pfcrt 76T,230,223,223,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2009,2013,pfcrt 76T,260,174,174,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2003,2005,pfmdr1 1246Y,226,7,7,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2009,2013,pfmdr1 1246Y,250,0,0,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2003,2005,pfmdr1 184F,223,217,217,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2009,2013,pfmdr1 184F,234,131,131,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2003,2005,pfmdr1 86Y,226,189,189,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
631,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,Cameroon,Mutengene,9.3146,4.08925,2009,2013,pfmdr1 86Y,208,94,94,,2,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Cameroon,,,,2012,2016,pfmdr1 86Y,27,12,12,,27,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
SR1CAR,http://www.ajtmh.org/docserver/fulltext/14761645/73/3/0730616.pdf?expires=1576372080&id=id&accname=guest&checksum=C7585C5AD8505208025A532372939E14,Menard,2005,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfmdr1 86Y,55,8,8,,,,added by HYE (study not identified in WWARN PDMS)
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt 76K/T,180,33,33,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt 76T,180,75,108,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt CIET,172,77,77,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt CINT,172,1,1,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt CMET,172,19,19,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt CMNT,172,2,2,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfcrt SMET,172,1,1,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfmdr1 1246D/Y,178,18,18,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfmdr1 1246Y,178,14,32,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfmdr1 86N/Y,224,25,25,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
16474071,http://www.ncbi.nlm.nih.gov/pubmed/16474071,Menard D,2006,Central African Republic,Bangui,18.5833,4.36667,2004,2004,pfmdr1 86Y,224,24,49,Amodiaquine,0,"Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.",
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Central African Republic,,,,2005,2009,pfmdr1 copy number >1,8,0,0,Lumefantrine,12,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Central African Republic,,,,2012,2015,pfcrt 76T,1,0,0,Amodiaquine,26,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Central African Republic,,,,2012,2015,pfcrt CIET,1,0,0,Amodiaquine,25,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Central African Republic,,,,2012,2016,pfmdr1 86Y,4,2,2,,23,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Chad,,,,2005,2009,pfmdr1 copy number >1,1,0,0,Lumefantrine,15,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Chad,,,,2006,2006,pfcrt 76T,1,0,0,Amodiaquine,17,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Chad,,,,2012,2015,pfcrt 76T,7,2,2,Amodiaquine,25,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Chad,,,,2012,2015,pfcrt CIET,7,2,2,Amodiaquine,19,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Chad,,,,2012,2016,pfmdr1 86Y,6,1,1,,24,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Comoros,,,,1998,2004,pfcrt 76T,1,0,0,Amodiaquine,11,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
17827355,http://www.ncbi.nlm.nih.gov/pubmed/?term=17827355,"Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, Badiaga S, Bertaux L, Delmont J, Morillon M, Silai R, Brouqui P, Parzy D",2007,Comoros,,43.4584,-11.9192,2004,2006,pfcrt 76K/T,207,28,28,Amodiaquine,1,"Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.",travelers
17827355,http://www.ncbi.nlm.nih.gov/pubmed/?term=17827355,"Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, Badiaga S, Bertaux L, Delmont J, Morillon M, Silai R, Brouqui P, Parzy D",2007,Comoros,,43.4584,-11.9192,2004,2006,pfcrt 76T,207,115,143,Amodiaquine,1,"Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.",travelers
SR1COM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375783/,Menard,2007,Comoros,,43.4584,-11.9192,2006,2006,pfcrt 76T,141,113,113,,,,added by HYE (study not identified in WWARN PDMS)
SR1COM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375783/,Menard,2007,Comoros,,43.4584,-11.9192,2006,2006,pfmdr1 86Y,141,140,140,,,,added by HYE (study not identified in WWARN PDMS)
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Comoros,"Moroni, Foumbouni, Fomboni, Wanani, Domoni, Pomoni",43.4584,-11.9192,2006,2006,pfcrt CIET,266,112,112,Amodiaquine,1,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,Mixed infections included in the prevalence o
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Comoros,"Moroni, Foumbouni, Fomboni, Wanani, Domoni, Pomoni",43.2473,-11.7172,2006,2006,pfmdr1 copy number >1,233,0,0,Lumefantrine,1,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,Mixed infections included in the prevalence o
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfcrt 76T,115,83,83,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfcrt 76T,87,17,17,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfcrt CIET,115,15,15,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfcrt CIET,87,11,11,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfcrt CMET,115,10,10,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfcrt CMET,87,2,2,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfcrt CMNT,115,13,13,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfcrt CMNT,87,2,2,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfcrt SMET,115,12,12,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfcrt SMET,87,0,0,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfcrt SMNT,115,3,3,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfmdr1 1246Y,115,30,30,Amodiaquine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfmdr1 1246Y,87,12,12,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfmdr1 184F,115,60,60,Lumefantrine,1,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfmdr1 184F,87,26,26,Lumefantrine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2006,2007,pfmdr1 86Y,115,100,100,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
507,http://www.ncbi.nlm.nih.gov/pubmed/?term=27527604,"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, Su XZ, Liu Y, Pan L, Li G, Li D, Zhang H, Bacar A, Abdallah KS, Attoumane R, Mliva AM, Zheng S, Xu Q, Lu F, Guan Y, Song J",2016,Comoros,"Mitsoudje, Mitasoumiouli",43.4584,-11.9192,2013,2014,pfmdr1 86Y,87,35,35,Amodiaquine,2,Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.,Unclear how mixed genotyped infections were analyzed
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Congo,,,,1998,2004,pfcrt 76T,1,1,1,Amodiaquine,5,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Congo,,,,2005,2009,pfmdr1 copy number >1,2,0,0,Lumefantrine,14,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
22463364,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3349535&tool=pmcentrez&rendertype=abstract,Koukouikila-Koussounda F,2012,Congo,Brazzaville,15.2136,-4.2689,2010,2010,pfcrt 76T,51,47,47,Amodiaquine,0,Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt 76T,40,39,39,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt 76T,28,20,20,Lumefantrine,2,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt CMET,40,39,39,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt CMET,28,20,20,Lumefantrine,2,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfmdr1 1246Y,41,9,9,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfmdr1 1246Y,26,0,0,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfmdr1 184F,41,20,20,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfmdr1 184F,26,14,14,Lumefantrine,2,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfmdr1 86Y,41,30,30,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
480,http://www.ncbi.nlm.nih.gov/pubmed/?term=28420403,"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, Ntoumi F, Velavan TP",2017,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfmdr1 86Y,26,7,7,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.,
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt 76T,33,1,1,,4,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt 76T,13,8,8,,5,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt 76T,33,1,1,,4,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt 76T,13,0,0,,5,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt CIET,33,1,1,,4,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt CIET,13,8,8,,5,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt CMET,33,1,1,,4,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt CMET,13,0,0,,5,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfcrt CMNK,33,28,28,,4,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfcrt CMNK,13,2,2,,5,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2010,2010,pfmdr1 86Y,36,3,3,,4,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,Brazzaville,15.2833,-4.26667,2015,2015,pfmdr1 86Y,7,2,2,,5,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,"Lopola, Ouesso, Thanry",16.0519,1.61241,2013,2013,pfcrt 76T,20,2,2,,6,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,"Lopola, Ouesso, Thanry",16.0519,1.61241,2013,2013,pfcrt 76T,20,4,4,,6,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,"Lopola, Ouesso, Thanry",16.0519,1.61241,2013,2013,pfcrt CIET,20,2,2,,6,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,"Lopola, Ouesso, Thanry",16.0519,1.61241,2013,2013,pfcrt CMET,20,4,4,,6,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,"Lopola, Ouesso, Thanry",16.0519,1.61241,2013,2013,pfcrt CMNK,20,9,9,,6,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
712,https://www.ncbi.nlm.nih.gov/pubmed/?term=30121345,"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B.",2018,Congo,"Lopola, Ouesso, Thanry",16.0519,1.61241,2013,2013,pfmdr1 86Y,17,2,2,,6,High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015.,asymptomatic
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Congo,,,,2012,2016,pfmdr1 86Y,28,8,8,,29,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Cote d'Ivoire,,,,2012,2013,pfcrt 76T,10,3,3,Amodiaquine,15,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Côte d'Ivoire,,,,1998,2004,pfcrt 76T,5,4,4,Amodiaquine,1,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
SR1COT,https://www.ajol.info/index.php/tjpr/article/view/63556/51398,Ouattara,2010,Côte d'Ivoire,Adzope,-3.8554,6.1071,2007,2007,pfcrt 76K/T,72,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR1COT,https://www.ajol.info/index.php/tjpr/article/view/63556/51398,Ouattara,2010,Côte d'Ivoire,Adzope,-3.8554,6.1071,2007,2007,pfcrt 76T,72,41,51,,,,added by HYE (study not identified in WWARN PDMS)
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Côte d'Ivoire,,,,2005,2009,pfmdr1 copy number = 2,38,2,2,Lumefantrine,1,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Côte d'Ivoire,,,,2004,2005,pfcrt 76T,4,3,3,Amodiaquine,7,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Bonoua,-3.59392,5.27118,2005,2005,pfcrt 76K/T,48,0,0,Amodiaquine,1,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Bonoua,-3.59392,5.27118,2005,2005,pfcrt 76T,48,48,48,Amodiaquine,1,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Bonoua,-3.59392,5.27118,2005,2005,pfcrt CIET,48,48,48,Amodiaquine,1,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Samo,-3.51786,5.28725,2005,2005,pfcrt 76K/T,44,3,3,Amodiaquine,2,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,Mixed haplotypes in two positions: 4/44
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Samo,-3.51786,5.28725,2005,2005,pfcrt 76T,44,40,43,Amodiaquine,2,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,Mixed haplotypes in two positions: 4/44
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Samo,-3.51786,5.28725,2005,2005,pfcrt CIET,44,38,38,Amodiaquine,2,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,Mixed haplotypes in two positions: 4/44
22904636,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418069/,Ako BA,2012,Côte d'Ivoire,Samo,-3.51786,5.28725,2005,2005,pfcrt CMET,44,1,1,Amodiaquine,2,Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.,Mixed haplotypes in two positions: 4/44
25706423,http://www.ncbi.nlm.nih.gov/pubmed/?term=25706423,"Bla BK, Yavo W, Trébissou J, Kipré RG, Yapi FH, N'guessan JD, Djaman JA",2014,Côte d'Ivoire,Abobo,-4.02862,5.4268,2006,2007,pfcrt 76T,32,18,18,Amodiaquine,1,"Polymorphisms of the Pfatpase 6 and Pfcrt gene and their relationship with the in vitro susceptibility to dihydroartemisinin and chloroquine of Plasmodium falciparum isolates from Abobo, Côte d'Ivoire.",
1COT,https://link.springer.com/content/pdf/10.1515%2Fap-2018-0096.pdf,Konate,2018,Côte d'Ivoire,Abengourou,-3.4801,6.7157,2016,2016,pfcrt 76T,106,9,9,,,,added by HYE (study not identified in WWARN PDMS)
1COT,https://link.springer.com/content/pdf/10.1515%2Fap-2018-0096.pdf,Konate,2018,Côte d'Ivoire,Abidjan,-4.0083,5.36,2013,2014,pfcrt 76T,119,33,33,,,,added by HYE (study not identified in WWARN PDMS)
709,https://malariajournal.biomedcentral.com/articles/10.1186/s12936-018-2551-7,"Oléfongo Dagnogo1,2, Aristide Berenger Ako2 , Lacinan Ouattara3 , Noel Dougba Dago4 , David N’golo Coulibaly2 , André Ofanan Touré2  and Joseph Allico Djaman1,2*",2018,Côte d'Ivoire,Anonkoua Kouté,-4.04742,5.43089,2015,2015,pfcrt 76T,28,0,0,,1,Towards a re-emergence of chloroquine sensitivity in Côte d'Ivoire,Other mutation in locus pfcrt 76 were observed in article
709,https://malariajournal.biomedcentral.com/articles/10.1186/s12936-018-2551-7,"Oléfongo Dagnogo1,2, Aristide Berenger Ako2 , Lacinan Ouattara3 , Noel Dougba Dago4 , David N’golo Coulibaly2 , André Ofanan Touré2  and Joseph Allico Djaman1,2*",2018,Côte d'Ivoire,Ayamé,-3.15538,5.60318,2015,2015,pfcrt 76T,20,5,5,,3,Towards a re-emergence of chloroquine sensitivity in Côte d'Ivoire,
709,https://malariajournal.biomedcentral.com/articles/10.1186/s12936-018-2551-7,"Oléfongo Dagnogo1,2, Aristide Berenger Ako2 , Lacinan Ouattara3 , Noel Dougba Dago4 , David N’golo Coulibaly2 , André Ofanan Touré2  and Joseph Allico Djaman1,2*",2018,Côte d'Ivoire,Port Bouët,-3.8859,5.27725,2015,2015,pfcrt 76T,16,5,5,,2,Towards a re-emergence of chloroquine sensitivity in Côte d'Ivoire,Other mutation in locus pfcrt 76 were observed in article
1COT,https://link.springer.com/content/pdf/10.1515%2Fap-2018-0096.pdf,Konate,2018,Côte d'Ivoire,San Pedro,-6.6424,4.7579,2016,2016,pfcrt 76T,118,15,15,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Côte d'Ivoire,,,,2012,2016,pfmdr1 86Y,10,1,1,,16,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfcrt 76K/T,105,11,11,Amodiaquine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfcrt 76T,105,77,88,Amodiaquine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfmdr1 1246D/Y,103,8,8,Amodiaquine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfmdr1 1246Y,103,16,24,Amodiaquine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfmdr1 184F,102,27,36,Lumefantrine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfmdr1 184Y/F,102,9,9,Lumefantrine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfmdr1 86N/Y,102,21,21,Amodiaquine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
19346374,http://www.ajtmh.org/content/80/4/555.long,Mobula L,2009,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2008,2008,pfmdr1 86Y,102,47,68,Amodiaquine,0,"Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.",
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Democratic Republic of the Congo,,,,2002,2005,pfcrt 76T,2,2,2,Amodiaquine,10,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
24359280,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3878180&tool=pmcentrez&rendertype=abstract,Makaba Mvumbi D,2013,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2010,2010,pfcrt 76T,202,145,145,Amodiaquine,0,Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa,
24359280,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3878180&tool=pmcentrez&rendertype=abstract,Makaba Mvumbi D,2013,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2010,2010,pfcrt CIET,202,145,145,Amodiaquine,0,Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa,
24060234,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3849196&tool=pmcentrez&rendertype=abstract,Juliao PC,2013,Democratic Republic of the Congo,,,,2010,2010,pfcrt 76K/T,12,1,1,Amodiaquine,0,Importation of chloroquine-resistant Plasmodium falciparum by Guatemalan peacekeepers returning from the Democratic Republic of the Congo.,travelers
24060234,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3849196&tool=pmcentrez&rendertype=abstract,Juliao PC,2013,Democratic Republic of the Congo,,,,2010,2010,pfcrt 76T,12,0,0,Amodiaquine,0,Importation of chloroquine-resistant Plasmodium falciparum by Guatemalan peacekeepers returning from the Democratic Republic of the Congo.,travelers
24732459,http://www.ncbi.nlm.nih.gov/pubmed/?term=24732459,Antonia AL,2014,Democratic Republic of the Congo, ,,,2007,2007,pfcrt 76K/T,166,35,35,Amodiaquine,0,A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.,
24732459,http://www.ncbi.nlm.nih.gov/pubmed/?term=24732459,Antonia AL,2014,Democratic Republic of the Congo, ,,,2007,2007,pfcrt 76T,166,57,92,Amodiaquine,0,A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.,
24732459,http://www.ncbi.nlm.nih.gov/pubmed/?term=24732459,Antonia AL,2014,Democratic Republic of the Congo, ,,,2007,2007,pfcrt CIET,166,55,55,Amodiaquine,0,A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.,
24732459,http://www.ncbi.nlm.nih.gov/pubmed/?term=24732459,Antonia AL,2014,Democratic Republic of the Congo, ,,,2007,2007,pfcrt CMNT,166,2,2,Amodiaquine,0,A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Democratic Republic of the Congo,,,,2012,2015,pfcrt 76T,23,12,12,Amodiaquine,22,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Democratic Republic of the Congo,,,,2012,2015,pfcrt CIET,23,12,12,Amodiaquine,7,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Bolenge,18.2229,0.002214,2014,2014,pfcrt 76T,51,35,35,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Bolenge,18.2229,0.002214,2014,2014,pfcrt CIET,51,35,35,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Bolenge,18.2229,0.002214,2014,2014,pfmdr1 copy number >1,51,0,0,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Butembo,29.3018,0.114047,2014,2014,pfcrt 76T,22,13,13,Amodiaquine,4,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Butembo,29.3018,0.114047,2014,2014,pfcrt CIET,22,13,13,Amodiaquine,4,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Butembo,29.3018,0.114047,2014,2014,pfmdr1 copy number >1,22,3,3,Lumefantrine,4,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Kapolowe,26.9522,-10.9424,2014,2014,pfcrt 76T,63,42,42,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Kapolowe,26.9522,-10.9424,2014,2014,pfcrt CIET,63,42,42,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Kapolowe,26.9522,-10.9424,2014,2014,pfmdr1 copy number >1,63,0,0,Lumefantrine,2,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Luzizila,15.2385,-4.34714,2014,2014,pfcrt 76T,62,34,34,Amodiaquine,3,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Luzizila,15.2385,-4.34714,2014,2014,pfcrt CIET,62,34,34,Amodiaquine,3,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Luzizila,15.2385,-4.34714,2014,2014,pfmdr1 copy number >1,62,0,0,Lumefantrine,3,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Mweka,21.5588,-4.85312,2014,2014,pfcrt 76T,31,17,17,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Mweka,21.5588,-4.85312,2014,2014,pfcrt CIET,31,17,17,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Mweka,21.5588,-4.85312,2014,2014,pfmdr1 copy number >1,31,0,0,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Punia,26.4518,-1.46372,2014,2014,pfcrt 76T,51,33,33,Amodiaquine,5,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Punia,26.4518,-1.46372,2014,2014,pfcrt CIET,51,33,33,Amodiaquine,5,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
578,http://www.ncbi.nlm.nih.gov/pubmed/?term=28594879,"Mvumbi DM, Bobanga TL, Kayembe JN, Mvumbi GL, Situakibanza HN, Benoit-Vical F, Melin P, De Mol P, Hayette MP",2017,Democratic Republic of the Congo,Punia,26.4518,-1.46372,2014,2014,pfmdr1 copy number >1,51,0,0,Lumefantrine,5,Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.,
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Bas-Uele,26.411668,3.020952,2013,2014,pfcrt 76T,14,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Bas-Uele,26.411668,3.020952,2013,2014,pfmdr1 1246Y,14,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Bas-Uele,26.411668,3.020952,2013,2014,pfmdr1 184F,14,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Bas-Uele,26.411668,3.020952,2013,2014,pfmdr1 86Y,14,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Equateur,19.203205,0.529766,2013,2014,pfcrt 76T,13,11,11,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Equateur,19.203205,0.529766,2013,2014,pfmdr1 1246Y,13,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Equateur,19.203205,0.529766,2013,2014,pfmdr1 184F,13,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Equateur,19.203205,0.529766,2013,2014,pfmdr1 86Y,13,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Katanga,26.744662,-11.026605,2013,2014,pfcrt 76T,14,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Katanga,26.744662,-11.026605,2013,2014,pfmdr1 1246Y,14,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Katanga,26.744662,-11.026605,2013,2014,pfmdr1 184F,14,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Katanga,26.744662,-11.026605,2013,2014,pfmdr1 86Y,14,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Lomami,24.984958,-8.735631,2013,2014,pfcrt 76T,17,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Lomami,24.984958,-8.735631,2013,2014,pfmdr1 1246Y,17,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Lomami,24.984958,-8.735631,2013,2014,pfmdr1 184F,17,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Lomami,24.984958,-8.735631,2013,2014,pfmdr1 86Y,17,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Uele,29.018924,3.484675,2013,2014,pfcrt 76T,12,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Uele,29.018924,3.484675,2013,2014,pfmdr1 1246Y,12,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Uele,29.018924,3.484675,2013,2014,pfmdr1 184F,12,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Haut-Uele,29.018924,3.484675,2013,2014,pfmdr1 86Y,12,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Ituri,30.537617,2.861207,2013,2014,pfcrt 76T,27,20,20,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Ituri,30.537617,2.861207,2013,2014,pfmdr1 1246Y,27,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Ituri,30.537617,2.861207,2013,2014,pfmdr1 184F,27,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Ituri,30.537617,2.861207,2013,2014,pfmdr1 86Y,27,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai,20.974928,-6.869602,2013,2014,pfcrt 76T,14,8,8,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai,20.974928,-6.869602,2013,2014,pfmdr1 1246Y,14,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai,20.974928,-6.869602,2013,2014,pfmdr1 184F,14,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai,20.974928,-6.869602,2013,2014,pfmdr1 86Y,14,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Central,22.19076,-5.373338,2013,2014,pfcrt 76T,43,26,26,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Central,22.19076,-5.373338,2013,2014,pfmdr1 1246Y,43,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Central,22.19076,-5.373338,2013,2014,pfmdr1 184F,43,16,16,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Central,22.19076,-5.373338,2013,2014,pfmdr1 86Y,43,8,8,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Oriental,23.364347,-6.009008,2013,2014,pfcrt 76T,8,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Oriental,23.364347,-6.009008,2013,2014,pfmdr1 1246Y,8,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Oriental,23.364347,-6.009008,2013,2014,pfmdr1 184F,8,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kasai-Oriental,23.364347,-6.009008,2013,2014,pfmdr1 86Y,8,0,0,,,,added by HYE (study not identified in WWARN PDMS)
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2012,2014,pfmdr1 1246D/Y,108,2,2,Amodiaquine,1,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2012,2014,pfmdr1 1246Y,108,10,12,Amodiaquine,1,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2012,2014,pfmdr1 184F,108,44,47,Lumefantrine,1,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2012,2014,pfmdr1 184Y/F,108,3,3,Lumefantrine,1,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2012,2014,pfmdr1 86N/Y,108,10,10,Amodiaquine,1,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Democratic Republic of the Congo,Kinshasa,15.3139,-4.33167,2012,2014,pfmdr1 86Y,108,41,51,Amodiaquine,1,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kinshasa,15.292475,-4.367844,2013,2014,pfcrt 76T,20,15,15,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kinshasa,15.292475,-4.367844,2013,2014,pfmdr1 1246Y,20,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kinshasa,15.292475,-4.367844,2013,2014,pfmdr1 184F,20,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kinshasa,15.292475,-4.367844,2013,2014,pfmdr1 86Y,20,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kongo Central,12.960852,-4.950161,2013,2014,pfcrt 76T,37,34,34,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kongo Central,12.960852,-4.950161,2013,2014,pfmdr1 1246Y,37,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kongo Central,12.960852,-4.950161,2013,2014,pfmdr1 184F,37,17,17,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kongo Central,12.960852,-4.950161,2013,2014,pfmdr1 86Y,37,7,7,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwango,16.988903,-4.583721,2013,2014,pfcrt 76T,21,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwango,16.988903,-4.583721,2013,2014,pfmdr1 1246Y,21,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwango,16.988903,-4.583721,2013,2014,pfmdr1 184F,21,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwango,16.988903,-4.583721,2013,2014,pfmdr1 86Y,21,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwilu,19.02678,-4.057142,2013,2014,pfcrt 76T,11,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwilu,19.02678,-4.057142,2013,2014,pfmdr1 1246Y,11,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwilu,19.02678,-4.057142,2013,2014,pfmdr1 184F,11,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Kwilu,19.02678,-4.057142,2013,2014,pfmdr1 86Y,11,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lomami,25.029155,-6.455369,2013,2014,pfcrt 76T,30,8,8,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lomami,25.029155,-6.455369,2013,2014,pfmdr1 1246Y,30,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lomami,25.029155,-6.455369,2013,2014,pfmdr1 184F,30,11,11,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lomami,25.029155,-6.455369,2013,2014,pfmdr1 86Y,30,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lualaba,22.405265,-10.460888,2013,2014,pfcrt 76T,24,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lualaba,22.405265,-10.460888,2013,2014,pfmdr1 1246Y,24,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lualaba,22.405265,-10.460888,2013,2014,pfmdr1 184F,24,7,7,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Lualaba,22.405265,-10.460888,2013,2014,pfmdr1 86Y,24,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mai-Ndombe,19.3659,-1.40087,2013,2014,pfcrt 76T,21,17,17,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mai-Ndombe,19.3659,-1.40087,2013,2014,pfmdr1 1246Y,21,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mai-Ndombe,19.3659,-1.40087,2013,2014,pfmdr1 184F,21,7,7,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mai-Ndombe,19.3659,-1.40087,2013,2014,pfmdr1 86Y,21,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Maniema,26.263119,-2.256134,2013,2014,pfcrt 76T,38,14,14,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Maniema,26.263119,-2.256134,2013,2014,pfmdr1 1246Y,38,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Maniema,26.263119,-2.256134,2013,2014,pfmdr1 184F,38,12,12,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Maniema,26.263119,-2.256134,2013,2014,pfmdr1 86Y,38,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mongala,22.176322,1.984013,2013,2014,pfcrt 76T,16,11,11,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mongala,22.176322,1.984013,2013,2014,pfmdr1 1246Y,16,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mongala,22.176322,1.984013,2013,2014,pfmdr1 184F,16,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Mongala,22.176322,1.984013,2013,2014,pfmdr1 86Y,16,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Kivu,29.348242,0.357718,2013,2014,pfcrt 76T,14,13,13,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Kivu,29.348242,0.357718,2013,2014,pfmdr1 1246Y,14,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Kivu,29.348242,0.357718,2013,2014,pfmdr1 184F,14,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Kivu,29.348242,0.357718,2013,2014,pfmdr1 86Y,14,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Ubangi,21.908203,4.161589,2013,2014,pfcrt 76T,24,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Ubangi,21.908203,4.161589,2013,2014,pfmdr1 1246Y,24,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Ubangi,21.908203,4.161589,2013,2014,pfmdr1 184F,24,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Nord-Ubangi,21.908203,4.161589,2013,2014,pfmdr1 86Y,24,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sankuru,23.766128,-3.680731,2013,2014,pfcrt 76T,13,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sankuru,23.766128,-3.680731,2013,2014,pfmdr1 1246Y,13,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sankuru,23.766128,-3.680731,2013,2014,pfmdr1 184F,13,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sankuru,23.766128,-3.680731,2013,2014,pfmdr1 86Y,13,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Kivu,27.258285,-2.898634,2013,2014,pfcrt 76T,20,17,17,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Kivu,27.258285,-2.898634,2013,2014,pfmdr1 1246Y,20,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Kivu,27.258285,-2.898634,2013,2014,pfmdr1 184F,20,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Kivu,27.258285,-2.898634,2013,2014,pfmdr1 86Y,20,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Ubangi,19.994001,3.591133,2013,2014,pfcrt 76T,15,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Ubangi,19.994001,3.591133,2013,2014,pfmdr1 1246Y,15,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Ubangi,19.994001,3.591133,2013,2014,pfmdr1 184F,15,7,7,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Sud-Ubangi,19.994001,3.591133,2013,2014,pfmdr1 86Y,15,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tanganyka,28.062627,-6.19006,2013,2014,pfcrt 76T,37,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tanganyka,28.062627,-6.19006,2013,2014,pfmdr1 1246Y,37,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tanganyka,28.062627,-6.19006,2013,2014,pfmdr1 184F,37,14,14,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tanganyka,28.062627,-6.19006,2013,2014,pfmdr1 86Y,37,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshopo,25.636373,-0.142111,2013,2014,pfcrt 76T,11,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshopo,25.636373,-0.142111,2013,2014,pfmdr1 1246Y,11,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshopo,25.636373,-0.142111,2013,2014,pfmdr1 184F,11,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshopo,25.636373,-0.142111,2013,2014,pfmdr1 86Y,11,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshuapa,20.888191,-0.27912,2013,2014,pfcrt 76T,15,13,13,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshuapa,20.888191,-0.27912,2013,2014,pfmdr1 1246Y,15,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshuapa,20.888191,-0.27912,2013,2014,pfmdr1 184F,15,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR1DRC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093412/#sup3,Aydemir,2018,Democratic Republic of the Congo,Tshuapa,20.888191,-0.27912,2013,2014,pfmdr1 86Y,15,3,3,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Democratic Republic of the Congo,,,,2012,2016,pfmdr1 86Y,16,4,4,,26,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Miyobo,10.1739,1.74579,2005,2005,pfcrt 76K/T,184,28,28,Amodiaquine,1,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Miyobo,10.1739,1.74579,2005,2005,pfcrt 76T,184,99,127,Amodiaquine,1,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Miyobo,10.1739,1.74579,2005,2005,pfmdr1 1246D/Y,180,4,4,Amodiaquine,1,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Miyobo,10.1739,1.74579,2005,2005,pfmdr1 1246Y,180,0,4,Amodiaquine,1,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Miyobo,10.1739,1.74579,2005,2005,pfmdr1 86N/Y,181,34,34,Amodiaquine,1,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Miyobo,10.1739,1.74579,2005,2005,pfmdr1 86Y,181,118,152,Amodiaquine,1,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2005,2005,pfcrt 76K/T,113,23,23,Amodiaquine,2,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2005,2005,pfcrt 76T,113,66,89,Amodiaquine,2,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2005,2005,pfmdr1 1246Y,113,0,0,Amodiaquine,2,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2005,2005,pfmdr1 86N/Y,113,33,33,Amodiaquine,2,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
23537170,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3621214&tool=pmcentrez&rendertype=abstract,Mendes C,2013,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2005,2005,pfmdr1 86Y,113,63,96,Amodiaquine,2,Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.,Data also stratified by dry/wet season. Addit
SR1EQG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241786/,Li,2014,Equatorial Guinea,Bioko,8.7821,3.755,2012,2012,pfmdr1 184F,151,134,134,,,,added by HYE (study not identified in WWARN PDMS)
SR1EQG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241786/,Li,2014,Equatorial Guinea,Bioko,8.7821,3.755,2012,2012,pfmdr1 86Y,151,93,93,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfcrt 76K/T,151,10,10,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfcrt 76T,151,139,149,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfcrt CIET,151,139,149,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfmdr1 1246D/Y,157,0,0,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfmdr1 1246Y,157,0,0,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfmdr1 184F,157,137,137,,,,added by HYE (study not identified in WWARN PDMS)
1EQG,https://www.ncbi.nlm.nih.gov/pubmed/26325683,Li,2015,Equatorial Guinea,Bioko,8.7821,3.755,2011,2014,pfmdr1 86Y,157,79,79,,,,added by HYE (study not identified in WWARN PDMS)
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Equatorial Guinea,,,,2012,2015,pfcrt 76T,75,11,17,Amodiaquine,21,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Equatorial Guinea,,,,2012,2015,pfcrt CIET,75,11,17,Amodiaquine,16,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
557,http://www.ncbi.nlm.nih.gov/pubmed/?term=28086777,"Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A",2017,Equatorial Guinea,Bata,9.77049,1.86165,2013,2013,pfcrt 76T,244,74,74,Amodiaquine,1,"Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).",
557,http://www.ncbi.nlm.nih.gov/pubmed/?term=28086777,"Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A",2017,Equatorial Guinea,Bata,9.77049,1.86165,2013,2013,pfmdr1 1246Y,244,9,9,Amodiaquine,1,"Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).",
557,http://www.ncbi.nlm.nih.gov/pubmed/?term=28086777,"Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A",2017,Equatorial Guinea,Bata,9.77049,1.86165,2013,2013,pfmdr1 86Y,244,172,172,Amodiaquine,1,"Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).",
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfcrt 76K/T,108,15,15,Amodiaquine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfcrt 76T,108,52,67,Amodiaquine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfmdr1 1246D/Y,107,2,2,Amodiaquine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfmdr1 1246Y,107,1,3,Amodiaquine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfmdr1 86N/Y,108,39,39,Amodiaquine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfmdr1 86Y,108,54,93,Amodiaquine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Miyobo,10.1739,1.74579,2013,2013,pfmdr1 copy number >1,42,10,10,Lumefantrine,3,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfcrt 76K/T,43,10,10,Amodiaquine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfcrt 76T,43,5,15,Amodiaquine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfmdr1 1246D/Y,43,3,3,Amodiaquine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfmdr1 1246Y,43,5,8,Amodiaquine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfmdr1 86N/Y,43,7,7,Amodiaquine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfmdr1 86Y,43,14,21,Amodiaquine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2005,2005,pfmdr1 copy number >1,25,13,13,Lumefantrine,1,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
475,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,Equatorial Guinea,Ngonamanga,9.78368,2.04405,2013,2013,pfmdr1 copy number >1,22,5,5,Lumefantrine,2,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Equatorial Guinea,,,,2012,2016,pfmdr1 86Y,81,39,39,,28,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
26875763,http://www.ncbi.nlm.nih.gov/pubmed/?term=26875763,"Menegon M, Nurahmed AM, Talha AA, Nour BY, Severini C",2016,Eritrea,"Agordat, Barentu, Medefera",37.9131,15.5299,2013,2014,pfcrt 76T,180,152,152,Amodiaquine,1,Molecular surveillance of antimalarial drug resistance related genes in Plasmodium falciparum isolates from Eritrea.,
26875763,http://www.ncbi.nlm.nih.gov/pubmed/?term=26875763,"Menegon M, Nurahmed AM, Talha AA, Nour BY, Severini C",2016,Eritrea,"Agordat, Barentu, Medefera",37.9131,15.5299,2013,2014,pfmdr1 184F,180,154,154,Lumefantrine,1,Molecular surveillance of antimalarial drug resistance related genes in Plasmodium falciparum isolates from Eritrea.,
26875763,http://www.ncbi.nlm.nih.gov/pubmed/?term=26875763,"Menegon M, Nurahmed AM, Talha AA, Nour BY, Severini C",2016,Eritrea,"Agordat, Barentu, Medefera",37.9131,15.5299,2013,2014,pfmdr1 86Y,180,20,20,Amodiaquine,1,Molecular surveillance of antimalarial drug resistance related genes in Plasmodium falciparum isolates from Eritrea.,
20199676,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2845184&tool=pmcentrez&rendertype=abstract,Dlamini SV,2010,Eswatini,Lowveld,31.9274,-26.2108,2007,2007,pfcrt CIET,6,5,5,Amodiaquine,2,Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.,
20199676,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2845184&tool=pmcentrez&rendertype=abstract,Dlamini SV,2010,Eswatini,Lowveld,31.9274,-26.2108,2007,2007,pfmdr1 184F,6,4,4,Lumefantrine,2,Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.,
20199676,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2845184&tool=pmcentrez&rendertype=abstract,Dlamini SV,2010,Eswatini,Lowveld,31.9274,-26.2108,2007,2007,pfmdr1 86Y,6,2,2,Amodiaquine,2,Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.,
20199676,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2845184&tool=pmcentrez&rendertype=abstract,Dlamini SV,2010,Eswatini,Lowveld,31.9274,-26.2108,2007,2007,pfcrt 76T,6,5,5,Amodiaquine,2,Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.,
20199676,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2845184&tool=pmcentrez&rendertype=abstract,Dlamini SV,2010,Eswatini,Lowveld,31.9274,-26.2108,2007,2007,pfmdr1 1246Y,6,0,0,Amodiaquine,2,Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.,
16817953,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1524791&tool=pmcentrez&rendertype=abstract,Schunk M,2006,Ethiopia,Dilla,38.3083,6.40833,2004,2004,pfcrt 76K/T,69,0,0,Amodiaquine,0,High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.,
16817953,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1524791&tool=pmcentrez&rendertype=abstract,Schunk M,2006,Ethiopia,Dilla,38.3083,6.40833,2004,2004,pfcrt 76T,69,69,69,Amodiaquine,0,High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.,
16817953,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1524791&tool=pmcentrez&rendertype=abstract,Schunk M,2006,Ethiopia,Dilla,38.3083,6.40833,2004,2004,pfmdr1 86N/Y,69,11,11,Amodiaquine,0,High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.,
16817953,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1524791&tool=pmcentrez&rendertype=abstract,Schunk M,2006,Ethiopia,Dilla,38.3083,6.40833,2004,2004,pfmdr1 86Y,69,45,56,Amodiaquine,0,High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.,
20691106,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2922303&tool=pmcentrez&rendertype=abstract,Eshetu T,2010,Ethiopia,Jimma,36.8384,7.67848,2006,2006,pfmdr1 86Y,97,82,82,Amodiaquine,0,"Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.","Clinical data AL, Q, ATQ/PRG, post-treatment "
1ETH,https://www.ncbi.nlm.nih.gov/pubmed/21810256,Mula,2011,Ethiopia,West Arsi,38.8667,7.43333,2007,2009,pfcrt 76T,76,76,76,,,,added by HYE (study not identified in WWARN PDMS)
1ETH,https://www.ncbi.nlm.nih.gov/pubmed/21810256,Mula,2011,Ethiopia,West Arsi,38.8667,7.43333,2007,2009,pfmdr1 1246Y,76,13,13,,,,added by HYE (study not identified in WWARN PDMS)
1ETH,https://www.ncbi.nlm.nih.gov/pubmed/21810256,Mula,2011,Ethiopia,West Arsi,38.8667,7.43333,2007,2009,pfmdr1 86Y,76,25,25,,,,added by HYE (study not identified in WWARN PDMS)
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,Harar,42.1227,9.31256,2009,2009,pfcrt 76T,25,8,8,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,Harar,42.1227,9.31256,2009,2009,pfcrt CIET,25,0,0,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,Harar,42.1227,9.31256,2009,2009,pfmdr1 1246Y,25,0,0,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,Harar,42.1227,9.31256,2009,2009,pfmdr1 184F,25,3,3,Lumefantrine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,Harar,42.1227,9.31256,2009,2009,pfmdr1 86Y,25,7,7,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,Harar,42.1227,9.31256,2009,2009,pfmdr1 copy number >1,25,0,0,Lumefantrine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,"Omo Nada, Bala Wajo, Arba Minch",37.5641,6.0206,2011,2011,pfcrt 76T,170,23,23,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,"Omo Nada, Bala Wajo, Arba Minch",37.5641,6.0206,2011,2011,pfcrt CIET,170,0,0,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,"Omo Nada, Bala Wajo, Arba Minch",37.5641,6.0206,2011,2011,pfmdr1 1246Y,170,0,0,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,"Omo Nada, Bala Wajo, Arba Minch",37.5641,6.0206,2011,2011,pfmdr1 184F,170,7,7,Lumefantrine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,"Omo Nada, Bala Wajo, Arba Minch",37.5641,6.0206,2011,2011,pfmdr1 86Y,170,22,22,Amodiaquine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24964730,http://www.ncbi.nlm.nih.gov/pubmed/24964730,Kebede S,2014,Ethiopia,"Omo Nada, Bala Wajo, Arba Minch",37.5641,6.0206,2011,2011,pfmdr1 copy number >1,170,0,0,Lumefantrine,0,Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.,pfcrt haplotypes also available in the public
24674605,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3986696&tool=pmcentrez&rendertype=abstract,Golassa L,2014,Ethiopia,Shalla district,38.3629,7.29283,2012,2012,pfcrt 76T,99,99,99,Amodiaquine,0,High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia,Pfcrt flanking microsatellites.
24674605,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3986696&tool=pmcentrez&rendertype=abstract,Golassa L,2014,Ethiopia,Shalla district,38.3629,7.29283,2012,2012,pfcrt CIET,99,99,99,Amodiaquine,0,High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia,Pfcrt flanking microsatellites.
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Ethiopia,Adama,39.2583,8.5263,2012,2014,pfcrt 76T,31,31,31,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Ethiopia,Adama,39.2583,8.5263,2012,2014,pfmdr1 86Y,30,7,7,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Ethiopia,Gambella,34.5916,8.2472,2012,2014,pfcrt 76T,22,16,16,Amodiaquine,1,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Ethiopia,Gambella,34.5916,8.2472,2012,2014,pfmdr1 86Y,23,6,6,Amodiaquine,1,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
2ETH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490604/,Heuchert,2015,Ethiopia,Jimma,36.8358,7.6739,2013,2013,pfcrt 76K/T,159,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2ETH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490604/,Heuchert,2015,Ethiopia,Jimma,36.8358,7.6739,2013,2013,pfcrt 76T,159,152,152,,,,added by HYE (study not identified in WWARN PDMS)
2ETH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490604/,Heuchert,2015,Ethiopia,Jimma,36.8358,7.6739,2013,2013,pfmdr1 184F,171,171,171,,,,added by HYE (study not identified in WWARN PDMS)
2ETH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490604/,Heuchert,2015,Ethiopia,Jimma,36.8358,7.6739,2013,2013,pfmdr1 184Y/F,171,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2ETH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490604/,Heuchert,2015,Ethiopia,Jimma,36.8358,7.6739,2013,2013,pfmdr1 86N/Y,163,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2ETH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490604/,Heuchert,2015,Ethiopia,Jimma,36.8358,7.6739,2013,2013,pfmdr1 86Y,163,2,2,,,,added by HYE (study not identified in WWARN PDMS)
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Ethiopia,West Arsi,39.499998,7.749997,2012,2014,pfcrt 76T,99,99,99,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Ethiopia,West Arsi,39.499998,7.749997,2012,2014,pfmdr1 86Y,50,1,1,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Ethiopia,,,,2012,2015,pfcrt 76T,2,2,2,Amodiaquine,3,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Ethiopia,,,,2012,2015,pfcrt CIET,2,2,2,Amodiaquine,3,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Bure,37.0669,10.7061,2014,2014,pfcrt 76T,34,28,28,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Bure,37.0669,10.7061,2014,2014,pfmdr1 1246Y,34,0,0,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Bure,37.0669,10.7061,2014,2014,pfmdr1 184F,34,29,29,Lumefantrine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Bure,37.0669,10.7061,2014,2014,pfmdr1 86Y,34,1,1,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Bure,37.0669,10.7061,2014,2014,pfmdr1 copy number >1,34,22,22,Lumefantrine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Halaba,38.19,7.49333,2014,2014,pfcrt 76T,18,8,8,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Halaba,38.19,7.49333,2014,2014,pfmdr1 1246Y,18,0,0,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Halaba,38.19,7.49333,2014,2014,pfmdr1 184F,18,14,14,Lumefantrine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Halaba,38.19,7.49333,2014,2014,pfmdr1 86Y,18,0,0,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Halaba,38.19,7.49333,2014,2014,pfmdr1 copy number >1,18,9,9,Lumefantrine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Jimma,36.8384,7.67848,2014,2014,pfcrt 76T,44,25,25,Amodiaquine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Jimma,36.8384,7.67848,2014,2014,pfmdr1 1246Y,44,0,0,Amodiaquine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Jimma,36.8384,7.67848,2014,2014,pfmdr1 184F,44,39,39,Lumefantrine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Jimma,36.8384,7.67848,2014,2014,pfmdr1 86Y,44,4,4,Amodiaquine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Jimma,36.8384,7.67848,2014,2014,pfmdr1 copy number >1,44,29,29,Lumefantrine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Mankush,35.5658,10.7803,2014,2014,pfcrt 76T,30,9,9,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Mankush,35.5658,10.7803,2014,2014,pfmdr1 1246Y,30,0,0,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Mankush,35.5658,10.7803,2014,2014,pfmdr1 184F,30,26,26,Lumefantrine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Mankush,35.5658,10.7803,2014,2014,pfmdr1 86Y,30,2,2,Amodiaquine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Mankush,35.5658,10.7803,2014,2014,pfmdr1 copy number >1,30,19,19,Lumefantrine,1,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Metahara,39.917,8.89949,2014,2014,pfcrt 76T,44,25,25,Amodiaquine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Metahara,39.917,8.89949,2014,2014,pfmdr1 1246Y,44,0,0,Amodiaquine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Metahara,39.917,8.89949,2014,2014,pfmdr1 184F,44,44,44,Lumefantrine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Metahara,39.917,8.89949,2014,2014,pfmdr1 86Y,44,0,0,Amodiaquine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Metahara,39.917,8.89949,2014,2014,pfmdr1 copy number >1,44,27,27,Lumefantrine,2,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Shewa Robit,39.8965,9.99325,2014,2014,pfcrt 76T,28,20,20,Amodiaquine,3,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Shewa Robit,39.8965,9.99325,2014,2014,pfmdr1 1246Y,28,0,0,Amodiaquine,3,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Shewa Robit,39.8965,9.99325,2014,2014,pfmdr1 184F,28,28,28,Lumefantrine,3,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Shewa Robit,39.8965,9.99325,2014,2014,pfmdr1 86Y,28,5,5,Amodiaquine,3,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,Publication presents genotype prevalence pre-
571,http://www.ncbi.nlm.nih.gov/pubmed/?term=28746333,"Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, Getachew S, Tushune K, Zhong D, Zhou G, Petros B, Yan G",2017,Ethiopia,Shewa Robit,39.8965,9.99325,2014,2014,pfmdr1 copy number >1,28,19,19,Lumefantrine,3,Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.,
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Ethiopia,,,,2012,2016,pfmdr1 86Y,5,0,0,,8,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Gabon,,,,2005,2009,pfmdr1 copy number >1,4,0,0,Lumefantrine,13,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2004,2004,pfcrt 76K/T,96,2,2,Amodiaquine,1,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2009,2009,pfcrt 76K/T,134,2,2,Amodiaquine,2,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2004,2004,pfcrt 76T,96,90,92,Amodiaquine,1,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2009,2009,pfcrt 76T,134,129,131,Amodiaquine,2,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2004,2004,pfmdr1 1246D/Y,96,4,4,Amodiaquine,1,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2009,2009,pfmdr1 1246D/Y,134,9,9,Amodiaquine,2,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2009,2009,pfmdr1 1246Y,134,6,15,Amodiaquine,2,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2004,2004,pfmdr1 1246Y,96,6,10,Amodiaquine,1,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2009,2009,pfmdr1 86N/Y,134,11,11,Amodiaquine,2,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2004,2004,pfmdr1 86N/Y,96,9,9,Amodiaquine,1,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2009,2009,pfmdr1 86Y,134,81,92,Amodiaquine,2,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
21251998,http://www.ncbi.nlm.nih.gov/pubmed/21251998,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2004,2004,pfmdr1 86Y,96,72,81,Amodiaquine,1,"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.",
SR1GAB,https://www.researchgate.net/publication/221858322_Malaria_in_Gabon_results_of_a_clinical_and_laboratory_study_at_the_Chinese-Gabonese_Friendship_Hospital_of_Franceville,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2010,2010,pfmdr1 1246D/Y,135,11,11,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAB,https://www.researchgate.net/publication/221858322_Malaria_in_Gabon_results_of_a_clinical_and_laboratory_study_at_the_Chinese-Gabonese_Friendship_Hospital_of_Franceville,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2010,2010,pfmdr1 1246Y,135,17,28,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAB,https://www.researchgate.net/publication/221858322_Malaria_in_Gabon_results_of_a_clinical_and_laboratory_study_at_the_Chinese-Gabonese_Friendship_Hospital_of_Franceville,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2010,2010,pfmdr1 86N/Y,135,15,15,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAB,https://www.researchgate.net/publication/221858322_Malaria_in_Gabon_results_of_a_clinical_and_laboratory_study_at_the_Chinese-Gabonese_Friendship_Hospital_of_Franceville,Lekana-Douki JB,2011,Gabon,Franceville,13.5833,-1.63333,2010,2010,pfmdr1 86Y,135,56,71,,,,added by HYE (study not identified in WWARN PDMS)
22004584,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3215978&tool=pmcentrez&rendertype=abstract,Frank M,2011,Gabon,Lambaréné,10.2404,-0.701546,2005,2007,pfcrt 76T,144,140,141,Amodiaquine,2,A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.,Pfcrt flanking microsatellites
23153201,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3534593&tool=pmcentrez&rendertype=abstract,Zatra R,2012,Gabon,Franceville,13.5833,-1.63333,2009,2010,pfcrt 76T,46,45,45,Amodiaquine,0,"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.",In vitro data
23153201,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3534593&tool=pmcentrez&rendertype=abstract,Zatra R,2012,Gabon,Franceville,13.5833,-1.63333,2009,2010,pfcrt CIET,46,45,45,Amodiaquine,0,"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.",In vitro data
23153201,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3534593&tool=pmcentrez&rendertype=abstract,Zatra R,2012,Gabon,Franceville,13.5833,-1.63333,2009,2010,pfmdr1 1246D/Y,46,6,6,Amodiaquine,0,"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.",In vitro data
23153201,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3534593&tool=pmcentrez&rendertype=abstract,Zatra R,2012,Gabon,Franceville,13.5833,-1.63333,2009,2010,pfmdr1 1246Y,46,8,14,Amodiaquine,0,"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.",In vitro data
23153201,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3534593&tool=pmcentrez&rendertype=abstract,Zatra R,2012,Gabon,Franceville,13.5833,-1.63333,2009,2010,pfmdr1 86N/Y,46,1,1,Amodiaquine,0,"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.",In vitro data
23153201,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3534593&tool=pmcentrez&rendertype=abstract,Zatra R,2012,Gabon,Franceville,13.5833,-1.63333,2009,2010,pfmdr1 86Y,46,17,18,Amodiaquine,0,"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.",In vitro data
25506465,http://www.ncbi.nlm.nih.gov/pubmed/25506465,Salissou A,2014,Gabon,Franceville,13.5833,-1.63333,2013,2013,pfcrt 76T,26,19,19,Amodiaquine,1,Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal,
25506465,http://www.ncbi.nlm.nih.gov/pubmed/25506465,Salissou A,2014,Gabon,Franceville,13.5833,-1.63333,2013,2013,pfcrt CIET,26,19,19,Amodiaquine,1,Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal,
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2005,2005,pfcrt 76K/T,29,2,2,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2008,2008,pfcrt 76K/T,78,0,0,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2005,2005,pfcrt 76T,29,22,24,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2008,2008,pfcrt 76T,78,55,55,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2005,2005,pfmdr1 86N/Y,29,2,2,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2008,2008,pfmdr1 86N/Y,78,12,12,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2005,2005,pfmdr1 86Y,29,23,25,,,,added by HYE (study not identified in WWARN PDMS)
1GAB,https://academic.oup.com/trstmh/article/108/11/729/2765233#50950122,Mawili-Mboumba,2014,Gabon,Oyem,11.576,1.5992,2008,2008,pfmdr1 86Y,78,55,67,,,,added by HYE (study not identified in WWARN PDMS)
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfcrt 76K/T,36,0,0,Amodiaquine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfcrt 76T,36,26,26,Amodiaquine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfmdr1 1246Y,32,0,0,Amodiaquine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfmdr1 184F,38,31,31,Lumefantrine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfmdr1 184Y/F,38,0,0,Lumefantrine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfmdr1 86N/Y,41,7,7,Amodiaquine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Fougamou,10.5868,-1.22002,2013,2014,pfmdr1 86Y,41,13,20,Amodiaquine,2,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfcrt 76K/T,51,9,9,Amodiaquine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfcrt 76T,51,27,36,Amodiaquine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfmdr1 1246D/Y,55,5,5,Amodiaquine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfmdr1 1246Y,55,2,7,Amodiaquine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfmdr1 184F,31,25,25,Lumefantrine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfmdr1 184Y/F,31,0,0,Lumefantrine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfmdr1 86N/Y,37,2,2,Amodiaquine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Franceville,13.5833,-1.63333,2013,2014,pfmdr1 86Y,37,12,14,Amodiaquine,4,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfcrt 76K/T,115,0,0,Amodiaquine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfcrt 76T,115,95,95,Amodiaquine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfmdr1 1246D/Y,111,14,14,Amodiaquine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfmdr1 1246Y,111,2,16,Amodiaquine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfmdr1 184F,101,84,84,Lumefantrine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfmdr1 184Y/F,101,0,0,Lumefantrine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfmdr1 86N/Y,108,19,19,Amodiaquine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Koula-Moutou,12.4647,-1.14383,2013,2014,pfmdr1 86Y,108,40,59,Amodiaquine,3,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfcrt 76K/T,200,21,21,Amodiaquine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfcrt 76T,200,146,167,Amodiaquine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfmdr1 1246D/Y,271,9,9,Amodiaquine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfmdr1 1246Y,271,7,16,Amodiaquine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfmdr1 184F,237,175,175,Lumefantrine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfmdr1 184Y/F,237,0,0,Lumefantrine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfmdr1 86N/Y,249,26,26,Amodiaquine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
506,http://www.ncbi.nlm.nih.gov/pubmed/?term=27538948,"Maghendji-Nzondo S, Kouna LC, Mourembou G, Boundenga L, Imboumy-Limoukou RK, Matsiegui PB, Manego-Zoleko R, Mbatchi B, Raoult D, Toure-Ndouo F, Lekana-Douki JB",2016,Gabon,Lastourville,12.7391,-0.815042,2013,2014,pfmdr1 86Y,249,79,105,Amodiaquine,1,"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.",
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Gabon,,,,2012,2015,pfcrt 76T,6,5,5,Amodiaquine,23,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Gabon,,,,2012,2015,pfcrt CIET,6,5,5,Amodiaquine,10,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Gabon,Lambaréné,10.2404,-0.7015,2011,2012,pfmdr1 1246Y,114,1,1,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Gabon,Lambaréné,10.2404,-0.7015,2011,2012,pfmdr1 184F,114,83,85,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Gabon,Lambaréné,10.2404,-0.7015,2011,2012,pfmdr1 184Y/F,114,2,2,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Gabon,Lambaréné,10.2404,-0.7015,2011,2012,pfmdr1 86N/Y,114,13,13,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Gabon,Lambaréné,10.2404,-0.7015,2011,2012,pfmdr1 86Y,114,68,81,,,,added by HYE (study not identified in WWARN PDMS)
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Gabon,,,,2014,2014,pfcrt 76K/T,11,2,2,,23,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Gabon,,,,2014,2014,pfcrt 76T,11,7,9,,23,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Gabon,,,,2014,2014,pfcrt CIET,11,7,7,,23,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Gabon,,,,2014,2014,pfcrt CMNK,11,2,2,,23,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2011,2011,pfcrt 76K/T,17,1,1,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2012,2012,pfcrt 76K/T,25,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2013,2013,pfcrt 76K/T,19,2,2,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2014,2014,pfcrt 76K/T,17,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2011,2011,pfcrt 76T,17,15,16,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2012,2012,pfcrt 76T,25,24,24,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2013,2013,pfcrt 76T,19,15,17,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Franceville,13.6015,-1.6196,2014,2014,pfcrt 76T,17,12,12,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Koulamoutou,12.4667,-1.1413,2013,2013,pfcrt 76K/T,25,1,1,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Koulamoutou,12.4667,-1.1413,2014,2014,pfcrt 76K/T,28,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Koulamoutou,12.4667,-1.1413,2013,2013,pfcrt 76T,25,21,22,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Koulamoutou,12.4667,-1.1413,2014,2014,pfcrt 76T,28,24,24,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Lastourville,12.725,-0.8183,2013,2013,pfcrt 76K/T,28,1,1,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Lastourville,12.725,-0.8183,2014,2014,pfcrt 76K/T,17,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Lastourville,12.725,-0.8183,2013,2013,pfcrt 76T,28,25,26,,,,added by HYE (study not identified in WWARN PDMS)
2GAB,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118251/,Voumbo-Matoumona,2018,Gabon,Lastourville,12.725,-0.8183,2014,2014,pfcrt 76T,17,16,16,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Gabon,,,,2012,2016,pfmdr1 86Y,6,2,2,,25,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2004,2004,pfcrt 76K/T,70,8,8,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2007,2007,pfcrt 76K/T,78,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2008,2008,pfcrt 76K/T,36,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2004,2004,pfcrt 76T,70,43,51,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2007,2007,pfcrt 76T,78,38,44,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2008,2008,pfcrt 76T,36,12,16,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2004,2004,pfmdr1 86N/Y,70,9,9,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2007,2007,pfmdr1 86N/Y,78,5,5,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2008,2008,pfmdr1 86N/Y,36,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2004,2004,pfmdr1 86Y,70,21,30,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2007,2007,pfmdr1 86Y,78,16,21,,,,added by HYE (study not identified in WWARN PDMS)
SR2GAM,https://academic.oup.com/jid/article/209/7/1126/877527,Nwakanma,2014,Gambia,Farafenni,-15.6002,13.5723,2008,2008,pfmdr1 86Y,36,5,8,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2012,2012,pfcrt 76K/T,51,6,6,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2013,2013,pfcrt 76K/T,75,2,2,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2014,2014,pfcrt 76K/T,28,3,3,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2012,2012,pfcrt 76T,51,15,21,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2013,2013,pfcrt 76T,75,24,26,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2014,2014,pfcrt 76T,28,14,17,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2012,2012,pfmdr1 184F,51,26,26,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2013,2013,pfmdr1 184F,75,40,40,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2014,2014,pfmdr1 184F,28,7,7,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2012,2012,pfmdr1 184Y/F,51,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2013,2013,pfmdr1 184Y/F,75,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2014,2014,pfmdr1 184Y/F,28,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2012,2012,pfmdr1 86N/Y,51,2,2,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2013,2013,pfmdr1 86N/Y,75,7,7,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2014,2014,pfmdr1 86N/Y,28,1,1,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2012,2012,pfmdr1 86Y,51,7,9,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2013,2013,pfmdr1 86Y,75,8,15,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Gambia,Gambissara,-14.3108,13.2409,2014,2014,pfmdr1 86Y,28,7,8,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2012,2012,pfcrt 76T,78,70,70,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2013,2013,pfcrt 76T,125,106,106,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2014,2014,pfcrt 76T,67,59,59,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2015,2015,pfcrt 76T,101,87,87,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2012,2012,pfmdr1 1246Y,78,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2013,2013,pfmdr1 1246Y,125,4,4,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2014,2014,pfmdr1 1246Y,67,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2015,2015,pfmdr1 1246Y,101,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2012,2012,pfmdr1 184F,78,61,61,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2013,2013,pfmdr1 184F,125,85,85,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2014,2014,pfmdr1 184F,67,47,47,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2015,2015,pfmdr1 184F,101,65,65,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2012,2012,pfmdr1 86Y,78,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2013,2013,pfmdr1 86Y,125,9,9,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2014,2014,pfmdr1 86Y,67,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1GAM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700332/,Amambua-Ngwa,2017,Gambia,Brikama,-16.6409,13.2748,2015,2015,pfmdr1 86Y,101,5,5,,,,added by HYE (study not identified in WWARN PDMS)
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Hohoe,0.46,7.15,2004,2004,pfcrt 76K/T,130,46,46,Amodiaquine,1,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Hohoe,0.46,7.15,2004,2004,pfcrt 76T,130,59,105,Amodiaquine,1,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Hohoe,0.46,7.15,2004,2004,pfmdr1 86N/Y,130,23,23,Amodiaquine,1,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Hohoe,0.46,7.15,2004,2004,pfmdr1 86Y,130,78,101,Amodiaquine,1,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Navrongo,-1.1,10.9,2004,2004,pfcrt 76K/T,105,6,6,Amodiaquine,2,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Navrongo,-1.1,10.9,2004,2004,pfcrt 76T,105,42,48,Amodiaquine,2,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Navrongo,-1.1,10.9,2004,2004,pfmdr1 86N/Y,105,5,5,Amodiaquine,2,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Navrongo,-1.1,10.9,2004,2004,pfmdr1 86Y,105,56,61,Amodiaquine,2,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Sunyani,-2.333,7.333,2004,2004,pfcrt 76K/T,62,1,1,Amodiaquine,4,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Sunyani,-2.333,7.333,2004,2004,pfcrt 76T,62,37,38,Amodiaquine,4,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Sunyani,-2.333,7.333,2004,2004,pfmdr1 86N/Y,62,9,9,Amodiaquine,4,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Sunyani,-2.333,7.333,2004,2004,pfmdr1 86Y,62,24,33,Amodiaquine,4,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Tarkwa,-1.983,5.3,2004,2004,pfcrt 76K/T,42,6,6,Amodiaquine,3,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Tarkwa,-1.983,5.3,2004,2004,pfcrt 76T,42,35,41,Amodiaquine,3,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Tarkwa,-1.983,5.3,2004,2004,pfmdr1 86N/Y,42,6,6,Amodiaquine,3,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Tarkwa,-1.983,5.3,2004,2004,pfmdr1 86Y,42,26,32,Amodiaquine,3,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Yendi,-0.01667,9.4333,2004,2004,pfcrt 76K/T,67,1,1,Amodiaquine,5,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Yendi,-0.01667,9.4333,2004,2004,pfcrt 76T,67,30,31,Amodiaquine,5,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Yendi,-0.01667,9.4333,2004,2004,pfmdr1 86N/Y,67,8,8,Amodiaquine,5,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
17158810,http://www.ncbi.nlm.nih.gov/pubmed/17158810,Duah NO,2007,Ghana,Yendi,-0.01667,9.4333,2004,2004,pfmdr1 86Y,67,20,28,Amodiaquine,5,"Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.",
SR1GHA,https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-7-127,Adjei,2008,Ghana,Accra,-0.2,5.55,2004,2006,pfcrt 76T,104,75,75,,,,added by HYE (study not identified in WWARN PDMS)
SR1GHA,https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-7-127,Adjei,2008,Ghana,Accra,-0.2,5.55,2004,2006,pfcrt CIET,104,75,75,,,,added by HYE (study not identified in WWARN PDMS)
SR2GHA,https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-8-220,Owusu-Agyei,2009,Ghana,Kintampo,-1.7296,8.0593,2004,2004,pfcrt 76T,100,62,62,,,,added by HYE (study not identified in WWARN PDMS)
SR2GHA,https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-8-220,Owusu-Agyei,2009,Ghana,Kintampo,-1.7296,8.0593,2004,2004,pfmdr1 86Y,100,60,60,,,,added by HYE (study not identified in WWARN PDMS)
21327004,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994155/,Abruquah HH,2010,Ghana,Kumasi,-1.62197,6.68712,2007,2007,pfcrt 76K/T,140,3,3,Amodiaquine,0,"Resistance-mediating polymorphisms of Plasmodium falciparum among isolates from children with severe malaria in kumasi, ghana.","Severe malaria, 77,9% with detectable pre-tre"
21327004,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994155/,Abruquah HH,2010,Ghana,Kumasi,-1.62197,6.68712,2007,2007,pfcrt 76T,140,123,126,Amodiaquine,0,"Resistance-mediating polymorphisms of Plasmodium falciparum among isolates from children with severe malaria in kumasi, ghana.","Severe malaria, 77,9% with detectable pre-tre"
21327004,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994155/,Abruquah HH,2010,Ghana,Kumasi,-1.62197,6.68712,2007,2007,pfmdr1 184F,47,32,32,Lumefantrine,0,"Resistance-mediating polymorphisms of Plasmodium falciparum among isolates from children with severe malaria in kumasi, ghana.","Severe malaria, 77,9% with detectable pre-tre"
21327004,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994155/,Abruquah HH,2010,Ghana,Kumasi,-1.62197,6.68712,2007,2007,pfmdr1 86Y,47,26,26,Amodiaquine,0,"Resistance-mediating polymorphisms of Plasmodium falciparum among isolates from children with severe malaria in kumasi, ghana.","Severe malaria, 77,9% with detectable pre-tre"
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Ghana,,,,2005,2009,pfmdr1 copy number >1,2,0,0,Lumefantrine,9,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Bekwai,-1.58333,6.45,2007,2008,pfcrt 76T,40,26,26,Amodiaquine,3,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Bekwai,-1.58333,6.45,2007,2008,pfcrt CIET,40,26,26,Amodiaquine,3,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Bekwai,-1.58333,6.45,2007,2008,pfmdr1 86Y,41,15,15,Amodiaquine,3,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Cape Coast,-1.24723,5.10506,2007,2008,pfcrt 76T,48,32,32,Amodiaquine,4,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Cape Coast,-1.24723,5.10506,2007,2008,pfcrt CIET,48,32,32,Amodiaquine,4,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Cape Coast,-1.24723,5.10506,2007,2008,pfmdr1 86Y,47,21,21,Amodiaquine,4,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Navrongo,-1.09028,10.8847,2007,2008,pfcrt 76T,41,11,11,Amodiaquine,1,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Navrongo,-1.09028,10.8847,2007,2008,pfcrt CIET,41,11,11,Amodiaquine,1,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Navrongo,-1.09028,10.8847,2007,2008,pfmdr1 86Y,40,12,12,Amodiaquine,1,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21745377,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3146903&tool=pmcentrez&rendertype=abstract,Kwansa-Bentum B,2011,Ghana,"Nyanyano, Okyereko, Buduatta,  Apam, Kasoa, Achimota and Maamobi",-0.417994,5.48564,2010,2010,pfcrt 76T,60,29,29,Amodiaquine,0,Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.,In vitro data
21745377,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3146903&tool=pmcentrez&rendertype=abstract,Kwansa-Bentum B,2011,Ghana,"Nyanyano, Okyereko, Buduatta,  Apam, Kasoa, Achimota and Maamobi",-0.417994,5.48564,2010,2010,pfcrt CIET,60,29,29,Amodiaquine,0,Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.,In vitro data
21745377,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3146903&tool=pmcentrez&rendertype=abstract,Kwansa-Bentum B,2011,Ghana,"Nyanyano, Okyereko, Buduatta,  Apam, Kasoa, Achimota and Maamobi",-0.417994,5.48564,2010,2010,pfmdr1 184F,60,43,43,Lumefantrine,0,Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.,In vitro
21745377,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3146903&tool=pmcentrez&rendertype=abstract,Kwansa-Bentum B,2011,Ghana,"Nyanyano, Okyereko, Buduatta,  Apam, Kasoa, Achimota and Maamobi",-0.417994,5.48564,2010,2010,pfmdr1 86Y,60,15,15,Amodiaquine,0,Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.,In vitro
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Sunyani,-2.33333,7.33333,2007,2008,pfcrt 76T,49,16,16,Amodiaquine,2,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Sunyani,-2.33333,7.33333,2007,2008,pfcrt CIET,49,16,16,Amodiaquine,2,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,pfcrt and pfmdr1 flanking microsatellites
21288822,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3071065&tool=pmcentrez&rendertype=abstract,Alam TM,2011,Ghana,Sunyani,-2.33333,7.33333,2007,2008,pfmdr1 86Y,48,21,21,Amodiaquine,2,Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.,
22453078,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3369212&tool=pmcentrez&rendertype=abstract,Takahashi N,2012,Ghana,Winneba,-0.62284,5.33871,2004,2004,pfcrt 76T,25,22,22,Amodiaquine,8,Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.,"3/25 are mixed infections, however not sure b"
22453078,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3369212&tool=pmcentrez&rendertype=abstract,Takahashi N,2012,Ghana,Winneba,-0.62284,5.33871,2004,2004,pfcrt CIET,25,22,22,Amodiaquine,8,Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.,"3/25 are mixed infections, however not sure b"
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2005,2006,pfcrt 76T,39,36,36,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2007,2008,pfcrt 76T,50,39,39,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2010,2010,pfcrt 76T,14,8,8,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2005,2006,pfmdr1 1246Y,39,5,5,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2007,2008,pfmdr1 1246Y,50,3,3,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2010,2010,pfmdr1 1246Y,15,1,1,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2005,2006,pfmdr1 184F,39,32,32,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2007,2008,pfmdr1 184F,50,35,35,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2010,2010,pfmdr1 184F,15,12,12,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2005,2006,pfmdr1 86Y,39,26,26,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2007,2008,pfmdr1 86Y,50,30,30,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2010,2010,pfmdr1 86Y,15,12,12,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2005,2006,pfmdr1 copy number >1,19,8,8,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2007,2008,pfmdr1 copy number >1,38,0,0,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Begoro,-0.3795,6.3916,2010,2010,pfmdr1 copy number >1,9,0,0,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2005,2006,pfcrt 76T,40,28,28,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2007,2008,pfcrt 76T,50,32,32,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2010,2010,pfcrt 76T,14,8,8,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2005,2006,pfmdr1 1246Y,40,9,9,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2007,2008,pfmdr1 1246Y,48,3,3,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2010,2010,pfmdr1 1246Y,14,0,0,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2005,2006,pfmdr1 184F,40,14,14,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2007,2008,pfmdr1 184F,48,33,33,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2010,2010,pfmdr1 184F,14,11,11,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2005,2006,pfmdr1 86Y,40,18,18,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2007,2008,pfmdr1 86Y,48,23,23,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2010,2010,pfmdr1 86Y,14,6,6,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2005,2006,pfmdr1 copy number >1,5,0,0,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2007,2008,pfmdr1 copy number >1,22,2,2,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Bekwai,-1.5838,6.4532,2010,2010,pfmdr1 copy number >1,10,2,2,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2005,2006,pfcrt 76T,39,37,37,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2007,2008,pfcrt 76T,42,40,40,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2010,2010,pfcrt 76T,20,16,16,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2005,2006,pfmdr1 1246Y,39,3,3,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2007,2008,pfmdr1 1246Y,43,3,3,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2010,2010,pfmdr1 1246Y,20,7,7,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2005,2006,pfmdr1 184F,39,18,18,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2007,2008,pfmdr1 184F,43,25,25,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2010,2010,pfmdr1 184F,20,16,16,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2005,2006,pfmdr1 86Y,39,23,23,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2007,2008,pfmdr1 86Y,43,21,21,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2010,2010,pfmdr1 86Y,20,10,10,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2005,2006,pfmdr1 copy number >1,11,6,6,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2007,2008,pfmdr1 copy number >1,32,1,1,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Cape Coast,-1.2795,5.1315,2010,2010,pfmdr1 copy number >1,10,2,2,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2003,2004,pfcrt 76T,78,60,60,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2007,2008,pfcrt 76T,50,28,28,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2003,2004,pfmdr1 1246Y,28,3,3,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2007,2008,pfmdr1 1246Y,49,2,2,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2003,2004,pfmdr1 184F,28,22,22,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2007,2008,pfmdr1 184F,49,24,24,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2003,2004,pfmdr1 86Y,78,50,50,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2007,2008,pfmdr1 86Y,49,29,29,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2003,2004,pfmdr1 copy number >1,12,0,0,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Hohoe,0.4738,7.1519,2007,2008,pfmdr1 copy number >1,29,2,2,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2003,2004,pfcrt 76T,34,25,25,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2005,2006,pfcrt 76T,40,35,35,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2007,2008,pfcrt 76T,50,34,34,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2010,2010,pfcrt 76T,17,10,10,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2003,2004,pfmdr1 1246Y,27,1,1,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2005,2006,pfmdr1 1246Y,40,6,6,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2007,2008,pfmdr1 1246Y,49,6,6,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2010,2010,pfmdr1 1246Y,30,3,3,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2003,2004,pfmdr1 184F,27,7,7,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2005,2006,pfmdr1 184F,40,17,17,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2007,2008,pfmdr1 184F,49,34,34,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2010,2010,pfmdr1 184F,20,10,10,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2003,2004,pfmdr1 86Y,35,17,17,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2005,2006,pfmdr1 86Y,40,15,15,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2007,2008,pfmdr1 86Y,49,26,26,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2010,2010,pfmdr1 86Y,20,3,3,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2003,2004,pfmdr1 copy number >1,13,1,1,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2005,2006,pfmdr1 copy number >1,15,3,3,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2007,2008,pfmdr1 copy number >1,29,1,1,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Navrongo,-1.0921,10.894,2010,2010,pfmdr1 copy number >1,10,3,3,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2003,2004,pfcrt 76T,74,49,49,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2005,2006,pfcrt 76T,35,30,30,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2007,2008,pfcrt 76T,50,25,25,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2005,2006,pfmdr1 1246Y,35,5,5,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2007,2008,pfmdr1 1246Y,50,7,7,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2005,2006,pfmdr1 184F,35,17,17,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2007,2008,pfmdr1 184F,50,24,24,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2003,2004,pfmdr1 86Y,74,42,42,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2005,2006,pfmdr1 86Y,35,11,11,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2007,2008,pfmdr1 86Y,50,23,23,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2003,2004,pfmdr1 copy number >1,8,1,1,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2005,2006,pfmdr1 copy number >1,30,3,3,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Sunyani,-2.3123,7.3349,2007,2008,pfmdr1 copy number >1,10,0,0,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2003,2004,pfcrt 76T,50,49,49,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2007,2008,pfcrt 76T,18,17,17,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2007,2008,pfmdr1 1246Y,18,2,2,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2007,2008,pfmdr1 184F,18,12,12,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2003,2004,pfmdr1 86Y,50,48,48,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2007,2008,pfmdr1 86Y,18,12,12,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2005,2006,pfmdr1 copy number >1,2,0,0,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2007,2008,pfmdr1 copy number >1,15,4,4,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Tarkwa,-1.993,5.3018,2003,2004,pfmdr1 copy number >1,3,3,3,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2005,2006,pfcrt 76T,39,36,36,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2007,2008,pfcrt 76T,42,40,40,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2010,2010,pfcrt 76T,20,10,10,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2005,2006,pfmdr1 1246Y,39,6,6,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2007,2008,pfmdr1 1246Y,40,5,5,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2010,2010,pfmdr1 1246Y,20,1,1,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2005,2006,pfmdr1 184F,39,18,18,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2007,2008,pfmdr1 184F,40,19,19,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2010,2010,pfmdr1 184F,20,11,11,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2005,2006,pfmdr1 86Y,39,16,16,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2007,2008,pfmdr1 86Y,40,15,15,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2010,2010,pfmdr1 86Y,20,5,5,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2005,2006,pfmdr1 copy number >1,2,0,0,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2007,2008,pfmdr1 copy number >1,33,4,4,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Wa,-2.5099,10.0601,2010,2010,pfmdr1 copy number >1,9,3,3,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2003,2004,pfcrt 76T,88,44,44,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2005,2006,pfcrt 76T,40,29,29,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2007,2008,pfcrt 76T,50,30,30,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2010,2010,pfcrt 76T,20,9,9,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2005,2006,pfmdr1 1246Y,40,5,5,Lumefantrine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2007,2008,pfmdr1 1246Y,50,4,4,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2010,2010,pfmdr1 1246Y,20,3,3,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2005,2006,pfmdr1 184F,40,22,22,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2007,2008,pfmdr1 184F,50,30,30,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2010,2010,pfmdr1 184F,20,8,8,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2003,2004,pfmdr1 86Y,88,42,42,Amodiaquine,2,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2005,2006,pfmdr1 86Y,40,16,16,Amodiaquine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2007,2008,pfmdr1 86Y,50,18,18,Amodiaquine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2010,2010,pfmdr1 86Y,20,2,2,Amodiaquine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2005,2006,pfmdr1 copy number >1,20,4,4,Lumefantrine,1,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2007,2008,pfmdr1 copy number >1,35,6,6,Lumefantrine,4,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24172030,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3819684&tool=pmcentrez&rendertype=abstract,Duah NO,2013,Ghana,Yendi,-0.0093,9.445,2010,2010,pfmdr1 copy number >1,11,2,2,Lumefantrine,3,Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.,
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Ghana,,,,2012,2012,pfcrt 76K/T,2,0,0,Amodiaquine,2,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Ghana,,,,2012,2012,pfcrt 76T,2,1,1,Amodiaquine,2,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Ghana,,,,2012,2012,pfcrt CIET,2,1,1,Amodiaquine,2,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Ghana,,,,2012,2012,pfmdr1 86Y,2,1,1,Amodiaquine,2,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Ghana,,,,2012,2012,pfmdr1 copy number >1,2,0,0,Lumefantrine,2,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24727053,http://www.ncbi.nlm.nih.gov/pubmed/24727053,Afoakwah R,2014,Ghana,Accra,-0.2,5.55,2010,2011,pfcrt 76T,30,15,15,Amodiaquine,1,High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.,
24727053,http://www.ncbi.nlm.nih.gov/pubmed/24727053,Afoakwah R,2014,Ghana,Ashanti,-1.52086,6.74704,2010,2011,pfcrt 76T,53,28,28,Amodiaquine,5,High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.,
1GHA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088365/,Asare,2014,Ghana,Assin Foso,-1.2843,5.7022,2012,2012,pfcrt 76T,54,41,41,,,,added by HYE (study not identified in WWARN PDMS)
24727053,http://www.ncbi.nlm.nih.gov/pubmed/24727053,Afoakwah R,2014,Ghana,Brong-Ahafo,-1.67607,7.95592,2010,2011,pfcrt 76T,57,36,36,Amodiaquine,6,High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.,
1GHA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088365/,Asare,2014,Ghana,Cape Coast,-1.24723,5.10506,2012,2012,pfcrt 76T,56,45,45,,,,added by HYE (study not identified in WWARN PDMS)
24727053,http://www.ncbi.nlm.nih.gov/pubmed/24727053,Afoakwah R,2014,Ghana,Central Ghana,-1.05861,5.56078,2010,2011,pfcrt 76T,40,24,24,Amodiaquine,2,High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.,
1GHA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088365/,Asare,2014,Ghana,Elmina,-1.3421,5.1053,2012,2012,pfcrt 76T,52,41,41,,,,added by HYE (study not identified in WWARN PDMS)
1GHA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088365/,Asare,2014,Ghana,Twifo Praso,-1.5451,5.607,2012,2012,pfcrt 76T,52,26,26,,,,added by HYE (study not identified in WWARN PDMS)
24727053,http://www.ncbi.nlm.nih.gov/pubmed/24727053,Afoakwah R,2014,Ghana,Volta,0.450237,6.57814,2010,2011,pfcrt 76T,32,19,19,Amodiaquine,4,High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.,
24727053,http://www.ncbi.nlm.nih.gov/pubmed/24727053,Afoakwah R,2014,Ghana,Western Ghana,-2.14502,5.3902,2010,2011,pfcrt 76T,34,21,21,Amodiaquine,3,High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Ghana,,,,2004,2006,pfcrt 76K/T,27,0,0,Amodiaquine,1,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Ghana,,,,2006,2007,pfcrt 76K/T,80,3,3,Amodiaquine,2,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Ghana,,,,2004,2006,pfcrt 76T,27,16,16,Amodiaquine,1,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Ghana,,,,2006,2007,pfcrt 76T,80,25,28,Amodiaquine,2,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25348538,http://www.ncbi.nlm.nih.gov/pubmed/25348538,Feng J,2015,Ghana,,,,2013,2013,pfcrt 76T,17,13,13,Amodiaquine,0,Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China,travelers
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfcrt 76K/T,214,39,39,Amodiaquine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfcrt 76T,214,115,154,Amodiaquine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfmdr1 1246D/Y,214,17,17,Amodiaquine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfmdr1 1246Y,214,18,35,Amodiaquine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfmdr1 184F,214,188,188,Lumefantrine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfmdr1 184Y/F,214,0,0,Lumefantrine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfmdr1 86N/Y,214,0,0,Amodiaquine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
27026134,http://www.ncbi.nlm.nih.gov/pubmed/?term=27026134,"Asare KK, Boampong JN, Duah NO, Afoakwah R, Sehgal R, Quashie NB",2016,Ghana,Central region,-1.27314,5.5662,2013,2013,pfmdr1 86Y,214,77,77,Amodiaquine,1,Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal.,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Ghana,,,,2012,2015,pfcrt 76T,23,3,1,Amodiaquine,14,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Ghana,,,,2012,2015,pfcrt CIET,23,3,1,Amodiaquine,17,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Ghana,Kumasi,-1.62197,6.68712,2011,2012,pfmdr1 1246Y,89,3,3,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Ghana,Kumasi,-1.62197,6.68712,2011,2012,pfmdr1 184F,89,62,68,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Ghana,Kumasi,-1.62197,6.68712,2011,2012,pfmdr1 184Y/F,89,6,6,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Ghana,Kumasi,-1.62197,6.68712,2011,2012,pfmdr1 86N/Y,89,15,15,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Ghana,Kumasi,-1.62197,6.68712,2011,2012,pfmdr1 86Y,89,24,39,,,,added by HYE (study not identified in WWARN PDMS)
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Ghana,,,,2014,2014,pfcrt 76K/T,20,1,1,,8,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Ghana,,,,2014,2014,pfcrt 76T,20,2,3,,8,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Ghana,,,,2014,2014,pfcrt CIET,20,2,2,,8,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Ghana,,,,2014,2014,pfcrt CMNK,20,17,17,,8,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
656,https://www.ncbi.nlm.nih.gov/pubmed/?term=29582732,"Osarfo J, Tagbor H, Magnussen P, Alifrangis M.",2018,Ghana,Bekwai,-1.58333,6.45,2011,2012,pfmdr1 1246Y,144,2,2,,1,Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana.,
656,https://www.ncbi.nlm.nih.gov/pubmed/?term=29582732,"Osarfo J, Tagbor H, Magnussen P, Alifrangis M.",2018,Ghana,Bekwai,-1.58333,6.45,2011,2012,pfmdr1 184F,149,88,88,,1,Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana.,
656,https://www.ncbi.nlm.nih.gov/pubmed/?term=29582732,"Osarfo J, Tagbor H, Magnussen P, Alifrangis M.",2018,Ghana,Bekwai,-1.58333,6.45,2011,2012,pfmdr1 86Y,164,25,25,,1,Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana.,
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Ghana,,,,2012,2016,pfmdr1 86Y,33,6,6,,18,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Guinea,,,,2005,2009,pfmdr1 copy number >1,9,0,0,Lumefantrine,4,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Guinea,,,,2012,2015,pfcrt 76T,33,11,12,Amodiaquine,13,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Guinea,,,,2012,2015,pfcrt CIET,33,11,12,Amodiaquine,5,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Guinea,,,,2014,2014,pfcrt 76K/T,7,0,0,,9,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Guinea,,,,2014,2014,pfcrt 76T,7,4,4,,9,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Guinea,,,,2014,2014,pfcrt CIET,7,4,4,,9,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Guinea,,,,2014,2014,pfcrt CMNK,7,3,3,,9,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Guinea,,,,2012,2016,pfmdr1 86Y,33,19,19,,20,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
17488902,http://www.ncbi.nlm.nih.gov/pubmed/17488902,Ursing J,2007,Guinea-Bissau,Bandim,-15.5958,11.8511,2001,2004,pfcrt 76T,478,111,111,Amodiaquine,0,Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.,"Clinical CQ, high dose CQ and AQ data and pos"
17488902,http://www.ncbi.nlm.nih.gov/pubmed/17488902,Ursing J,2007,Guinea-Bissau,Bandim,-15.5958,11.8511,2001,2004,pfmdr1 1246Y,177,1,1,Amodiaquine,0,Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.,"Clinical CQ, high dose CQ and AQ data and pos"
17488902,http://www.ncbi.nlm.nih.gov/pubmed/17488902,Ursing J,2007,Guinea-Bissau,Bandim,-15.5958,11.8511,2001,2004,pfmdr1 184F,477,382,382,Lumefantrine,0,Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.,"Clinical CQ, high dose CQ and AQ data and pos"
17488902,http://www.ncbi.nlm.nih.gov/pubmed/17488902,Ursing J,2007,Guinea-Bissau,Bandim,-15.5958,11.8511,2001,2004,pfmdr1 86Y,477,227,227,Amodiaquine,0,Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.,"Clinical CQ, high dose CQ and AQ data and pos"
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfcrt 76K/T,93,10,10,Amodiaquine,4,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfcrt 76K/T,23,2,2,Amodiaquine,5,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfcrt 76T,93,25,35,Amodiaquine,4,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfcrt 76T,23,1,3,Amodiaquine,5,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfmdr1 86N/Y,21,6,6,Amodiaquine,5,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,In vitro data available
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfmdr1 86N/Y,74,22,22,Amodiaquine,4,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,In vitro data available
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfmdr1 86Y,21,4,10,Amodiaquine,5,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,In vitro data available
17467343,http://www.ncbi.nlm.nih.gov/pubmed/17467343,Ursing J,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfmdr1 86Y,74,15,37,Amodiaquine,4,Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?,In vitro data available
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfcrt 76K/T,93,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfcrt 76K/T,23,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfcrt 76T,93,25,35,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfcrt 76T,23,1,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfmdr1 86N/Y,74,22,22,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfmdr1 86N/Y,21,6,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2004,2004,pfmdr1 86Y,74,15,37,,,,added by HYE (study not identified in WWARN PDMS)
SR1GUIB,https://reader.elsevier.com/reader/sd/pii/S1567134807000421?token=359B07A76304C604A8A0F0C7C7A7B19104FB41E8985461B66087DE3854ED907AE474626B9B98CCD2324C525D47CB0D81,Ursing,2007,Guinea-Bissau,"Nhacra, Placc",-15.5386,11.9608,2005,2005,pfmdr1 86Y,21,4,10,,,,added by HYE (study not identified in WWARN PDMS)
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2004,2004,pfcrt 76T,153,40,40,Amodiaquine,2,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2005,2005,pfcrt 76T,167,40,40,Amodiaquine,3,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2006,2006,pfcrt 76T,113,32,32,Amodiaquine,4,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2007,2007,pfcrt 76T,104,30,30,Amodiaquine,5,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2007,2007,pfmdr1 86Y,104,41,41,Amodiaquine,5,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2006,2006,pfmdr1 86Y,113,49,49,Amodiaquine,4,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2005,2005,pfmdr1 86Y,168,62,62,Amodiaquine,3,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
19718439,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2729929&tool=pmcentrez&rendertype=abstract,Ursing J,2009,Guinea-Bissau,Bissau,-15.6,11.8667,2004,2004,pfmdr1 86Y,157,66,66,Amodiaquine,2,No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.,Stratification by month and parasitemia in th
21148503,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3086436&tool=pmcentrez&rendertype=abstract,Ursing J,2011,Guinea-Bissau,Bissau,-15.6,11.8667,2006,2008,pfcrt 76T,376,109,109,Amodiaquine,0,Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.,
21148503,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3086436&tool=pmcentrez&rendertype=abstract,Ursing J,2011,Guinea-Bissau,Bissau,-15.6,11.8667,2006,2008,pfmdr1 86Y,365,135,135,Amodiaquine,0,Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.,Post-treatment genotypes available after CQ a
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Guinea-Bissau,,,,2001,2004,pfcrt 76T,50,16,16,Amodiaquine,5,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Guinea-Bissau,,,,2001,2004,pfcrt CIET,50,16,16,Amodiaquine,5,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Guinea-Bissau,,,,2001,2004,pfcrt CMNT,50,0,0,Amodiaquine,5,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Guinea-Bissau,,,,2001,2004,pfcrt SMNT,50,0,0,Amodiaquine,5,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Guinea-Bissau,,,,2001,2004,pfmdr1 86Y,50,24,24,Amodiaquine,5,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Guinea-Bissau,,,,2001,2004,pfmdr1 copy number >1,50,0,0,Lumefantrine,5,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2004,2004,pfcrt 76T,151,37,37,Amodiaquine,1,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2005,2005,pfcrt 76T,169,39,39,Amodiaquine,2,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2006,2006,pfcrt 76T,88,20,20,Amodiaquine,3,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2007,2007,pfcrt 76T,40,10,10,Amodiaquine,4,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2008,2008,pfcrt 76T,134,42,42,Amodiaquine,5,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2010,2010,pfcrt 76T,296,141,141,Amodiaquine,6,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2011,2011,pfcrt 76T,345,195,195,Amodiaquine,7,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2012,2012,pfcrt 76T,121,41,41,Amodiaquine,8,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2010,2010,pfmdr1 184F,288,218,218,Lumefantrine,6,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2011,2011,pfmdr1 184F,332,245,245,Lumefantrine,7,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2012,2012,pfmdr1 184F,92,73,73,Lumefantrine,8,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2004,2004,pfmdr1 86Y,155,66,66,Amodiaquine,1,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2005,2005,pfmdr1 86Y,170,61,61,Amodiaquine,2,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2006,2006,pfmdr1 86Y,88,37,37,Amodiaquine,3,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2007,2007,pfmdr1 86Y,40,19,19,Amodiaquine,4,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2008,2008,pfmdr1 86Y,135,49,49,Amodiaquine,5,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2010,2010,pfmdr1 86Y,297,89,89,Amodiaquine,6,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2011,2011,pfmdr1 86Y,322,93,93,Amodiaquine,7,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2012,2012,pfmdr1 86Y,126,43,43,Amodiaquine,8,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2010,2010,pfmdr1 copy number = 2,273,1,1,Lumefantrine,6,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2008,2008,pfmdr1 copy number >1,139,1,1,Lumefantrine,5,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2010,2010,pfmdr1 copy number >1,273,1,1,Lumefantrine,6,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2004,2004,pfmdr1 copy number >1,152,0,0,Lumefantrine,1,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2005,2005,pfmdr1 copy number >1,173,0,0,Lumefantrine,2,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2006,2006,pfmdr1 copy number >1,88,0,0,Lumefantrine,3,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2007,2007,pfmdr1 copy number >1,39,0,0,Lumefantrine,4,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2011,2011,pfmdr1 copy number >1,337,0,0,Lumefantrine,7,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
25421474,http://www.ncbi.nlm.nih.gov/pubmed/25421474,Jovel IT,2015,Guinea-Bissau,Bissau,-15.6178,11.8817,2012,2012,pfmdr1 copy number >1,126,0,0,Lumefantrine,8,"Temporal and Seasonal Changes of Genetic Polymorphisms Associated with Altered Drug Susceptibility to Chloroquine, Lumefantrine, and Quinine in Guinea-Bissau between 2003 and 2012",
567,http://www.ncbi.nlm.nih.gov/pubmed/?term=28546554,"Nag S, Dalgaard MD, Kofoed PE, Ursing J, Crespo M, Andersen LO, Aarestrup FM, Lund O, Alifrangis M",2017,Guinea-Bissau,Bissau,-15.6178,11.8817,2014,2016,pfcrt 76T,317,166,166,Amodiaquine,1,High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.,
567,http://www.ncbi.nlm.nih.gov/pubmed/?term=28546554,"Nag S, Dalgaard MD, Kofoed PE, Ursing J, Crespo M, Andersen LO, Aarestrup FM, Lund O, Alifrangis M",2017,Guinea-Bissau,Bissau,-15.6178,11.8817,2014,2016,pfmdr1 86Y,318,31,31,Amodiaquine,1,High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.,
17176345,http://www.ncbi.nlm.nih.gov/pubmed/17176345,Holmgren G,2006,Kenya,Siaya district,34.2422,-0.0617,2004,2004,pfmdr1 copy number >1,72,1,1,Lumefantrine,0,Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya.,Clinical AQ and post-treatment genotype data 
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Kenya,,,,1998,2004,pfcrt 76T,1,1,1,Amodiaquine,12,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfcrt 76K/T,200,15,15,Amodiaquine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfcrt 76T,200,163,178,Amodiaquine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfmdr1 1246D/Y,200,52,52,Amodiaquine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfmdr1 1246Y,200,68,120,Amodiaquine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfmdr1 184F,200,12,61,Lumefantrine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfmdr1 184Y/F,200,49,49,Lumefantrine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfmdr1 86N/Y,200,82,82,Amodiaquine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kakamega,34.7519,0.282731,2005,2005,pfmdr1 86Y,200,67,149,Amodiaquine,2,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfcrt 76K/T,200,18,18,Amodiaquine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfcrt 76T,200,145,163,Amodiaquine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfmdr1 1246D/Y,200,50,50,Amodiaquine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfmdr1 1246Y,200,66,116,Amodiaquine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfmdr1 184F,200,37,89,Lumefantrine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfmdr1 184Y/F,200,52,52,Lumefantrine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfmdr1 86N/Y,200,58,58,Amodiaquine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kisii,34.772,-0.678306,2005,2005,pfmdr1 86Y,200,33,91,Amodiaquine,1,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfcrt 76K/T,200,22,22,Amodiaquine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfcrt 76T,200,168,190,Amodiaquine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 1246D/Y,200,72,72,Amodiaquine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 1246Y,200,61,133,Amodiaquine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 184F,200,39,95,Lumefantrine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 184Y/F,200,56,56,Lumefantrine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 86N/Y,200,66,66,Amodiaquine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
18671871,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533336&tool=pmcentrez&rendertype=abstract,Zhong D,2008,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 86Y,200,69,135,Amodiaquine,3,Molecular epidemiology of drug-resistant malaria in western Kenya highlands.,Stratification asymptomatic vs. Symptomatic i
19187521,http://www.ncbi.nlm.nih.gov/pubmed/19187521,Thwing JI,2009,Kenya,Bondo,34.2744,-0.09978,2007,2007,pfcrt 76T,96,78,78,Amodiaquine,0,In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.,Clinical data ASAQ. Not clear how mixed infec
19187521,http://www.ncbi.nlm.nih.gov/pubmed/19187521,Thwing JI,2009,Kenya,Bondo,34.2744,-0.09978,2007,2007,pfmdr1 1246Y,61,26,26,Amodiaquine,0,In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.,Clinical data ASAQ. Not clear how mixed infec
19187521,http://www.ncbi.nlm.nih.gov/pubmed/19187521,Thwing JI,2009,Kenya,Bondo,34.2744,-0.09978,2007,2007,pfmdr1 184F,56,9,9,Lumefantrine,0,In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.,Clinical data ASAQ. Not clear how mixed infec
19187521,http://www.ncbi.nlm.nih.gov/pubmed/19187521,Thwing JI,2009,Kenya,Bondo,34.2744,-0.09978,2007,2007,pfmdr1 86Y,55,30,30,Amodiaquine,0,In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.,Clinical data ASAQ. Not clear how mixed infec
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfcrt 76K/T,28,3,3,Amodiaquine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfcrt 76T,28,21,24,Amodiaquine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfmdr1 1246D/Y,28,11,11,Amodiaquine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfmdr1 1246Y,28,16,27,Amodiaquine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfmdr1 184F,28,0,20,Lumefantrine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfmdr1 184Y/F,28,20,20,Lumefantrine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfmdr1 86N/Y,28,10,10,Amodiaquine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Chemelil,35.1333,-0.0833333,2006,2006,pfmdr1 86Y,28,10,20,Amodiaquine,1,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfcrt 76K/T,33,2,2,Amodiaquine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfcrt 76T,33,26,28,Amodiaquine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfmdr1 1246D/Y,33,12,12,Amodiaquine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfmdr1 1246Y,33,18,30,Amodiaquine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfmdr1 184F,33,0,23,Lumefantrine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfmdr1 184Y/F,33,23,23,Lumefantrine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfmdr1 86N/Y,33,15,15,Amodiaquine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Iguhu,34.7562,0.164699,2006,2006,pfmdr1 86Y,33,8,23,Amodiaquine,4,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19450282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2694831&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2006,2006,pfcrt 76T,48,30,30,Amodiaquine,11,Chloroquine resistance before and after its withdrawal in Kenya.,
19450282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2694831&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2006,2006,pfmdr1 86Y,38,31,31,Amodiaquine,11,Chloroquine resistance before and after its withdrawal in Kenya.,Mixed infections excluded.
19770282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2786317&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2005,2008,pfcrt 76K/T,112,11,11,Amodiaquine,0,"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.",In vitro data
19770282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2786317&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2005,2008,pfcrt 76T,112,70,81,Amodiaquine,0,"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.",In vitro data
19770282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2786317&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2005,2008,pfmdr1 86N/Y,72,8,8,Amodiaquine,0,"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.","In vitro, long term adapted isolates"
19770282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2786317&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2005,2008,pfmdr1 86Y,72,47,55,Amodiaquine,0,"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.","In vitro, long term adapted isolates"
19770282,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2786317&tool=pmcentrez&rendertype=abstract,Mwai L,2009,Kenya,Kilifi,39.85,-3.63333,2005,2008,pfmdr1 copy number >1,78,0,0,Lumefantrine,0,"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.","In vitro, long term adapted isolates"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfcrt 76K/T,68,27,27,Amodiaquine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfcrt 76T,68,34,61,Amodiaquine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfmdr1 1246D/Y,68,56,56,Amodiaquine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfmdr1 1246Y,68,8,64,Amodiaquine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfmdr1 184F,68,0,37,Lumefantrine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfmdr1 184Y/F,68,37,37,Lumefantrine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfmdr1 86N/Y,68,37,37,Amodiaquine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Kisian,34.6663,-0.0748716,2006,2006,pfmdr1 86Y,68,18,55,Amodiaquine,3,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfcrt 76K/T,36,7,7,Amodiaquine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfcrt 76T,36,23,30,Amodiaquine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfmdr1 1246D/Y,36,17,17,Amodiaquine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfmdr1 1246Y,36,15,32,Amodiaquine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfmdr1 184F,36,0,26,Lumefantrine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfmdr1 184Y/F,36,26,26,Lumefantrine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfmdr1 86N/Y,36,16,16,Amodiaquine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
19398039,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745398&tool=pmcentrez&rendertype=abstract,Bonizzoni M,2009,Kenya,Miwani,34.9768,-0.0602319,2006,2006,pfmdr1 86Y,36,17,33,Amodiaquine,2,Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.,"Asymptomatic, microsatellite analysis, for ha"
21106088,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001743&tool=pmcentrez&rendertype=abstract,Spalding MD,2010,Kenya,Kisumu,34.768,-0.0917016,2003,2005,pfcrt 76T,244,237,237,Amodiaquine,0,"Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.",Results from an additional study was presente
21106088,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001743&tool=pmcentrez&rendertype=abstract,Spalding MD,2010,Kenya,Kisumu,34.768,-0.0917016,2003,2005,pfmdr1 1246Y,90,4,4,Amodiaquine,0,"Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.",Results from an additional study was presente
21106088,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001743&tool=pmcentrez&rendertype=abstract,Spalding MD,2010,Kenya,Kisumu,34.768,-0.0917016,2003,2005,pfmdr1 184F,244,244,244,Lumefantrine,0,"Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.",Results from an additional study was presente
21106088,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001743&tool=pmcentrez&rendertype=abstract,Spalding MD,2010,Kenya,Kisumu,34.768,-0.0917016,2003,2005,pfmdr1 86Y,243,184,184,Amodiaquine,0,"Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.",Results from an additional study was presente
21734121,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3122340&tool=pmcentrez&rendertype=abstract,Akala HM,2011,Kenya,"Kisumu, Kisii, and Kericho District Hospitals, and Chulaimbo Sub-District Hospital",34.768,-0.0917016,2007,2008,pfmdr1 184F,308,77,77,Lumefantrine,0,Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.,
21734121,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3122340&tool=pmcentrez&rendertype=abstract,Akala HM,2011,Kenya,"Kisumu, Kisii, and Kericho District Hospitals, and Chulaimbo Sub-District Hospital",34.768,-0.0917016,2007,2008,pfmdr1 86Y,308,203,203,Amodiaquine,0,Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.,
21734121,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3122340&tool=pmcentrez&rendertype=abstract,Akala HM,2011,Kenya,"Kisumu, Kisii, and Kericho District Hospitals, and Chulaimbo Sub-District Hospital",34.768,-0.0917016,2007,2008,pfmdr1 copy number >1,308,0,0,Lumefantrine,0,Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.,
22641431,http://www.ncbi.nlm.nih.gov/pubmed/22641431,Mang'era CM,2012,Kenya,Tiwi,39.5833,-4.23333,2008,2008,pfcrt 76K/T,77,8,8,Amodiaquine,2,"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.",
22641431,http://www.ncbi.nlm.nih.gov/pubmed/22641431,Mang'era CM,2012,Kenya,Tiwi,39.5833,-4.23333,2008,2008,pfcrt 76T,77,32,40,Amodiaquine,2,"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.",
22641431,http://www.ncbi.nlm.nih.gov/pubmed/22641431,Mang'era CM,2012,Kenya,Tiwi,39.5833,-4.23333,2008,2008,pfcrt CIET,77,30,30,Amodiaquine,2,"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.",
22641431,http://www.ncbi.nlm.nih.gov/pubmed/22641431,Mang'era CM,2012,Kenya,Tiwi,39.5833,-4.23333,2008,2008,pfcrt CMET,77,2,2,Amodiaquine,2,"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.",
22641431,http://www.ncbi.nlm.nih.gov/pubmed/22641431,Mang'era CM,2012,Kenya,Tiwi,39.5833,-4.23333,2008,2008,pfmdr1 86N/Y,77,6,6,Amodiaquine,2,"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.",
22641431,http://www.ncbi.nlm.nih.gov/pubmed/22641431,Mang'era CM,2012,Kenya,Tiwi,39.5833,-4.23333,2008,2008,pfmdr1 86Y,77,43,49,Amodiaquine,2,"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.",
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2005,2005,pfcrt 76K/T,70,10,10,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2008,2008,pfcrt 76K/T,47,2,2,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2005,2005,pfcrt 76T,70,53,63,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2008,2008,pfcrt 76T,47,42,44,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2005,2005,pfmdr1 1246D/Y,70,22,22,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2008,2008,pfmdr1 1246D/Y,47,25,25,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2005,2005,pfmdr1 1246Y,70,55,70,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2008,2008,pfmdr1 1246Y,47,19,44,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2005,2005,pfmdr1 86N/Y,70,21,21,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2008,2008,pfmdr1 86N/Y,47,12,12,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2005,2005,pfmdr1 86Y,70,21,42,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kakamega,34.7519,0.2827,2008,2008,pfmdr1 86Y,47,9,21,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2008,2008,pfcrt 76T,87,63,63,Amodiaquine,1,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2009,2009,pfcrt 76T,69,47,47,Amodiaquine,2,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2010,2010,pfcrt 76T,124,54,54,Amodiaquine,3,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2011,2011,pfcrt 76T,53,17,17,Amodiaquine,4,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2008,2008,pfcrt CIET,87,63,63,Amodiaquine,1,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2009,2009,pfcrt CIET,69,47,47,Amodiaquine,2,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2010,2010,pfcrt CIET,124,54,54,Amodiaquine,3,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2011,2011,pfcrt CIET,53,17,17,Amodiaquine,4,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2008,2008,pfmdr1 86N/Y,243,54,54,Amodiaquine,1,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2011,2011,pfmdr1 86N/Y,314,66,66,Amodiaquine,4,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2009,2009,pfmdr1 86N/Y,225,45,45,Amodiaquine,2,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2010,2010,pfmdr1 86N/Y,395,31,31,Amodiaquine,3,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2008,2008,pfmdr1 86Y,243,109,163,Amodiaquine,1,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2011,2011,pfmdr1 86Y,314,38,104,Amodiaquine,4,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2009,2009,pfmdr1 86Y,225,56,101,Amodiaquine,2,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
23675533,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652850&tool=pmcentrez&rendertype=abstract,Eyase FL,2013,Kenya,"Kisumu, Kisii, Kericho",34.768,-0.0917016,2010,2010,pfmdr1 86Y,395,87,118,Amodiaquine,3,The role of Pfmdr1 and Pfcrt in changing chloroquine,In vitro data.
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfcrt 76K/T,44,5,5,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2008,2008,pfcrt 76K/T,99,12,12,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfcrt 76T,44,29,34,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2008,2008,pfcrt 76T,99,44,56,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 1246D/Y,44,14,14,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2008,2008,pfmdr1 1246D/Y,99,50,50,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 1246Y,44,23,35,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2008,2008,pfmdr1 1246Y,99,38,88,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 86N/Y,44,27,27,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2008,2008,pfmdr1 86N/Y,99,40,40,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2005,2005,pfmdr1 86Y,44,9,36,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
SR1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541741/,Vardo-Zalilk,2013,Kenya,Kombewa,34.55,-0.0428065,2008,2008,pfmdr1 86Y,99,25,76,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot
23836177,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3754354&tool=pmcentrez&rendertype=abstract,Okombo J,2013,Kenya,Mbita,34.206,-0.436792,2009,2009,pfmdr1 1246Y,80,30,30,Amodiaquine,1,The polymorphic linker domain of pfmdr1 is associated with resistance-conferring mutations in Plasmodium falciparum populations from East and West Africa.,Mixed genotype infections not accounted for. 
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Kenya,,,,2012,2012,pfcrt 76K/T,1,1,1,Amodiaquine,1,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Kenya,,,,2012,2012,pfcrt 76T,1,0,1,Amodiaquine,1,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Kenya,,,,2012,2012,pfcrt CIET,1,0,0,Amodiaquine,1,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Kenya,,,,2012,2012,pfmdr1 86Y,1,0,0,Amodiaquine,1,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Kenya,,,,2012,2012,pfmdr1 copy number >1,1,0,0,Lumefantrine,1,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2006,2006,pfcrt 76T,105,52,52,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2013,2013,pfcrt 76T,87,15,15,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2006,2006,pfmdr1 1246Y,47,18,18,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2013,2013,pfmdr1 1246Y,47,0,0,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2006,2006,pfmdr1 184F,47,14,14,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2013,2013,pfmdr1 184F,47,15,15,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2006,2006,pfmdr1 86Y,47,27,27,,,,added by HYE (study not identified in WWARN PDMS)
2KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266795/#s0095,Okombo,2014,Kenya,Kilifi,39.9093,-3.5107,2013,2013,pfmdr1 86Y,48,1,1,,,,added by HYE (study not identified in WWARN PDMS)
1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068580/#B37,Cheruiyot,2014,Kenya,"Kisumi, Kisii, Kericho",35.2863,-0.3689,2011,2012,pfcrt 76T,88,57,57,,,,added by HYE (study not identified in WWARN PDMS)
1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068580/#B37,Cheruiyot,2014,Kenya,"Kisumi, Kisii, Kericho",35.2863,-0.3689,2011,2012,pfmdr1 184F,88,42,42,,,,added by HYE (study not identified in WWARN PDMS)
1KEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068580/#B37,Cheruiyot,2014,Kenya,"Kisumi, Kisii, Kericho",35.2863,-0.3689,2011,2012,pfmdr1 86Y,88,29,29,,,,added by HYE (study not identified in WWARN PDMS)
25395861,http://www.ncbi.nlm.nih.gov/pubmed/25395861,Akala HM,2014,Kenya,Kisumu,34.768,-0.091702,2008,2008,pfcrt 76K/T,155,41,41,Amodiaquine,0,Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions,
25395861,http://www.ncbi.nlm.nih.gov/pubmed/25395861,Akala HM,2014,Kenya,Kisumu,34.768,-0.091702,2008,2008,pfcrt 76T,155,106,147,Amodiaquine,0,Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions,
25395861,http://www.ncbi.nlm.nih.gov/pubmed/25395861,Akala HM,2014,Kenya,Kisumu,34.768,-0.091702,2008,2008,pfmdr1 86N/Y,160,43,43,Amodiaquine,0,Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions,
25395861,http://www.ncbi.nlm.nih.gov/pubmed/25395861,Akala HM,2014,Kenya,Kisumu,34.768,-0.091702,2008,2008,pfmdr1 86Y,160,61,104,Amodiaquine,0,Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions,
24994911,http://www.ncbi.nlm.nih.gov/pubmed/24994911,Henriques,2014,Kenya,Mbita,34.206,-0.436792,2011,2011,pfcrt 76K/T,278,89,89,Amodiaquine,0,Directional Selection at the pfmdr1,"Post-treatment (AL, DHA-PIP) genotypes availa"
24994911,http://www.ncbi.nlm.nih.gov/pubmed/24994911,Henriques,2014,Kenya,Mbita,34.206,-0.436792,2011,2011,pfcrt 76T,278,135,224,Amodiaquine,0,Directional Selection at the pfmdr1,"Post-treatment (AL, DHA-PIP) genotypes availa"
24994911,http://www.ncbi.nlm.nih.gov/pubmed/24994911,Henriques,2014,Kenya,Mbita,34.206,-0.436792,2011,2011,pfcrt CIET,278,135,135,Amodiaquine,0,Directional Selection at the pfmdr1,"Post-treatment (AL, DHA-PIP) genotypes availa"
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Kenya,,,,2004,2006,pfcrt 76K/T,12,0,0,Amodiaquine,9,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Kenya,,,,2006,2007,pfcrt 76K/T,6,0,0,Amodiaquine,10,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Kenya,,,,2004,2006,pfcrt 76T,12,10,10,Amodiaquine,9,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Kenya,,,,2006,2007,pfcrt 76T,6,5,5,Amodiaquine,10,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Asembo,34.3833,-0.183333,2007,2007,pfcrt 76T,61,57,57,Amodiaquine,3,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Asembo,34.3833,-0.183333,2007,2007,pfcrt CIET,61,46,46,Amodiaquine,3,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Asembo,34.3833,-0.183333,2007,2007,pfmdr1 1246Y,61,25,25,Amodiaquine,3,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Asembo,34.3833,-0.183333,2007,2007,pfmdr1 184F,61,10,10,Lumefantrine,3,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Asembo,34.3833,-0.183333,2007,2007,pfmdr1 86Y,61,43,43,Amodiaquine,3,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Gem,34.5382,0.08982,2007,2007,pfcrt 76T,97,79,79,Amodiaquine,2,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Gem,34.5382,0.08982,2007,2007,pfcrt CIET,97,78,78,Amodiaquine,2,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Gem,34.5382,0.08982,2007,2007,pfmdr1 1246Y,97,42,42,Amodiaquine,2,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Gem,34.5382,0.08982,2007,2007,pfmdr1 184F,97,25,25,Lumefantrine,2,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Gem,34.5382,0.08982,2007,2007,pfmdr1 86Y,97,62,62,Amodiaquine,2,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Karemo,34.3186,0.043023,2007,2007,pfcrt 76T,95,72,72,Amodiaquine,1,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Karemo,34.3186,0.043023,2007,2007,pfcrt CIET,95,66,66,Amodiaquine,1,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Karemo,34.3186,0.043023,2007,2007,pfmdr1 1246Y,95,34,34,Amodiaquine,1,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Karemo,34.3186,0.043023,2007,2007,pfmdr1 184F,95,24,24,Lumefantrine,1,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
25889220,http://www.ncbi.nlm.nih.gov/pubmed/?term=25889220,"Shah M, Omosun Y, Lal A, Odero C, Gatei W, Otieno K, Gimnig JE, ter Kuile F, Hawley WA, Nahlen B, Kariuki S, Walker E, Slutsker L, Hamel M, Shi YP",2015,Kenya,Karemo,34.3186,0.043023,2007,2007,pfmdr1 86Y,95,68,68,Amodiaquine,1,Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.,Mixed infections excluded
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfcrt 76K/T,745,73,73,Amodiaquine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfcrt 76T,745,212,285,Amodiaquine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfmdr1 1246D/Y,745,20,20,Amodiaquine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfmdr1 1246Y,745,103,123,Amodiaquine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfmdr1 184F,745,304,484,Lumefantrine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfmdr1 184Y/F,745,180,180,Lumefantrine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfmdr1 86N/Y,745,85,85,Amodiaquine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
26236581,http://www.ncbi.nlm.nih.gov/pubmed/26236581,Achieng AO,2015,Kenya,Kisumu,34.768,-0.091702,2008,2014,pfmdr1 86Y,745,111,196,Amodiaquine,2,Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.,
SR2KEN,https://www.nature.com/articles/srep08308,Ngalah,2015,Kenya,Kisumu,34.768,-0.091702,2013,2014,pfmdr1 copy number >1,71,7,7,,,,added by HYE (study not identified in WWARN PDMS)
26296743,http://www.ncbi.nlm.nih.gov/pubmed/26296743,Kiarie WC,2015,Kenya,Msambweni,39.4807,-4.48017,2013,2013,pfcrt 76K/T,99,0,0,Amodiaquine,1,"Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13Â years after cessation of chloroquine use in Msambweni, Kenya.",
26296743,http://www.ncbi.nlm.nih.gov/pubmed/26296743,Kiarie WC,2015,Kenya,Msambweni,39.4807,-4.48017,2013,2013,pfcrt 76T,99,41,41,Amodiaquine,1,"Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13Â years after cessation of chloroquine use in Msambweni, Kenya.",
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfcrt 76T,203,20,20,Amodiaquine,2,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,In vitro data available in publication
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfcrt CIET,203,20,20,Amodiaquine,2,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,In vitro data available in publication
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 1246D/Y,194,26,26,Amodiaquine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 1246Y,194,12,38,Amodiaquine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 184F,193,72,121,Lumefantrine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 184Y/F,193,49,49,Lumefantrine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 86N/Y,200,6,6,Amodiaquine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 86Y,200,7,13,Amodiaquine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
26392510,http://www.ncbi.nlm.nih.gov/pubmed/?term=26392510,"Lucchi NW, Komino F, Okoth SA, Goldman I, Onyona P, Wiegand RE, Juma E, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,Kenya,Siaya and Bondo District Hospitals,34.2847,0.057996,2010,2013,pfmdr1 copy number >1,41,0,0,Lumefantrine,1,In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Kenya,,,,2012,2015,pfcrt 76T,3,0,0,Amodiaquine,4,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Kenya,Kisumu,34.768,-0.0917016,2011,2012,pfmdr1 1246Y,84,11,11,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Kenya,Kisumu,34.768,-0.0917016,2011,2012,pfmdr1 184F,84,47,53,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Kenya,Kisumu,34.768,-0.0917016,2011,2012,pfmdr1 184Y/F,84,6,6,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Kenya,Kisumu,34.768,-0.0917016,2011,2012,pfmdr1 86N/Y,84,6,6,,,,added by HYE (study not identified in WWARN PDMS)
2OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442681/#CR33,Nguetse,2017,Kenya,Kisumu,34.768,-0.0917016,2011,2012,pfmdr1 86Y,84,15,21,,,,added by HYE (study not identified in WWARN PDMS)
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfcrt 76K/T,48,2,2,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfcrt 76T,48,4,6,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfmdr1 1246D/Y,41,1,1,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfmdr1 1246Y,41,0,1,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfmdr1 184F,41,29,29,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfmdr1 184Y/F,41,0,0,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfmdr1 86N/Y,41,0,0,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kakamega,34.7519,0.282731,2015,2015,pfmdr1 86Y,41,0,0,,8,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
720,https://www.ncbi.nlm.nih.gov/pubmed/?term=30376843,"Muiruri P, Juma DW, Ingasia LA, Chebon LJ, Opot B, Ngalah BS, Cheruiyot J, Andagalu B, Akala HM, Nyambati VCS, Ng'ang'a JK, Kamau E.",2018,Kenya,Kericho,35.2877,-0.367868,2012,2013,pfmdr1 86Y,28,0,0,,3,Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya.,
720,https://www.ncbi.nlm.nih.gov/pubmed/?term=30376843,"Muiruri P, Juma DW, Ingasia LA, Chebon LJ, Opot B, Ngalah BS, Cheruiyot J, Andagalu B, Akala HM, Nyambati VCS, Ng'ang'a JK, Kamau E.",2018,Kenya,Kisii,34.772,-0.678306,2012,2013,pfmdr1 86Y,61,5,5,,2,Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya.,No information on mixed infections
720,https://www.ncbi.nlm.nih.gov/pubmed/?term=30376843,"Muiruri P, Juma DW, Ingasia LA, Chebon LJ, Opot B, Ngalah BS, Cheruiyot J, Andagalu B, Akala HM, Nyambati VCS, Ng'ang'a JK, Kamau E.",2018,Kenya,Kisumu,34.768,-0.091702,2012,2013,pfmdr1 86Y,91,3,3,,1,Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya.,No information on mixed infections
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfcrt 76K/T,75,1,1,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfcrt 76T,75,1,2,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfmdr1 1246D/Y,86,4,4,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfmdr1 1246Y,86,4,8,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfmdr1 184F,86,29,41,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfmdr1 184Y/F,86,12,12,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfmdr1 86N/Y,86,1,1,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
614,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, TomÃ¡s-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,Kenya,Kombewa,34.55,-0.0428065,2015,2015,pfmdr1 86Y,86,1,2,,4,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic
720,https://www.ncbi.nlm.nih.gov/pubmed/?term=30376843,"Muiruri P, Juma DW, Ingasia LA, Chebon LJ, Opot B, Ngalah BS, Cheruiyot J, Andagalu B, Akala HM, Nyambati VCS, Ng'ang'a JK, Kamau E.",2018,Kenya,Malindi,40.1229,-3.22174,2012,2013,pfmdr1 86Y,40,12,12,,4,Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya.,No information on mixed infections
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Kenya,,,,2012,2016,pfmdr1 86Y,4,2,2,,9,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Liberia,,,,2005,2009,pfmdr1 copy number >1,1,0,0,Lumefantrine,10,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfcrt 76K/T,294,7,7,Amodiaquine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfcrt 76T,294,268,275,Amodiaquine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfmdr1 1246D/Y,294,58,58,Amodiaquine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,Mixed infections excluded for haplotypes
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfmdr1 1246Y,294,55,113,Amodiaquine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,Mixed infections excluded for haplotypes
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfmdr1 184F,294,104,128,Lumefantrine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,Mixed infections excluded for haplotypes
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfmdr1 184Y/F,294,24,24,Lumefantrine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,Mixed infections excluded for haplotypes
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfmdr1 86N/Y,294,47,47,Amodiaquine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,Mixed infections excluded for haplotypes
504,http://www.ncbi.nlm.nih.gov/pubmed/?term=27596849,"Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S",2016,Liberia,Nimba county,-8.7674,6.74875,2008,2009,pfmdr1 86Y,294,157,204,Amodiaquine,1,Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.,Mixed infections excluded for haplotypes
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Liberia,,,,2012,2013,pfcrt 76T,23,22,22,Amodiaquine,16,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Liberia,,,,2012,2013,pfcrt CIET,23,22,22,Amodiaquine,15,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Liberia,,,,2014,2014,pfcrt 76K/T,14,0,0,,10,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Liberia,,,,2014,2014,pfcrt 76T,14,13,13,,10,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Liberia,,,,2014,2014,pfcrt CIET,14,13,13,,10,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Liberia,,,,2014,2014,pfcrt CMNK,14,1,1,,10,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
SR1LIB,https://watermark.silverchair.com/41-8-1079.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAm8wggJrBgkqhkiG9w0BBwagggJcMIICWAIBADCCAlEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMbZKrVh8zBti3HrkSAgEQgIICIigY8654sdX-z002kTGsdKbUfAeZOyPbVaYJtmMFn2QdEWwLFrjAK9gjc4FpWtb_3W-8i8IRnZOMeV_m9ZGbG7LZYvo4xKbQtmwPpVqY19U9McDA2l0V7TvYeW6ewXFJgc-bzBA4yEmkLpDb2KZpmgMqvWG0arSRgfMPZ8GNteVmkU_zH9oyHxMsI9ZiKyHsSOR_cXjRbc1MbUydd3pjAew6fUwSHmiBS5-i5qIPsX5FO-C-cmuc9aERkl7s_lw1uQr6tgfrOCT2PJwW1vPdHiZuEt0aExaqHdLzhm_gJRhDUwNYJjRMwPOHF5WO_mug7Gc7BT3p_D22_6XGMJnl0l8dkaP32uRuTJdFxVwimSMTYDlsKXb_jUqJjSsHEnVlPy24wT-9PXyI09SStZK5JBFviu80pqJhGp2dSFcoi8H1eFIb_PgoqbDqvrlDe0A1UoFN5uTvyHv84SZINn1seI5sHM8wJUy5vuAcnIV7tMXjRU3N7p8r7yZk8suXn2ui8T6mOfvLVzYfo7H9SUwC0iSx_0owcsv-d959KF4B-Stls8_7AE7Z7-IOyAXDxuyJsn0WlGqMbn0SEkzPDN07c7y_nTFx0_GsPZ3n07-Ae06vvydoTuAyMqGy2RhfahTFg7eiwous87kcARbj9uEO2D6b0TSZDNDXcNBJA3WcoVbuu8Ki__GSXdtj0ojxNdPiJ36cckeZZzEJFqYi7fCgUoZ40g,Martinez‐Perez,2018,Liberia,Monrovia,-10.8074,6.3156,2016,2017,pfcrt 76T,24,15,15,,,,added by HYE (study not identified in WWARN PDMS)
SR1LIB,https://watermark.silverchair.com/41-8-1079.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAm8wggJrBgkqhkiG9w0BBwagggJcMIICWAIBADCCAlEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMbZKrVh8zBti3HrkSAgEQgIICIigY8654sdX-z002kTGsdKbUfAeZOyPbVaYJtmMFn2QdEWwLFrjAK9gjc4FpWtb_3W-8i8IRnZOMeV_m9ZGbG7LZYvo4xKbQtmwPpVqY19U9McDA2l0V7TvYeW6ewXFJgc-bzBA4yEmkLpDb2KZpmgMqvWG0arSRgfMPZ8GNteVmkU_zH9oyHxMsI9ZiKyHsSOR_cXjRbc1MbUydd3pjAew6fUwSHmiBS5-i5qIPsX5FO-C-cmuc9aERkl7s_lw1uQr6tgfrOCT2PJwW1vPdHiZuEt0aExaqHdLzhm_gJRhDUwNYJjRMwPOHF5WO_mug7Gc7BT3p_D22_6XGMJnl0l8dkaP32uRuTJdFxVwimSMTYDlsKXb_jUqJjSsHEnVlPy24wT-9PXyI09SStZK5JBFviu80pqJhGp2dSFcoi8H1eFIb_PgoqbDqvrlDe0A1UoFN5uTvyHv84SZINn1seI5sHM8wJUy5vuAcnIV7tMXjRU3N7p8r7yZk8suXn2ui8T6mOfvLVzYfo7H9SUwC0iSx_0owcsv-d959KF4B-Stls8_7AE7Z7-IOyAXDxuyJsn0WlGqMbn0SEkzPDN07c7y_nTFx0_GsPZ3n07-Ae06vvydoTuAyMqGy2RhfahTFg7eiwous87kcARbj9uEO2D6b0TSZDNDXcNBJA3WcoVbuu8Ki__GSXdtj0ojxNdPiJ36cckeZZzEJFqYi7fCgUoZ40g,Martinez‐Perez,2018,Liberia,Monrovia,-10.8074,6.3156,2016,2017,pfmdr1 1246Y,24,2,2,,,,added by HYE (study not identified in WWARN PDMS)
SR1LIB,https://watermark.silverchair.com/41-8-1079.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAm8wggJrBgkqhkiG9w0BBwagggJcMIICWAIBADCCAlEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMbZKrVh8zBti3HrkSAgEQgIICIigY8654sdX-z002kTGsdKbUfAeZOyPbVaYJtmMFn2QdEWwLFrjAK9gjc4FpWtb_3W-8i8IRnZOMeV_m9ZGbG7LZYvo4xKbQtmwPpVqY19U9McDA2l0V7TvYeW6ewXFJgc-bzBA4yEmkLpDb2KZpmgMqvWG0arSRgfMPZ8GNteVmkU_zH9oyHxMsI9ZiKyHsSOR_cXjRbc1MbUydd3pjAew6fUwSHmiBS5-i5qIPsX5FO-C-cmuc9aERkl7s_lw1uQr6tgfrOCT2PJwW1vPdHiZuEt0aExaqHdLzhm_gJRhDUwNYJjRMwPOHF5WO_mug7Gc7BT3p_D22_6XGMJnl0l8dkaP32uRuTJdFxVwimSMTYDlsKXb_jUqJjSsHEnVlPy24wT-9PXyI09SStZK5JBFviu80pqJhGp2dSFcoi8H1eFIb_PgoqbDqvrlDe0A1UoFN5uTvyHv84SZINn1seI5sHM8wJUy5vuAcnIV7tMXjRU3N7p8r7yZk8suXn2ui8T6mOfvLVzYfo7H9SUwC0iSx_0owcsv-d959KF4B-Stls8_7AE7Z7-IOyAXDxuyJsn0WlGqMbn0SEkzPDN07c7y_nTFx0_GsPZ3n07-Ae06vvydoTuAyMqGy2RhfahTFg7eiwous87kcARbj9uEO2D6b0TSZDNDXcNBJA3WcoVbuu8Ki__GSXdtj0ojxNdPiJ36cckeZZzEJFqYi7fCgUoZ40g,Martinez‐Perez,2018,Liberia,Monrovia,-10.8074,6.3156,2016,2017,pfmdr1 184F,24,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR1LIB,https://watermark.silverchair.com/41-8-1079.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAm8wggJrBgkqhkiG9w0BBwagggJcMIICWAIBADCCAlEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMbZKrVh8zBti3HrkSAgEQgIICIigY8654sdX-z002kTGsdKbUfAeZOyPbVaYJtmMFn2QdEWwLFrjAK9gjc4FpWtb_3W-8i8IRnZOMeV_m9ZGbG7LZYvo4xKbQtmwPpVqY19U9McDA2l0V7TvYeW6ewXFJgc-bzBA4yEmkLpDb2KZpmgMqvWG0arSRgfMPZ8GNteVmkU_zH9oyHxMsI9ZiKyHsSOR_cXjRbc1MbUydd3pjAew6fUwSHmiBS5-i5qIPsX5FO-C-cmuc9aERkl7s_lw1uQr6tgfrOCT2PJwW1vPdHiZuEt0aExaqHdLzhm_gJRhDUwNYJjRMwPOHF5WO_mug7Gc7BT3p_D22_6XGMJnl0l8dkaP32uRuTJdFxVwimSMTYDlsKXb_jUqJjSsHEnVlPy24wT-9PXyI09SStZK5JBFviu80pqJhGp2dSFcoi8H1eFIb_PgoqbDqvrlDe0A1UoFN5uTvyHv84SZINn1seI5sHM8wJUy5vuAcnIV7tMXjRU3N7p8r7yZk8suXn2ui8T6mOfvLVzYfo7H9SUwC0iSx_0owcsv-d959KF4B-Stls8_7AE7Z7-IOyAXDxuyJsn0WlGqMbn0SEkzPDN07c7y_nTFx0_GsPZ3n07-Ae06vvydoTuAyMqGy2RhfahTFg7eiwous87kcARbj9uEO2D6b0TSZDNDXcNBJA3WcoVbuu8Ki__GSXdtj0ojxNdPiJ36cckeZZzEJFqYi7fCgUoZ40g,Martinez‐Perez,2018,Liberia,Monrovia,-10.8074,6.3156,2016,2017,pfmdr1 86Y,24,9,9,,,,added by HYE (study not identified in WWARN PDMS)
SR1LIB,https://watermark.silverchair.com/41-8-1079.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAm8wggJrBgkqhkiG9w0BBwagggJcMIICWAIBADCCAlEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMbZKrVh8zBti3HrkSAgEQgIICIigY8654sdX-z002kTGsdKbUfAeZOyPbVaYJtmMFn2QdEWwLFrjAK9gjc4FpWtb_3W-8i8IRnZOMeV_m9ZGbG7LZYvo4xKbQtmwPpVqY19U9McDA2l0V7TvYeW6ewXFJgc-bzBA4yEmkLpDb2KZpmgMqvWG0arSRgfMPZ8GNteVmkU_zH9oyHxMsI9ZiKyHsSOR_cXjRbc1MbUydd3pjAew6fUwSHmiBS5-i5qIPsX5FO-C-cmuc9aERkl7s_lw1uQr6tgfrOCT2PJwW1vPdHiZuEt0aExaqHdLzhm_gJRhDUwNYJjRMwPOHF5WO_mug7Gc7BT3p_D22_6XGMJnl0l8dkaP32uRuTJdFxVwimSMTYDlsKXb_jUqJjSsHEnVlPy24wT-9PXyI09SStZK5JBFviu80pqJhGp2dSFcoi8H1eFIb_PgoqbDqvrlDe0A1UoFN5uTvyHv84SZINn1seI5sHM8wJUy5vuAcnIV7tMXjRU3N7p8r7yZk8suXn2ui8T6mOfvLVzYfo7H9SUwC0iSx_0owcsv-d959KF4B-Stls8_7AE7Z7-IOyAXDxuyJsn0WlGqMbn0SEkzPDN07c7y_nTFx0_GsPZ3n07-Ae06vvydoTuAyMqGy2RhfahTFg7eiwous87kcARbj9uEO2D6b0TSZDNDXcNBJA3WcoVbuu8Ki__GSXdtj0ojxNdPiJ36cckeZZzEJFqYi7fCgUoZ40g,Martinez‐Perez,2018,Liberia,Monrovia,-10.8074,6.3156,2016,2017,pfmdr1 copy number >1,24,0,0,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Liberia,,,,2012,2016,pfmdr1 86Y,22,16,16,,17,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Madagascar,,,,1998,2004,pfcrt 76T,3,0,0,Amodiaquine,6,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
17556614,http://www.ncbi.nlm.nih.gov/pubmed/17556614,Rason MA,2007,Madagascar,Saharevo,47.3333,-21.8167,2004,2004,pfcrt 76T,64,0,0,Amodiaquine,1,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,
17556614,http://www.ncbi.nlm.nih.gov/pubmed/17556614,Rason MA,2007,Madagascar,Saharevo,47.3333,-21.8167,2004,2004,pfmdr1 86Y,64,48,48,Amodiaquine,1,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,
17556614,http://www.ncbi.nlm.nih.gov/pubmed/17556614,Rason MA,2007,Madagascar,Sainte Marie,46.9667,-16.1333,2004,2004,pfcrt 76T,26,0,0,Amodiaquine,2,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,
17556614,http://www.ncbi.nlm.nih.gov/pubmed/17556614,Rason MA,2007,Madagascar,Sainte Marie,46.9667,-16.1333,2004,2004,pfmdr1 86Y,26,14,14,Amodiaquine,2,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,In vitro data available.
17556614,http://www.ncbi.nlm.nih.gov/pubmed/17556614,Rason MA,2007,Madagascar,Tsiroanomandidy,46.05,-18.7698,2004,2004,pfcrt 76T,27,1,1,Amodiaquine,3,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,
17556614,http://www.ncbi.nlm.nih.gov/pubmed/17556614,Rason MA,2007,Madagascar,Tsiroanomandidy,46.05,-18.7698,2004,2004,pfmdr1 86Y,27,17,17,Amodiaquine,3,Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.,
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Madagascar,Multisite,47.5167,-18.9333,2007,2007,pfcrt 76T,400,0,0,Amodiaquine,3,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,In vitro data
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Madagascar,Multisite,47.5167,-18.9333,2006,2006,pfcrt CIET,293,1,1,Amodiaquine,2,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,In vitro data. Mixed infections included in t
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Madagascar,Multisite,47.5167,-18.9333,2007,2007,pfcrt CIET,400,0,0,Amodiaquine,3,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,In vitro data. Mixed infections included in t
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Madagascar,Multisite,47.5167,-18.9333,2006,2006,pfmdr1 copy number >1,233,0,0,Lumefantrine,2,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,In vitro data. Mixed infections included in t
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Madagascar,Multisite,47.5167,-18.9333,2007,2007,pfmdr1 copy number >1,233,0,0,Lumefantrine,3,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,In vitro data. Mixed infections included in t
19704124,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772329&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2009,Madagascar,,,,2006,2006,pfcrt 76T,293,1,1,Amodiaquine,2,Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.,In vitro data
20967251,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2954150&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Madagascar,"Ejeda, Ihosy, Maevatanana, Mian- drivazo, Tsiroanomandidy, Moramanga, Farafangana and Andapa",,,2006,2007,pfcrt 76T,666,2,2,Amodiaquine,0,"Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.",post treatment (CQ) genotypes and in vitro da
20967251,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2954150&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Madagascar,"Ejeda, Ihosy, Maevatanana, Mian- drivazo, Tsiroanomandidy, Moramanga, Farafangana and Andapa",,,2006,2007,pfmdr1 1246Y,240,80,80,Amodiaquine,0,"Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.",post treatment (CQ) genotypes and in vitro da
20967251,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2954150&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Madagascar,"Ejeda, Ihosy, Maevatanana, Mian- drivazo, Tsiroanomandidy, Moramanga, Farafangana and Andapa",,,2006,2007,pfmdr1 184F,240,172,172,Lumefantrine,0,"Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.",post treatment (CQ) genotypes and in vitro da
20967251,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2954150&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Madagascar,"Ejeda, Ihosy, Maevatanana, Mian- drivazo, Tsiroanomandidy, Moramanga, Farafangana and Andapa",,,2006,2007,pfmdr1 86Y,240,147,147,Amodiaquine,0,"Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.",post treatment (CQ) genotypes and in vitro da
20967251,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2954150&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Madagascar,"Ejeda, Ihosy, Maevatanana, Mian- drivazo, Tsiroanomandidy, Moramanga, Farafangana and Andapa",,,2006,2007,pfmdr1 copy number >1,290,0,0,Lumefantrine,0,"Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.",post treatment (CQ) genotypes and in vitro da
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Madagascar,,,,2006,2007,pfcrt 76T,40,0,0,Amodiaquine,1,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Madagascar,,,,2014,2014,pfcrt 76K/T,4,0,0,,1,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Madagascar,,,,2014,2014,pfcrt 76T,4,0,0,,1,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Madagascar,,,,2014,2014,pfcrt CIET,4,0,0,,1,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Madagascar,,,,2014,2014,pfcrt CMNK,4,4,4,,1,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
1MLW,https://www.nejm.org/doi/10.1056/NEJMoa062032?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov,Laufer,2006,Malawi,Blantyre,35.0058,-15.7861,2005,2005,pfcrt 76T,199,0,0,,,,added by HYE (study not identified in WWARN PDMS)
17553226,http://www.ncbi.nlm.nih.gov/pubmed/17553226,Juliano JJ,2007,Malawi,Blantyre,35.0058,-15.7861,2004,2004,pfcrt 76K/T,27,1,1,Amodiaquine,1,"Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi.",
17553226,http://www.ncbi.nlm.nih.gov/pubmed/17553226,Juliano JJ,2007,Malawi,Blantyre,35.0058,-15.7861,2004,2004,pfcrt 76T,27,0,1,Amodiaquine,1,"Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi.",
17556619,http://www.ncbi.nlm.nih.gov/pubmed/17556619,Nkhoma S,2007,Malawi,Blantyre,35.0058,-15.7861,2003,2004,pfcrt 76T,56,0,0,Amodiaquine,0,In vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi.,
17556619,http://www.ncbi.nlm.nih.gov/pubmed/17556619,Nkhoma S,2007,Malawi,Blantyre,35.0058,-15.7861,2003,2004,pfmdr1 1246D/Y,56,2,2,Amodiaquine,0,In vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi.,In vitro data available.
17556619,http://www.ncbi.nlm.nih.gov/pubmed/17556619,Nkhoma S,2007,Malawi,Blantyre,35.0058,-15.7861,2003,2004,pfmdr1 1246Y,56,0,0,Amodiaquine,0,In vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi.,In vitro data available.
17556619,http://www.ncbi.nlm.nih.gov/pubmed/17556619,Nkhoma S,2007,Malawi,Blantyre,35.0058,-15.7861,2003,2004,pfmdr1 86Y,56,1,1,Amodiaquine,0,In vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi.,In vitro data available.
17553226,http://www.ncbi.nlm.nih.gov/pubmed/17553226,Juliano JJ,2007,Malawi,"Mpemba, Madziabango",34.9663,-15.8877,2004,2004,pfcrt 76K/T,60,21,21,Amodiaquine,2,"Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi.",
17553226,http://www.ncbi.nlm.nih.gov/pubmed/17553226,Juliano JJ,2007,Malawi,"Mpemba, Madziabango",34.9663,-15.8877,2004,2004,pfcrt 76T,60,0,21,Amodiaquine,2,"Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi.",
18270569,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2229666&tool=pmcentrez&rendertype=abstract,Bell DJ,2008,Malawi,Blantyre,35.0058,-15.7861,2003,2005,pfcrt 76T,244,0,0,Amodiaquine,0,"Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.",Clinical SP and SP combinations data and post
18270569,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2229666&tool=pmcentrez&rendertype=abstract,Bell DJ,2008,Malawi,Blantyre,35.0058,-15.7861,2003,2005,pfmdr1 86Y,244,25,25,Amodiaquine,0,"Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.",Clinical SP and SP combinations data and post
19624477,http://www.ncbi.nlm.nih.gov/pubmed/19624477,Bridges DJ,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfcrt 76T,148,0,0,Amodiaquine,2,Low level genotypic chloroquine resistance near Malawi's northern border with Tanzania.,
SR1MAL,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746100/,Nkhoma S,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfmdr1 1246D/Y,160,3,3,,,,added by HYE (study not identified in WWARN PDMS)
SR1MAL,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746100/,Nkhoma S,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfmdr1 1246Y,160,3,6,,,,added by HYE (study not identified in WWARN PDMS)
SR1MAL,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746100/,Nkhoma S,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfmdr1 184F,160,25,39,,,,added by HYE (study not identified in WWARN PDMS)
SR1MAL,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746100/,Nkhoma S,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfmdr1 184Y/F,160,14,14,,,,added by HYE (study not identified in WWARN PDMS)
SR1MAL,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746100/,Nkhoma S,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfmdr1 86N/Y,160,20,20,,,,added by HYE (study not identified in WWARN PDMS)
SR1MAL,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746100/,Nkhoma S,2009,Malawi,Blantyre,35.0058,-15.7861,2007,2007,pfmdr1 86Y,160,23,43,,,,added by HYE (study not identified in WWARN PDMS)
20662717,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380613/pdf/nihms371461.pdf,Laufer MK,2010,Malawi,Blantyre,35.0058,-15.7861,2005,2005,pfcrt 76T,210,0,0,Amodiaquine,2,Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites.,Pfcrt-flanking microsatellites analysed.
22912697,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3422316&tool=pmcentrez&rendertype=abstract,Laufer MK,2012,Malawi,Ndirande,35.0416,-15.7697,2007,2008,pfcrt 76K/T,911,2,2,Amodiaquine,0,"A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.",
22912697,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3422316&tool=pmcentrez&rendertype=abstract,Laufer MK,2012,Malawi,Ndirande,35.0416,-15.7697,2007,2008,pfcrt 76T,911,0,2,Amodiaquine,0,"A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.",
24723474,http://www.ncbi.nlm.nih.gov/pubmed/24723474,Frosch AEP,2014,Malawi,"Blantyre, Lilongwe,Mwanza, Chiradzulu, Phalombe, Nkhotakota, Rumphi, Karonga", ,,2009,2009,pfcrt 76K/T,685,1,1,Amodiaquine,0,Return of Widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi.,
24723474,http://www.ncbi.nlm.nih.gov/pubmed/24723474,Frosch AEP,2014,Malawi,"Blantyre, Lilongwe,Mwanza, Chiradzulu, Phalombe, Nkhotakota, Rumphi, Karonga", ,,2009,2009,pfcrt 76T,685,0,0,Amodiaquine,0,Return of Widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi.,
555,http://www.ncbi.nlm.nih.gov/pubmed/?term=27899115,"Ravenhall M, Benavente ED, Mipando M, Jensen AT, Sutherland CJ, Roper C, Sepúlveda N, Kwiatkowski DP, Montgomery J, Phiri KS, Terlouw A, Craig A, Campino S, Ocholla H, Clark TG",2016,Malawi,"Chikwawa, Zomba",34.8267,-16.0191,2010,2012,pfcrt 76T,220,0,0,Amodiaquine,1,Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.,
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Malawi,,,,2011,2014,pfcrt 76K/T,2,0,0,,2,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Malawi,,,,2011,2014,pfcrt 76T,2,0,0,,2,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Malawi,,,,2011,2014,pfcrt CIET,2,0,0,,2,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Malawi,,,,2011,2014,pfcrt CMNK,2,2,2,,2,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Mali,,,,1998,2004,pfcrt 76T,3,3,3,Amodiaquine,8,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
18337343,http://www.ncbi.nlm.nih.gov/pubmed/18337343,Djimdé AA,2008,Mali,Bougoula-Hameau,-6.91667,10.7833,2002,2004,pfcrt 76T,170,128,128,Amodiaquine,0,"Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.","Clinical ASAQ, AS+SP data and post-treatment "
18337343,http://www.ncbi.nlm.nih.gov/pubmed/18337343,Djimdé AA,2008,Mali,Bougoula-Hameau,-6.91667,10.7833,2002,2004,pfmdr1 86Y,170,98,98,Amodiaquine,0,"Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.","Clinical ASAQ, AS+SP data and post-treatment "
19245687,http://www.ncbi.nlm.nih.gov/pubmed/?term=19245687,"Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK",2009,Mali,Kolle,-7.4729,11.3417,2003,2004,pfcrt 76T,172,111,111,Amodiaquine,2,"Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.",
19245687,http://www.ncbi.nlm.nih.gov/pubmed/?term=19245687,"Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK",2009,Mali,Kolle,-7.4729,11.3417,2003,2004,pfmdr1 86Y,169,60,60,Amodiaquine,2,"Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.",
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Mali,,,,2005,2009,pfmdr1 copy number >1,6,0,0,Lumefantrine,5,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Mali,,,,2005,2006,pfcrt 76T,17,10,10,Amodiaquine,12,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
23893800,http://www.ncbi.nlm.nih.gov/pubmed/23893800,Doumbo S,2013,Mali,Fana,-6.94731,12.7872,2005,2006,pfcrt 76T,16,11,11,Amodiaquine,0,"[Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali]",
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Mali,,,,2004,2006,pfcrt 76K/T,26,0,0,Amodiaquine,6,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Mali,,,,2006,2007,pfcrt 76K/T,29,4,4,Amodiaquine,7,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Mali,,,,2004,2006,pfcrt 76T,26,18,18,Amodiaquine,6,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Mali,,,,2006,2007,pfcrt 76T,29,20,24,Amodiaquine,7,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
500,http://www.ncbi.nlm.nih.gov/pubmed/?term=27662368,"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, Coumare S, Bahonan S, Sangare B, Dicko Y, Diallo N, Tembely A, Traore D, Niangaly H, Dao F, Haidara A, Dicko A, Doumbo OK, Djimde AA",2016,Mali,Koutiala,-5.4625,12.382,2012,2012,pfcrt 76T,191,130,130,Amodiaquine,1,Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.,
500,http://www.ncbi.nlm.nih.gov/pubmed/?term=27662368,"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, Coumare S, Bahonan S, Sangare B, Dicko Y, Diallo N, Tembely A, Traore D, Niangaly H, Dao F, Haidara A, Dicko A, Doumbo OK, Djimde AA",2016,Mali,Koutiala,-5.4625,12.382,2014,2014,pfcrt 76T,132,94,94,Amodiaquine,2,Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.,
500,http://www.ncbi.nlm.nih.gov/pubmed/?term=27662368,"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, Coumare S, Bahonan S, Sangare B, Dicko Y, Diallo N, Tembely A, Traore D, Niangaly H, Dao F, Haidara A, Dicko A, Doumbo OK, Djimde AA",2016,Mali,Koutiala,-5.4625,12.382,2012,2012,pfmdr1 86Y,191,51,51,Amodiaquine,1,Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.,
500,http://www.ncbi.nlm.nih.gov/pubmed/?term=27662368,"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, Coumare S, Bahonan S, Sangare B, Dicko Y, Diallo N, Tembely A, Traore D, Niangaly H, Dao F, Haidara A, Dicko A, Doumbo OK, Djimde AA",2016,Mali,Koutiala,-5.4625,12.382,2014,2014,pfmdr1 86Y,99,21,21,Amodiaquine,2,Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Mali,,,,2012,2015,pfcrt 76T,4,1,2,Amodiaquine,17,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Mali,,,,2012,2015,pfcrt CIET,4,1,2,Amodiaquine,13,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
572,http://www.ncbi.nlm.nih.gov/pubmed/?term=28797263,"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A",2017,Mali,Bafoulabe,-10.8346,13.8093,2014,2014,pfcrt 76T,57,51,51,Amodiaquine,2,"Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.",
572,http://www.ncbi.nlm.nih.gov/pubmed/?term=28797263,"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A",2017,Mali,Bafoulabe,-10.8346,13.8093,2014,2014,pfmdr1 86Y,54,13,13,Amodiaquine,2,"Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.",
558,http://www.ncbi.nlm.nih.gov/pubmed/?term=28148267,"Dama S, Niangaly H, Ouattara A, Sagara I, Sissoko S, Traore OB, Bamadio A, Dara N, Djimde M, Alhousseini ML, Goita S, Maiga H, Dara A, Doumbo OK, Djimde AA",2017,Mali,Bamako,-8.1356,12.6129,2014,2014,pfcrt 76T,170,130,130,Amodiaquine,1,Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.,
558,http://www.ncbi.nlm.nih.gov/pubmed/?term=28148267,"Dama S, Niangaly H, Ouattara A, Sagara I, Sissoko S, Traore OB, Bamadio A, Dara N, Djimde M, Alhousseini ML, Goita S, Maiga H, Dara A, Doumbo OK, Djimde AA",2017,Mali,Bamako,-8.1356,12.6129,2014,2014,pfmdr1 86Y,158,46,46,Amodiaquine,1,Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.,
612,http://www.ncbi.nlm.nih.gov/pubmed/?term=28916443,"Koita OA, Sangaré L, Miller HD, Sissako A, Coulibaly M, Thompson TA, Fongoro S, Diarra Y, Ba M, Maiga A, Diallo B, Mushatt DM, Mather FJ, Shaffer JG, Anwar AH, Krogstad DJ",2017,Mali,Bamako,-8.1356,12.6129,2013,2015,pfcrt 76T,66,29,29,Amodiaquine,1,"AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.",
612,http://www.ncbi.nlm.nih.gov/pubmed/?term=28916443,"Koita OA, Sangaré L, Miller HD, Sissako A, Coulibaly M, Thompson TA, Fongoro S, Diarra Y, Ba M, Maiga A, Diallo B, Mushatt DM, Mather FJ, Shaffer JG, Anwar AH, Krogstad DJ",2017,Mali,Bamako,-8.1356,12.6129,2013,2015,pfcrt CIET,66,29,29,Amodiaquine,1,"AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.",
572,http://www.ncbi.nlm.nih.gov/pubmed/?term=28797263,"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A",2017,Mali,Kita,-9.4895,13.0341,2014,2014,pfcrt 76T,48,44,44,Amodiaquine,1,"Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.",
572,http://www.ncbi.nlm.nih.gov/pubmed/?term=28797263,"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A",2017,Mali,Kita,-9.4895,13.0341,2014,2014,pfmdr1 86Y,42,8,8,Amodiaquine,1,"Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.",
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Mali,,,,2012,2016,pfmdr1 86Y,4,2,2,,13,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Mauritania,,,,1998,2004,pfcrt 76T,1,0,0,Amodiaquine,7,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Mauritania,,,,2005,2009,pfmdr1 copy number >1,3,0,0,Lumefantrine,8,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Mauritania,,,,2006,2006,pfcrt 76T,1,0,0,Amodiaquine,13,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Ayoun el Atrous,-9.62316,16.6587,2010,2010,pfcrt 76K/T,56,8,8,Amodiaquine,1,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Ayoun el Atrous,-9.62316,16.6587,2010,2010,pfcrt 76T,56,36,44,Amodiaquine,1,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Ayoun el Atrous,-9.62316,16.6587,2010,2010,pfmdr1 1246Y,37,0,0,Amodiaquine,1,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Ayoun el Atrous,-9.62316,16.6587,2010,2010,pfmdr1 184F,43,29,29,Lumefantrine,1,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Ayoun el Atrous,-9.62316,16.6587,2010,2010,pfmdr1 86Y,50,15,15,Amodiaquine,1,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Ayoun el Atrous,-9.62316,16.6587,2010,2010,pfmdr1 copy number >1,7,0,0,Lumefantrine,1,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfcrt 76K/T,137,15,15,Amodiaquine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfcrt 76T,137,80,95,Amodiaquine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfmdr1 1246Y,83,2,2,Amodiaquine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfmdr1 184F,127,81,81,Lumefantrine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfmdr1 86Y,132,30,30,Amodiaquine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfmdr1 copy number = 2,88,9,9,Lumefantrine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Kobenni,-9.41323,15.8175,2010,2010,pfmdr1 copy number = 3,88,1,1,Lumefantrine,2,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Tintane,-10.1636,16.3915,2010,2010,pfcrt 76K/T,87,10,10,Amodiaquine,3,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Tintane,-10.1636,16.3915,2010,2010,pfcrt 76T,87,44,54,Amodiaquine,3,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Tintane,-10.1636,16.3915,2010,2010,pfmdr1 1246Y,70,0,0,Amodiaquine,3,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.","In vitro data. Pfcrt was also analysed, but t"
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Tintane,-10.1636,16.3915,2010,2010,pfmdr1 184F,77,57,57,Lumefantrine,3,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Tintane,-10.1636,16.3915,2010,2010,pfmdr1 86Y,82,16,16,Amodiaquine,3,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
564,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,Mauritania,Tintane,-10.1636,16.3915,2010,2010,pfmdr1 copy number >1,7,0,0,Lumefantrine,3,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2006,2006,pfcrt 76T,641,616,616,Amodiaquine,1,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2007,2007,pfcrt 76T,610,557,557,Amodiaquine,2,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2008,2008,pfcrt 76T,419,319,319,Amodiaquine,3,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2009,2009,pfcrt 76T,224,102,102,Amodiaquine,4,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2010,2010,pfcrt 76T,309,100,100,Amodiaquine,5,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2006,2006,pfmdr1 86Y,1247,931,931,Amodiaquine,1,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2007,2007,pfmdr1 86Y,677,615,615,Amodiaquine,2,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2008,2008,pfmdr1 86Y,476,309,309,Amodiaquine,3,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2009,2009,pfmdr1 86Y,455,256,256,Amodiaquine,4,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2010,2010,pfmdr1 86Y,379,117,117,Amodiaquine,5,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2007,2007,pfmdr1 copy number >1,610,0,0,Lumefantrine,2,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2006,2006,pfmdr1 copy number >1,641,0,0,Lumefantrine,1,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2008,2008,pfmdr1 copy number >1,419,0,0,Lumefantrine,3,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2010,2010,pfmdr1 copy number >1,309,0,0,Lumefantrine,5,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
22022487,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195082&tool=pmcentrez&rendertype=abstract,Raman J,2011,Mozambique,Gaza Province,32.7181,-23.0222,2009,2009,pfmdr1 copy number >1,224,0,0,Lumefantrine,4,"Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.",Multicentre study
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfcrt 76K/T,136,41,41,Amodiaquine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfcrt 76T,136,54,95,Amodiaquine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfcrt CIET,136,54,54,Amodiaquine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfmdr1 184F,136,25,30,Lumefantrine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfmdr1 184Y/F,136,5,5,Lumefantrine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfmdr1 86N/Y,136,34,34,Amodiaquine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,Linga Linga,35.4042,-23.717,2009,2009,pfmdr1 86Y,136,48,82,Amodiaquine,1,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfcrt 76K/T,195,55,55,Amodiaquine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfcrt 76T,195,49,104,Amodiaquine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfcrt CIET,195,49,49,Amodiaquine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfmdr1 184F,195,39,84,Lumefantrine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfmdr1 184Y/F,195,45,45,Lumefantrine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfmdr1 86N/Y,195,82,82,Amodiaquine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
23382159,http://www.ncbi.nlm.nih.gov/pubmed/23382159,Thomsen TT,2013,Mozambique,"Linga Linga, Furvela",35.4042,-23.717,2010,2010,pfmdr1 86Y,195,29,111,Amodiaquine,2,"Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.",Prevalence of pfmdr1 184: not sure if the fre
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2003,2005,pfmdr1 1246D/Y,121,24,24,Amodiaquine,0,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2010,2012,pfmdr1 1246D/Y,337,3,3,Amodiaquine,1,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2003,2005,pfmdr1 1246Y,121,7,31,Amodiaquine,0,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2010,2012,pfmdr1 1246Y,337,8,11,Amodiaquine,1,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2003,2005,pfmdr1 184F,62,12,13,Lumefantrine,0,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2010,2012,pfmdr1 184F,348,79,80,Lumefantrine,1,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2003,2005,pfmdr1 184Y/F,62,1,1,Lumefantrine,0,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2010,2012,pfmdr1 184Y/F,348,1,1,Lumefantrine,1,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2003,2005,pfmdr1 86N/Y,133,29,29,Amodiaquine,0,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2010,2012,pfmdr1 86N/Y,340,43,43,Amodiaquine,1,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2003,2005,pfmdr1 86Y,133,26,55,Amodiaquine,0,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
25098280,http://www.ncbi.nlm.nih.gov/pubmed/25098280,Lobo E,2014,Mozambique,Maputo,32.5833,-25.9667,2010,2012,pfmdr1 86Y,340,249,292,Amodiaquine,1,Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Mozambique,,,,2012,2015,pfcrt 76T,10,1,1,Amodiaquine,9,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Mozambique,,,,2012,2015,pfcrt CIET,10,1,1,Amodiaquine,11,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
566,http://www.ncbi.nlm.nih.gov/pubmed/?term=28465550,"Galatas B, Nhamussua L, Candrinho B, Mabote L, Cisteró P, Gupta H, Rabinovich R, Menéndez C, Macete E, Saute F, Mayor A, Alonso P, Bassat Q, Aide P",2017,Mozambique,Manhica,32.8031,-25.4033,2015,2015,pfcrt 76K/T,108,4,4,Amodiaquine,1,"In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies.",
566,http://www.ncbi.nlm.nih.gov/pubmed/?term=28465550,"Galatas B, Nhamussua L, Candrinho B, Mabote L, Cisteró P, Gupta H, Rabinovich R, Menéndez C, Macete E, Saute F, Mayor A, Alonso P, Bassat Q, Aide P",2017,Mozambique,Manhica,32.8031,-25.4033,2015,2015,pfcrt 76T,108,1,5,Amodiaquine,1,"In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies.",
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Mozambique,,,,2014,2014,pfcrt 76K/T,12,0,0,,3,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Mozambique,,,,2014,2014,pfcrt 76T,12,0,0,,3,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Mozambique,,,,2014,2014,pfcrt CIET,12,0,0,,3,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Mozambique,,,,2014,2014,pfcrt CMNK,12,12,12,,3,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Chokwe,32.9832,-24.5323,2015,2015,pfmdr1 184F,87,39,39,Lumefantrine,2,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Chokwe,32.9832,-24.5323,2015,2015,pfmdr1 86Y,87,6,6,Amodiaquine,2,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Dondo,34.7409,-19.6115,2015,2015,pfmdr1 184F,88,38,38,Lumefantrine,1,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Dondo,34.7409,-19.6115,2015,2015,pfmdr1 86Y,88,4,4,Amodiaquine,1,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Moatize,33.7238,-16.1171,2015,2015,pfmdr1 184F,89,42,42,Lumefantrine,1,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Moatize,33.7238,-16.1171,2015,2015,pfmdr1 86Y,89,0,0,Amodiaquine,1,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Montepuez,38.9981,-13.134,2015,2015,pfmdr1 184F,87,45,45,Lumefantrine,1,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
599,http://www.ncbi.nlm.nih.gov/pubmed/?term=29260689,"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A",2018,Mozambique,Montepuez,38.9981,-13.134,2015,2015,pfmdr1 86Y,87,1,1,Amodiaquine,1,"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.",
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Mozambique,,,,2012,2016,pfmdr1 86Y,14,1,1,,3,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
1NIG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654903/,Laminou Ibrahim,2009,Niger,Zindarou and Banizoumbou,2.15,13.5667,2003,2006,pfcrt 76T,318,103,103,,,,added by HYE (study not identified in WWARN PDMS)
1NIG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654903/,Laminou Ibrahim,2009,Niger,Zindarou and Banizoumbou,2.15,13.5667,2003,2006,pfmdr1 86Y,86,61,61,,,,added by HYE (study not identified in WWARN PDMS)
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Niger,,,,2006,2006,pfcrt 76T,2,2,2,Amodiaquine,15,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
25506465,http://www.ncbi.nlm.nih.gov/pubmed/25506465,Salissou A,2014,Niger,Gaya,3.44667,11.8878,2011,2011,pfcrt 76T,26,3,3,Amodiaquine,0,Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal,
25506465,http://www.ncbi.nlm.nih.gov/pubmed/25506465,Salissou A,2014,Niger,Gaya,3.44667,11.8878,2011,2011,pfcrt 76T,26,1,1,Amodiaquine,0,Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal,
25506465,http://www.ncbi.nlm.nih.gov/pubmed/25506465,Salissou A,2014,Niger,Gaya,3.44667,11.8878,2011,2011,pfcrt CIET,26,3,3,Amodiaquine,0,Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal,
25506465,http://www.ncbi.nlm.nih.gov/pubmed/25506465,Salissou A,2014,Niger,Gaya,3.44667,11.8878,2011,2011,pfcrt CINT,26,1,1,Amodiaquine,0,Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal,
615,https://www.ncbi.nlm.nih.gov/pubmed/29486766,"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, Amambua-Ngwa A, D'Alessandro U, GuÃ©rin PJ, Fandeur T, Sibley CH.",2018,Niger,Gabi,8.08167,17.6078,2011,2012,pfmdr1 1246Y,121,5,5,,1,Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.,
615,https://www.ncbi.nlm.nih.gov/pubmed/29486766,"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, Amambua-Ngwa A, D'Alessandro U, GuÃ©rin PJ, Fandeur T, Sibley CH.",2018,Niger,Gabi,8.08167,17.6078,2011,2012,pfmdr1 184F,121,11,11,,1,Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.,
615,https://www.ncbi.nlm.nih.gov/pubmed/29486766,"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, Amambua-Ngwa A, D'Alessandro U, GuÃ©rin PJ, Fandeur T, Sibley CH.",2018,Niger,Gabi,8.08167,17.6078,2011,2012,pfmdr1 86Y,121,7,7,,1,Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.,
16837724,http://www.ncbi.nlm.nih.gov/pubmed/16837724,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfcrt 76K/T,101,16,16,Amodiaquine,0,Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.,Clinical AQ data available.
16837724,http://www.ncbi.nlm.nih.gov/pubmed/16837724,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfcrt 76T,101,63,79,Amodiaquine,0,Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.,Clinical AQ data available.
16837724,http://www.ncbi.nlm.nih.gov/pubmed/16837724,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfmdr1 86N/Y,101,29,29,Amodiaquine,0,Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.,Clinical AQ data available.
16837724,http://www.ncbi.nlm.nih.gov/pubmed/16837724,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfmdr1 86Y,101,28,57,Amodiaquine,0,Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.,Clinical AQ data available.
16874478,http://www.ncbi.nlm.nih.gov/pubmed/16874478,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2002,2004,pfcrt 76K/T,111,26,26,Amodiaquine,0,Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.,Clinical CQ data and post-treatment genotype 
16874478,http://www.ncbi.nlm.nih.gov/pubmed/16874478,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2002,2004,pfcrt 76T,111,63,89,Amodiaquine,0,Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.,Clinical CQ data and post-treatment genotype 
16874478,http://www.ncbi.nlm.nih.gov/pubmed/16874478,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2002,2004,pfmdr1 86N/Y,111,37,37,Amodiaquine,0,Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.,Clinical CQ data and post-treatment genotype 
16874478,http://www.ncbi.nlm.nih.gov/pubmed/16874478,Happi CT,2006,Nigeria,Ibadan,3.91667,7.39639,2002,2004,pfmdr1 86Y,111,39,76,Amodiaquine,0,Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.,Clinical CQ data and post-treatment genotype 
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Nigeria,,,,1998,2004,pfcrt 76T,1,0,0,Amodiaquine,4,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
17428334,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Ojurongbe O,2007,Nigeria,Osogbo,4.56122,7.76581,2004,2005,pfcrt 76K/T,116,19,19,Amodiaquine,0,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Clinical CQ data and post-treatment genotypes
17428334,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Ojurongbe O,2007,Nigeria,Osogbo,4.56122,7.76581,2004,2005,pfcrt 76T,116,86,105,Amodiaquine,0,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Clinical CQ data and post-treatment genotypes
17428334,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Ojurongbe O,2007,Nigeria,Osogbo,4.56122,7.76581,2004,2005,pfmdr1 184F,116,74,81,Lumefantrine,0,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Clinical CQ data and post-treatment genotypes
17428334,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Ojurongbe O,2007,Nigeria,Osogbo,4.56122,7.76581,2004,2005,pfmdr1 184Y/F,116,7,7,Lumefantrine,0,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Clinical CQ data and post-treatment genotypes
17428334,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Ojurongbe O,2007,Nigeria,Osogbo,4.56122,7.76581,2004,2005,pfmdr1 86N/Y,116,8,8,Amodiaquine,0,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Clinical CQ data and post-treatment genotypes
17428334,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855061&tool=pmcentrez&rendertype=abstract,Ojurongbe O,2007,Nigeria,Osogbo,4.56122,7.76581,2004,2005,pfmdr1 86Y,116,34,42,Amodiaquine,0,"Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.",Clinical CQ data and post-treatment genotypes
18399317,http://www.ncbi.nlm.nih.gov/pubmed/18399317,Tatfeng YM,2008,Nigeria,Benin City,5.6145,6.3176,2006,2006,pfcrt 76T,353,80,80,Amodiaquine,0,"Chloroquine prophylaxis associated with high prevalence of Plasmodium falciparum pfcrt K76T mutation in people with sickle-cell disease in Benin City, Nigeria.",Associations with sickle cell aneamia availab
2NGRA,https://www.researchgate.net/publication/23720598_High_prevalence_of_Plasmodium_falciparum_Pfmdr1_86Y_mutant_gene_in_sickle_cell_disease_in_Nigeria/link/5ae99b6ba6fdcc03cd903d5e/download,Agbonlahor,2008,Nigeria,Benin City,5.6037,6.335,2006,2006,pfmdr1 86Y,187,32,32,,,,added by HYE (study not identified in WWARN PDMS)
19953193,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,Folarin OA,2008,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfcrt 76K/T,78,8,8,Amodiaquine,0,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",
19953193,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,Folarin OA,2008,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfcrt 76T,78,47,55,Amodiaquine,0,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",
19953193,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,Folarin OA,2008,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfmdr1 184F,70,10,13,Lumefantrine,0,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",In vitro data available.
19953193,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,Folarin OA,2008,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfmdr1 184Y/F,70,3,3,Lumefantrine,0,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",In vitro data available.
19953193,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,Folarin OA,2008,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfmdr1 86N/Y,81,28,28,Amodiaquine,0,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",In vitro data available.
19953193,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785046/pdf/nihms75070.pdf,Folarin OA,2008,Nigeria,Ibadan,3.91667,7.39639,2005,2005,pfmdr1 86Y,81,27,55,Amodiaquine,0,"Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.",In vitro data available.
19075074,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650543&tool=pmcentrez&rendertype=abstract,Happi CT,2009,Nigeria,Ibadan,3.91667,7.39639,2006,2007,pfmdr1 1246D/Y,90,11,11,Amodiaquine,0,Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.,"Clinical data AL, post-treatment genotypes av"
19075074,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650543&tool=pmcentrez&rendertype=abstract,Happi CT,2009,Nigeria,Ibadan,3.91667,7.39639,2006,2007,pfmdr1 1246Y,90,10,21,Amodiaquine,0,Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.,"Clinical data AL, post-treatment genotypes av"
19075074,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650543&tool=pmcentrez&rendertype=abstract,Happi CT,2009,Nigeria,Ibadan,3.91667,7.39639,2006,2007,pfmdr1 184F,90,7,11,Lumefantrine,0,Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.,"Clinical data AL, post-treatment genotypes av"
19075074,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650543&tool=pmcentrez&rendertype=abstract,Happi CT,2009,Nigeria,Ibadan,3.91667,7.39639,2006,2007,pfmdr1 184Y/F,90,4,4,Lumefantrine,0,Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.,"Clinical data AL, post-treatment genotypes av"
19075074,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650543&tool=pmcentrez&rendertype=abstract,Happi CT,2009,Nigeria,Ibadan,3.91667,7.39639,2006,2007,pfmdr1 86N/Y,90,30,30,Amodiaquine,0,Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.,"Clinical data AL, post-treatment genotypes av"
19075074,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650543&tool=pmcentrez&rendertype=abstract,Happi CT,2009,Nigeria,Ibadan,3.91667,7.39639,2006,2007,pfmdr1 86Y,90,24,54,Amodiaquine,0,Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.,"Clinical data AL, post-treatment genotypes av"
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Lafia,8.51667,8.49167,2006,2007,pfcrt 76K/T,75,1,1,Amodiaquine,2,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Lafia,8.51667,8.49167,2006,2007,pfcrt 76T,75,70,71,Amodiaquine,2,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Lafia,8.51667,8.49167,2006,2007,pfcrt CIET,75,66,66,Amodiaquine,2,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Lafia,8.51667,8.49167,2006,2007,pfmdr1 86N/Y,75,7,7,Amodiaquine,2,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Lafia,8.51667,8.49167,2006,2007,pfmdr1 86Y,75,29,36,Amodiaquine,2,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Osogbo,4.56122,7.76581,2006,2007,pfcrt 76K/T,81,3,3,Amodiaquine,1,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Osogbo,4.56122,7.76581,2006,2007,pfcrt 76T,81,70,73,Amodiaquine,1,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Osogbo,4.56122,7.76581,2006,2007,pfcrt CIET,81,72,72,Amodiaquine,1,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Osogbo,4.56122,7.76581,2006,2007,pfmdr1 86N/Y,81,7,7,Amodiaquine,1,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
21120702,http://www.ncbi.nlm.nih.gov/pubmed/21120702,Ojurongbe O,2010,Nigeria,Osogbo,4.56122,7.76581,2006,2007,pfmdr1 86Y,81,28,35,Amodiaquine,1,Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.,
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Nigeria,,,,2005,2009,pfmdr1 copy number >1,2,0,0,Lumefantrine,9,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
SR1NGA,https://www.ajol.info/index.php/sajchh/article/view/70006/58075,Efunshile,2011,Nigeria,Sagamu ,3.6319,6.8322,2009,2009,pfcrt 76T,98,95,95,,,,added by HYE (study not identified in WWARN PDMS)
22302850,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3269269&tool=pmcentrez&rendertype=abstract,Gbotosho GO,2012,Nigeria,Ibadan,3.91667,7.39639,2004,2004,pfcrt 76T,70,55,55,Amodiaquine,1,Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure.,
22302850,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3269269&tool=pmcentrez&rendertype=abstract,Gbotosho GO,2012,Nigeria,Ibadan,3.91667,7.39639,2004,2004,pfcrt CIET,70,50,50,Amodiaquine,1,Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure.,Not clear how mixed infections were accounted
22302850,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3269269&tool=pmcentrez&rendertype=abstract,Gbotosho GO,2012,Nigeria,Ibadan,3.91667,7.39639,2004,2004,pfcrt CMNT,70,5,5,Amodiaquine,1,Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure.,Not clear how mixed infections were accounted
22302850,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3269269&tool=pmcentrez&rendertype=abstract,Gbotosho GO,2012,Nigeria,Ibadan,3.91667,7.39639,2004,2004,pfmdr1 86Y,70,32,32,Amodiaquine,1,Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure.,Not clear how mixed infections were accounted
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Nigeria,,,,2012,2012,pfcrt 76K/T,2,1,1,Amodiaquine,3,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Nigeria,,,,2012,2012,pfcrt 76T,2,1,2,Amodiaquine,3,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Nigeria,,,,2012,2012,pfcrt CIET,2,1,1,Amodiaquine,3,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Nigeria,,,,2012,2012,pfmdr1 86Y,2,0,0,Amodiaquine,3,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,Nigeria,,,,2012,2012,pfmdr1 copy number >1,2,0,0,Lumefantrine,3,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfcrt 76K/T,119,5,5,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfcrt 76T,119,109,114,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfcrt CIET,119,109,109,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfmdr1 1246D/Y,29,0,0,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfmdr1 1246Y,29,0,0,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfmdr1 184F,71,49,60,Lumefantrine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfmdr1 184Y/F,71,11,11,Lumefantrine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfmdr1 86N/Y,74,14,14,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
25928117,http://www.ncbi.nlm.nih.gov/pubmed/25928117,Oladipo OO,2015,Nigeria,Lagos,3.38457,6.51941,2007,2008,pfmdr1 86Y,74,46,60,Amodiaquine,1,"Persistence of chloroquine-resistant haplotypes of Plasmodium falcipum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.",
596,http://www.ncbi.nlm.nih.gov/pubmed/?term=27031449,"Balogun ST, Sandabe UK, Bdliya DN, Adedeji WA, Okon KO, Fehintola FA",2015,Nigeria,Maiduguri,13.1532,11.8226,2010,2010,pfcrt 76T,56,3,3,Amodiaquine,1,Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among almajirai in northeast Nigeria.,
596,http://www.ncbi.nlm.nih.gov/pubmed/?term=27031449,"Balogun ST, Sandabe UK, Bdliya DN, Adedeji WA, Okon KO, Fehintola FA",2015,Nigeria,Maiduguri,13.1532,11.8226,2010,2010,pfmdr1 86Y,52,0,0,Amodiaquine,1,Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among almajirai in northeast Nigeria.,asymptomatic
26808627,http://www.ncbi.nlm.nih.gov/pubmed/?term=26808627,"Agomo CO, Oyibo WA, Sutherland C, Hallet R, Oguike M",2016,Nigeria,Lagos,3.38457,6.51941,2011,2011,pfcrt 76K/T,54,12,12,Amodiaquine,1,"Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.",
26808627,http://www.ncbi.nlm.nih.gov/pubmed/?term=26808627,"Agomo CO, Oyibo WA, Sutherland C, Hallet R, Oguike M",2016,Nigeria,Lagos,3.38457,6.51941,2011,2011,pfcrt 76T,54,29,41,Amodiaquine,1,"Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.",
26808627,http://www.ncbi.nlm.nih.gov/pubmed/?term=26808627,"Agomo CO, Oyibo WA, Sutherland C, Hallet R, Oguike M",2016,Nigeria,Lagos,3.38457,6.51941,2011,2011,pfcrt CIET,54,29,29,Amodiaquine,1,"Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.",
26808627,http://www.ncbi.nlm.nih.gov/pubmed/?term=26808627,"Agomo CO, Oyibo WA, Sutherland C, Hallet R, Oguike M",2016,Nigeria,Lagos,3.38457,6.51941,2011,2011,pfcrt SMNT,54,0,0,Amodiaquine,1,"Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.",
26808627,http://www.ncbi.nlm.nih.gov/pubmed/?term=26808627,"Agomo CO, Oyibo WA, Sutherland C, Hallet R, Oguike M",2016,Nigeria,Lagos,3.38457,6.51941,2011,2011,pfmdr1 86Y,28,7,7,Amodiaquine,1,"Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.",Baseline samples from symptomatic pregnant women
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Nigeria,,,,2012,2015,pfcrt 76T,74,31,33,Amodiaquine,18,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Nigeria,,,,2012,2015,pfcrt CIET,74,31,33,Amodiaquine,14,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
2NGRA,https://www.ncbi.nlm.nih.gov/pubmed/29419995,Monjol,2017,Nigeria,Calabar,8.3417,4.9757,,,pfcrt 76T,100,28,28,,,,added by HYE (study not identified in WWARN PDMS)
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Nigeria,,,,2014,2014,pfcrt 76K/T,32,3,3,,11,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Nigeria,,,,2014,2014,pfcrt 76T,32,12,15,,11,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Nigeria,,,,2014,2014,pfcrt CIET,32,12,12,,11,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Nigeria,,,,2014,2014,pfcrt CMNK,32,17,17,,11,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
5NGRA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141860/,Diji-geske,2018,Nigeria,Ado-Odo/Ota,3.0576,6.6117,2015,2017,pfcrt 76T,106,45,45,,,,added by HYE (study not identified in WWARN PDMS)
3NGRA,https://www.sciencedirect.com/science/article/pii/S2314853517301609,Simon-Oke,2018,Nigeria,Akure,5.2058,7.2571,2015,2016,pfcrt 76T,100,95,95,,,,added by HYE (study not identified in WWARN PDMS)
4NGRA,https://www.sciencedirect.com/science/article/pii/S1567134818302582?via%3Dihub,Oboh,2018,Nigeria,Edo,5.8987,6.5438,2016,2017,pfcrt 76T,70,42,42,,,,added by HYE (study not identified in WWARN PDMS)
6NGRA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214618/,Folarin,2018,Nigeria,Ibadan,3.91667,7.39639, ,,pfcrt 76T,69,53,53,,,,added by HYE (study not identified in WWARN PDMS)
6NGRA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214618/,Folarin,2018,Nigeria,Ibadan,3.91667,7.39639, ,,pfmdr1 86Y,95,46,46,,,,added by HYE (study not identified in WWARN PDMS)
627,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,Kolapo Muyiwa Oyebola,2018,Nigeria,Lagos,3.38457,6.51941,2016,2016,pfcrt 76K/T,65,4,4,,1,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,
627,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,Kolapo Muyiwa Oyebola,2018,Nigeria,Lagos,3.38457,6.51941,2016,2016,pfcrt 76T,65,38,42,,1,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,
627,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,Kolapo Muyiwa Oyebola,2018,Nigeria,Lagos,3.38457,6.51941,2016,2016,pfmdr1 184F,65,38,51,,1,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,
627,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,Kolapo Muyiwa Oyebola,2018,Nigeria,Lagos,3.38457,6.51941,2016,2016,pfmdr1 184Y/F,65,13,13,,1,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,
627,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,Kolapo Muyiwa Oyebola,2018,Nigeria,Lagos,3.38457,6.51941,2016,2016,pfmdr1 86N/Y,65,7,7,,1,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,
627,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,Kolapo Muyiwa Oyebola,2018,Nigeria,Lagos,3.38457,6.51941,2016,2016,pfmdr1 86Y,65,56,63,,1,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,
4NGRA,https://www.sciencedirect.com/science/article/pii/S1567134818302582?via%3Dihub,Oboh,2018,Nigeria,Lagos,3.38457,6.51941,2016,2017,pfcrt 76T,41,26,26,,,,added by HYE (study not identified in WWARN PDMS)
SR2NGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976944/,Lawal,2018,Nigeria,Minna,6.5463,9.5836,2016,2016,pfmdr1 184F,7,0,0,,,,added by HYE (study not identified in WWARN PDMS)
SR2NGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976944/,Lawal,2018,Nigeria,Minna,6.5463,9.5836,2016,2016,pfmdr1 86Y,7,0,0,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Nigeria,,,,2012,2016,pfmdr1 86Y,87,22,22,,21,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfcrt 76K/T,104,14,14,Amodiaquine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfcrt 76T,104,63,77,Amodiaquine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfmdr1 1246D/Y,104,7,7,Amodiaquine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfmdr1 1246Y,104,5,12,Amodiaquine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfmdr1 184F,104,36,54,Lumefantrine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfmdr1 184Y/F,104,18,18,Lumefantrine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfmdr1 86N/Y,104,12,12,Amodiaquine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
21996622,http://www.ncbi.nlm.nih.gov/pubmed/21996622,Zeile I,2012,Rwanda,Butare,29.7373,-2.60273,2010,2010,pfmdr1 86Y,104,29,41,Amodiaquine,0,Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Mubuga,29.3133,-2.1346,2015,2015,pfmdr1 1246D/Y,197,19,19,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Mubuga,29.3133,-2.1346,2015,2015,pfmdr1 1246Y,197,16,35,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Mubuga,29.3133,-2.1346,2015,2015,pfmdr1 184F,175,42,100,Lumefantrine,2,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Mubuga,29.3133,-2.1346,2015,2015,pfmdr1 184Y/F,175,58,58,Lumefantrine,2,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Mubuga,29.3133,-2.1346,2015,2015,pfmdr1 86N/Y,196,28,28,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Mubuga,29.3133,-2.1346,2015,2015,pfmdr1 86Y,196,5,33,Amodiaquine,2,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Ruhuha,30.0592,-2.31204,2015,2015,pfmdr1 1246D/Y,178,29,29,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Ruhuha,30.0592,-2.31204,2015,2015,pfmdr1 1246Y,178,8,37,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Ruhuha,30.0592,-2.31204,2015,2015,pfmdr1 184F,171,53,107,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Ruhuha,30.0592,-2.31204,2015,2015,pfmdr1 184Y/F,171,54,54,Lumefantrine,1,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Ruhuha,30.0592,-2.31204,2015,2015,pfmdr1 86N/Y,186,31,31,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
502,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,Rwanda,Ruhuha,30.0592,-2.31204,2015,2015,pfmdr1 86Y,186,9,40,Amodiaquine,1,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,
16420686,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1363351&tool=pmcentrez&rendertype=abstract,Ferriera I,2006,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfmdr1 copy number >1,8,0,0,Lumefantrine,0,Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum.,"In vitro data on AQ, ARM and AS available."
17313506,http://www.ncbi.nlm.nih.gov/pubmed/17313506,Ferreira ID,2007,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfcrt 76T,70,70,70,Amodiaquine,0,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.","In vitro data on AQ, ARM and AS available."
17313506,http://www.ncbi.nlm.nih.gov/pubmed/17313506,Ferreira ID,2007,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfmdr1 1246D/Y,70,13,13,Amodiaquine,0,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.",In vitro data available.
17313506,http://www.ncbi.nlm.nih.gov/pubmed/17313506,Ferreira ID,2007,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfmdr1 1246Y,70,3,16,Amodiaquine,0,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.","In vitro data on AQ, ARM and AS available."
17313506,http://www.ncbi.nlm.nih.gov/pubmed/17313506,Ferreira ID,2007,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfmdr1 184F,70,53,53,Lumefantrine,0,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.","In vitro data on AQ, ARM and AS available."
17313506,http://www.ncbi.nlm.nih.gov/pubmed/17313506,Ferreira ID,2007,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfmdr1 86N/Y,70,10,10,Amodiaquine,0,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.","In vitro data on AQ, ARM and AS available."
17313506,http://www.ncbi.nlm.nih.gov/pubmed/17313506,Ferreira ID,2007,Sao Tome and Principe,Sao Tomé,6.73334,0.330192,2004,2004,pfmdr1 86Y,70,15,25,Amodiaquine,0,"In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.","In vitro data on AQ, ARM and AS available."
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Senegal,,,,1998,2004,pfcrt 76T,5,1,1,Amodiaquine,3,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
18523801,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2583234&tool=pmcentrez&rendertype=abstract,Sarr O,2008,Senegal,Pikine,-17.4,14.75,2004,2004,pfcrt 76T,68,40,40,Amodiaquine,0,"Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.",Clinical data AQ+SP available.
20352101,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2843705&tool=pmcentrez&rendertype=abstract,Bob NS,2010,Senegal,Dakar,-17.366,14.7645,2007,2007,pfcrt 76K/T,110,10,10,Amodiaquine,1,Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area.,Mild vs. Severe malaria
20352101,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2843705&tool=pmcentrez&rendertype=abstract,Bob NS,2010,Senegal,Dakar,-17.366,14.7645,2007,2007,pfcrt 76T,110,84,94,Amodiaquine,1,Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area.,Mild vs. Severe malaria
20352101,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2843705&tool=pmcentrez&rendertype=abstract,Bob NS,2010,Senegal,Dakar,-17.366,14.7645,2007,2007,pfcrt CIET,110,84,84,Amodiaquine,1,Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area.,Mild vs. Severe malaria
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Senegal,,,,2005,2009,pfmdr1 copy number >1,10,0,0,Lumefantrine,3,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
20439955,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2861372&tool=pmcentrez&rendertype=abstract,Andriantsoanirina V,2010,Senegal,,,,2005,2005,pfcrt 76T,2,1,1,Amodiaquine,16,Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.,travelers
22694921,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,Wurtz N,2012,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 1246Y,168,0,0,Amodiaquine,0,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",
22694921,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,Wurtz N,2012,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 184F,173,117,117,Lumefantrine,0,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",
22694921,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,Wurtz N,2012,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 184Y/F,173,0,0,Lumefantrine,0,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",
22694921,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,Wurtz N,2012,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 86N/Y,174,1,1,Amodiaquine,0,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",
22694921,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,Wurtz N,2012,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 86Y,174,29,30,Amodiaquine,0,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",
22694921,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,Wurtz N,2012,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 copy number = 2,167,1,1,Lumefantrine,0,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Mbour, Fatick, Bambey",-16.9667,14.4167,2009,2009,pfcrt 76K/T,146,14,14,Amodiaquine,1,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Mbour, Fatick, Bambey",-16.9667,14.4167,2010,2010,pfcrt 76K/T,139,11,11,Amodiaquine,2,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Mbour, Fatick, Bambey",-16.9667,14.4167,2009,2009,pfcrt 76T,146,29,43,Amodiaquine,1,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Mbour, Fatick, Bambey",-16.9667,14.4167,2010,2010,pfcrt 76T,139,24,35,Amodiaquine,2,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Mbour, Fatick, Bambey",-16.9667,14.4167,2009,2009,pfcrt CIET,146,29,29,Amodiaquine,1,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Mbour, Fatick, Bambey",-16.9667,14.4167,2010,2010,pfcrt CIET,139,24,24,Amodiaquine,2,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2004,2004,pfcrt 76T,79,51,51,Amodiaquine,5,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2005,2005,pfcrt 76T,98,32,32,Amodiaquine,6,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2006,2006,pfcrt 76T,82,48,48,Amodiaquine,7,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2009,2009,pfcrt 76T,37,23,23,Amodiaquine,8,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",In vitro data
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2006,2006,pfmdr1 86Y,82,18,18,Amodiaquine,7,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",Asymptomatic
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2004,2004,pfmdr1 86Y,79,21,21,Amodiaquine,5,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2005,2005,pfmdr1 86Y,98,19,19,Amodiaquine,6,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",
22706959,http://www.ncbi.nlm.nih.gov/pubmed/22706959,Ly O,2012,Senegal,Pikine,-17.4,14.75,2009,2009,pfmdr1 86Y,37,8,8,Amodiaquine,8,"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.",
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Tambacounda, Velingara, and Saraya",-13.6672,13.7689,2010,2010,pfcrt 76K/T,81,12,12,Amodiaquine,3,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Tambacounda, Velingara, and Saraya",-13.6672,13.7689,2010,2010,pfcrt 76T,81,16,28,Amodiaquine,3,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Tambacounda, Velingara, and Saraya",-13.6672,13.7689,2010,2010,pfcrt CIET,81,16,16,Amodiaquine,3,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Tambacounda, Velingara, Saraya",-13.6672,13.7689,2011,2011,pfcrt 76K/T,83,9,9,Amodiaquine,4,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Tambacounda, Velingara, Saraya",-13.6672,13.7689,2011,2011,pfcrt 76T,83,15,24,Amodiaquine,4,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
22927495,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516312&tool=pmcentrez&rendertype=abstract,Ndiaye M,2012,Senegal,"Tambacounda, Velingara, Saraya",-13.6672,13.7689,2011,2011,pfcrt CIET,83,15,15,Amodiaquine,4,Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.,
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfcrt 76K/T,156,18,18,Amodiaquine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro data
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfcrt 76T,156,68,86,Amodiaquine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro data
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 1246D/Y,156,0,0,Amodiaquine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 1246Y,156,2,2,Amodiaquine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 184F,156,77,78,Lumefantrine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 184Y/F,156,1,1,Lumefantrine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 86N/Y,161,2,2,Amodiaquine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro
23510258,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,Fall B,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 86Y,161,24,26,Amodiaquine,0,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro
23697703,http://www.ncbi.nlm.nih.gov/pubmed/?term=23697703,Pascual A,2013,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 copy number = 2,172,9,9,Lumefantrine,1,Plasmodium falciparum with multidrug resistance 1 gene duplications,In vitro data.
23697703,http://www.ncbi.nlm.nih.gov/pubmed/?term=23697703,Pascual A,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 copy number = 2,129,8,8,Lumefantrine,2,Plasmodium falciparum with multidrug resistance 1 gene duplications,In vitro data
23697703,http://www.ncbi.nlm.nih.gov/pubmed/?term=23697703,Pascual A,2013,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 copy number >1,172,9,9,Lumefantrine,1,Plasmodium falciparum with multidrug resistance 1 gene duplications,In vitro data.
23697703,http://www.ncbi.nlm.nih.gov/pubmed/?term=23697703,Pascual A,2013,Senegal,Dakar,-17.366,14.7645,2010,2011,pfmdr1 copy number >1,129,8,8,Lumefantrine,2,Plasmodium falciparum with multidrug resistance 1 gene duplications,In vitro data
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2008,2008,pfcrt 76T,35,8,8,Amodiaquine,1,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2009,2009,pfcrt 76T,35,13,13,Amodiaquine,2,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2010,2010,pfcrt 76T,5,2,2,Amodiaquine,3,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2008,2008,pfcrt CIET,35,8,8,Amodiaquine,1,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2009,2009,pfcrt CIET,35,13,13,Amodiaquine,2,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2010,2010,pfcrt CIET,5,2,2,Amodiaquine,3,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2010,2010,pfmdr1 184F,5,2,2,Lumefantrine,3,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2008,2008,pfmdr1 184F,19,13,13,Lumefantrine,1,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2009,2009,pfmdr1 184F,34,28,28,Lumefantrine,2,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2010,2010,pfmdr1 86Y,5,0,0,Amodiaquine,3,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2008,2008,pfmdr1 86Y,19,0,0,Amodiaquine,1,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
23617576,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3652725&tool=pmcentrez&rendertype=abstract,Lo AC,2013,Senegal,"Mbour, Bambey, Fatick",-16.9667,14.4167,2009,2009,pfmdr1 86Y,33,15,15,Amodiaquine,2,Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.,Article also contains prevalence after season
24314037,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3924193&tool=pmcentrez&rendertype=abstract,Van Tyne D,2013,Senegal,Thiès,-16.9,14.7667,2008,2011,pfmdr1 184F,360,202,224,Lumefantrine,0,Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.,"In vitro data. Pfcrt was also analysed, but t"
24314037,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3924193&tool=pmcentrez&rendertype=abstract,Van Tyne D,2013,Senegal,Thiès,-16.9,14.7667,2008,2011,pfmdr1 184Y/F,360,22,22,Lumefantrine,0,Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.,"In vitro data. Pfcrt was also analysed, but t"
24314037,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3924193&tool=pmcentrez&rendertype=abstract,Van Tyne D,2013,Senegal,Thiès,-16.9,14.7667,2008,2011,pfmdr1 86N/Y,340,7,7,Amodiaquine,0,Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.,Ex vivo data available
24314037,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3924193&tool=pmcentrez&rendertype=abstract,Van Tyne D,2013,Senegal,Thiès,-16.9,14.7667,2008,2011,pfmdr1 86Y,340,37,44,Amodiaquine,0,Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.,"In vitro data. Pfcrt was also analysed, but t"
594,http://www.ncbi.nlm.nih.gov/pubmed/?term=25199781,"Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, Nakoulima A, Diatta B, Fall KB, Mbaye PS, Diémé Y, Bercion R, Wade B, Pradines B",2014,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 1246Y,174,0,0,Amodiaquine,1,"Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.",
594,http://www.ncbi.nlm.nih.gov/pubmed/?term=25199781,"Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, Nakoulima A, Diatta B, Fall KB, Mbaye PS, Diémé Y, Bercion R, Wade B, Pradines B",2014,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 184F,174,125,125,Lumefantrine,1,"Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.",
594,http://www.ncbi.nlm.nih.gov/pubmed/?term=25199781,"Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, Nakoulima A, Diatta B, Fall KB, Mbaye PS, Diémé Y, Bercion R, Wade B, Pradines B",2014,Senegal,Dakar,-17.366,14.7645,2009,2010,pfmdr1 86Y,174,26,26,Amodiaquine,1,"Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.",
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Senegal,,,,2006,2007,pfcrt 76K/T,6,1,1,Amodiaquine,8,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Senegal,,,,2006,2007,pfcrt 76T,6,2,3,Amodiaquine,8,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfcrt 76T,102,36,36,Amodiaquine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfcrt CIET,102,32,32,Amodiaquine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfcrt CMET,102,4,4,Amodiaquine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfmdr1 184F,99,53,53,Lumefantrine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfmdr1 184Y/F,99,0,0,Lumefantrine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfmdr1 86N/Y,99,1,1,Amodiaquine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
515,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diemé Y, Wade B, Pradines B",2016,Senegal,Dakar,-17.366,14.7645,2013,2014,pfmdr1 86Y,99,5,6,Amodiaquine,1,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfcrt 76K/T,50,4,4,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfcrt 76T,50,0,4,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfmdr1 1246Y,50,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfmdr1 184F,50,34,35,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfmdr1 184Y/F,50,1,1,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfmdr1 86N/Y,50,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Dakar,-17.366,14.7645,2014,2014,pfmdr1 86Y,50,5,5,,,,added by HYE (study not identified in WWARN PDMS)
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfcrt 76K/T,60,1,1,Amodiaquine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfcrt 76T,60,12,13,Amodiaquine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfcrt 76T,50,10,10,Amodiaquine,2,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 1246Y,119,0,0,Amodiaquine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Asymptomatic
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 1246Y,50,0,0,Amodiaquine,2,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 184F,119,93,97,Lumefantrine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 184F,50,30,33,Lumefantrine,2,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 184Y/F,119,4,4,Lumefantrine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 184Y/F,50,3,3,Lumefantrine,2,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 86N/Y,87,1,1,Amodiaquine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 86N/Y,50,0,0,Amodiaquine,2,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 86Y,87,2,3,Amodiaquine,1,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
505,http://www.ncbi.nlm.nih.gov/pubmed/?term=27562216,"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, Yade MS, Diongue K, Gaye A, Ndiaye IM, Ndiaye T, Sy M, Diallo MA, Badiane AS, Ndiaye M, Seck MC, Sy N, Koita O, Krogstad DJ, Nwakanma D, Ndiaye D",2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 86Y,50,1,1,Amodiaquine,2,Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.,Ex vivo data available
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfcrt 76K/T,26,6,6,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfcrt 76K/T,120,8,8,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfcrt 76K/T,50,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfcrt 76T,26,10,16,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfcrt 76T,120,32,40,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfcrt 76T,50,9,9,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfmdr1 1246Y,26,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 1246Y,120,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 1246Y,50,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfmdr1 184F,26,15,15,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 184F,120,93,102,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 184F,50,32,35,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfmdr1 184Y/F,26,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 184Y/F,120,9,9,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 184Y/F,50,3,3,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfmdr1 86N/Y,26,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 86N/Y,120,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 86N/Y,50,0,0,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2011,2011,pfmdr1 86Y,26,3,3,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2012,2012,pfmdr1 86Y,120,1,1,,,,added by HYE (study not identified in WWARN PDMS)
3OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094217/,Dieye,2016,Senegal,Thies,-16.9249,14.7896,2013,2013,pfmdr1 86Y,50,1,1,,,,added by HYE (study not identified in WWARN PDMS)
1SEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817740/,Ndiaye,2017,Senegal,"Dakar, Thiese",-17.4677,14.7167,2013,2014,pfcrt 76T,82,7,7,,,,added by HYE (study not identified in WWARN PDMS)
1SEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817740/,Ndiaye,2017,Senegal,"Kédougou, Tambacounda, Vélingara",-12.2548,12.7033,2013,2014,pfcrt 76T,168,65,65,,,,added by HYE (study not identified in WWARN PDMS)
570,http://www.ncbi.nlm.nih.gov/pubmed/?term=28615016,"Mbaye A, Gaye A, Dieye B, Ndiaye YD, Bei AK, Affara M, Deme AB, Yade MS, Diongue K, Ndiaye IM, Ndiaye T, Sy M, Sy N, Koita O, Krogstad DJ, Volkman S, Nwakanma D, Ndiaye D",2017,Senegal,Pikine,-17.4,14.75,2014,2014,pfcrt 76K/T,54,3,3,Amodiaquine,1,"Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.",
570,http://www.ncbi.nlm.nih.gov/pubmed/?term=28615016,"Mbaye A, Gaye A, Dieye B, Ndiaye YD, Bei AK, Affara M, Deme AB, Yade MS, Diongue K, Ndiaye IM, Ndiaye T, Sy M, Sy N, Koita O, Krogstad DJ, Volkman S, Nwakanma D, Ndiaye D",2017,Senegal,Pikine,-17.4,14.75,2014,2014,pfcrt 76T,54,28,31,Amodiaquine,1,"Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.",
570,http://www.ncbi.nlm.nih.gov/pubmed/?term=28615016,"Mbaye A, Gaye A, Dieye B, Ndiaye YD, Bei AK, Affara M, Deme AB, Yade MS, Diongue K, Ndiaye IM, Ndiaye T, Sy M, Sy N, Koita O, Krogstad DJ, Volkman S, Nwakanma D, Ndiaye D",2017,Senegal,Pikine,-17.4,14.75,2014,2014,pfmdr1 86Y,54,6,6,Amodiaquine,1,"Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.",In vitro data
1SEN,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817740/,Ndiaye,2017,Senegal,"Podor, Richard Toll, Sakal, Louga",-14.9593,16.6601,2013,2014,pfcrt 76T,162,39,39,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Senegal,,,,2012,2016,pfmdr1 86Y,2,0,0,,22,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Sierra Leone,,,,2012,2015,pfcrt 76T,25,14,16,Amodiaquine,19,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Sierra Leone,,,,2012,2015,pfcrt CIET,25,14,16,Amodiaquine,22,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sierra Leone,,,,2014,2014,pfcrt 76K/T,9,2,2,,12,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sierra Leone,,,,2014,2014,pfcrt 76T,9,4,6,,12,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sierra Leone,,,,2014,2014,pfcrt CIET,9,4,4,,12,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sierra Leone,,,,2014,2014,pfcrt CMNK,9,3,3,,12,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Sierra Leone,,,,2012,2016,pfmdr1 86Y,32,12,12,,19,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
23272998,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3544602&tool=pmcentrez&rendertype=abstract,Vaughan-Williams CH,2012,South Africa,Umkhanyakude Health District,31.9027,-28.6914,2012,2012,pfcrt 76K/T,16,1,1,Amodiaquine,0,Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.,
23272998,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3544602&tool=pmcentrez&rendertype=abstract,Vaughan-Williams CH,2012,South Africa,Umkhanyakude Health District,31.9027,-28.6914,2012,2012,pfcrt 76T,16,3,4,Amodiaquine,0,Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.,
23272998,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3544602&tool=pmcentrez&rendertype=abstract,Vaughan-Williams CH,2012,South Africa,Umkhanyakude Health District,31.9027,-28.6914,2012,2012,pfcrt CIET,16,3,3,Amodiaquine,0,Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.,
23272998,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3544602&tool=pmcentrez&rendertype=abstract,Vaughan-Williams CH,2012,South Africa,Umkhanyakude Health District,31.9027,-28.6914,2012,2012,pfmdr1 86Y,16,0,0,Amodiaquine,0,Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.,
23272998,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3544602&tool=pmcentrez&rendertype=abstract,Vaughan-Williams CH,2012,South Africa,Umkhanyakude Health District,31.9027,-28.6914,2012,2012,pfmdr1 copy number >1,16,0,0,Lumefantrine,0,Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.,
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Africa,,,,2014,2014,pfcrt 76K/T,5,0,0,,14,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Africa,,,,2014,2014,pfcrt 76T,5,1,1,,14,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Africa,,,,2014,2014,pfcrt CIET,5,1,1,,14,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Africa,,,,2014,2014,pfcrt CMNK,5,4,4,,14,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,South Sudan,,,,2012,2012,pfcrt 76K/T,1,1,1,Amodiaquine,4,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,South Sudan,,,,2012,2012,pfcrt 76T,1,0,1,Amodiaquine,4,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,South Sudan,,,,2012,2012,pfcrt CIET,1,0,0,Amodiaquine,4,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,South Sudan,,,,2012,2012,pfmdr1 86Y,1,0,0,Amodiaquine,4,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
24028570,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3847303&tool=pmcentrez&rendertype=abstract,van Schalkwyk DA,2013,South Sudan,,,,2012,2012,pfmdr1 copy number >1,1,0,0,Lumefantrine,4,Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Sudan,,,,2014,2014,pfcrt 76K/T,6,0,0,,15,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Sudan,,,,2014,2014,pfcrt 76T,6,2,2,,15,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Sudan,,,,2014,2014,pfcrt CIET,6,2,2,,15,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,South Sudan,,,,2014,2014,pfcrt CMNK,6,4,4,,15,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,South Sudan,,,,2012,2016,pfmdr1 86Y,3,1,1,,7,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
20226032,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2848148&tool=pmcentrez&rendertype=abstract,Gadalla NB,2010,Sudan,Asar,30.0874,16.0858,2007,2007,pfcrt 76K/T,86,11,11,Amodiaquine,0,Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.,"Clinical CQ data, post-treatment D1-3 genotyp"
20226032,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2848148&tool=pmcentrez&rendertype=abstract,Gadalla NB,2010,Sudan,Asar,30.0874,16.0858,2007,2007,pfcrt 76T,86,67,78,Amodiaquine,0,Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.,"Clinical CQ data, post-treatment D1-3 genotyp"
20226032,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2848148&tool=pmcentrez&rendertype=abstract,Gadalla NB,2010,Sudan,Asar,30.0874,16.0858,2007,2007,pfcrt CIET,86,67,67,Amodiaquine,0,Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.,"Clinical CQ data, post-treatment D1-3 genotyp"
20682863,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2911166&tool=pmcentrez&rendertype=abstract,Menegon M,2010,Sudan,Elfau,34.0836,14.1122,2007,2007,pfcrt 76T,27,24,24,Amodiaquine,2,"Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.",In vitro CQ
20682863,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2911166&tool=pmcentrez&rendertype=abstract,Menegon M,2010,Sudan,Elfau,34.0836,14.1122,2007,2007,pfmdr1 86Y,27,23,23,Amodiaquine,2,"Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.",In vitro CQ
20212335,http://www.jidc.org/index.php/journal/article/view/20212335,Yusuf RU,2010,Sudan,Nuba Montains,30.1815,11.7455,2003,2004,pfmdr1 86N/Y,160,4,4,Amodiaquine,0,The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.,"Clinical data AS+SP, AQ+SP"
20212335,http://www.jidc.org/index.php/journal/article/view/20212335,Yusuf RU,2010,Sudan,Nuba Montains,30.1815,11.7455,2003,2004,pfmdr1 86Y,160,143,147,Amodiaquine,0,The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.,"Clinical data AS+SP, AQ+SP"
20682863,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2911166&tool=pmcentrez&rendertype=abstract,Menegon M,2010,Sudan,Wad Medani,33.5203,14.3995,2007,2007,pfcrt 76T,171,120,120,Amodiaquine,1,"Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.",In vitro CQ
20682863,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2911166&tool=pmcentrez&rendertype=abstract,Menegon M,2010,Sudan,Wad Medani,33.5203,14.3995,2007,2007,pfmdr1 86Y,171,87,87,Amodiaquine,1,"Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.",
21896916,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195064&tool=pmcentrez&rendertype=abstract,Gadalla NB,2011,Sudan,"Asar, Daraweesh, Abu Adam, New Halfa",35.3686,14.0243,2008,2008,pfmdr1 86Y,89,80,80,Amodiaquine,0,Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.,Clinical Al data and post-treatment genotypes
21896916,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3195064&tool=pmcentrez&rendertype=abstract,Gadalla NB,2011,Sudan,"Asar, Daraweesh, Abu Adam, New Halfa",35.3686,14.0243,2008,2008,pfmdr1 copy number >1,57,3,3,Lumefantrine,0,Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.,Clinical Al data and post-treatment genotypes
23836177,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3754354&tool=pmcentrez&rendertype=abstract,Okombo J,2013,Sudan,Gedaref,35.3833,14.0333,2006,2006,pfmdr1 1246Y,47,2,2,Amodiaquine,2,The polymorphic linker domain of pfmdr1 is associated with resistance-conferring mutations in Plasmodium falciparum populations from East and West Africa.,Mixed genotype infections not accounted for.
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfcrt 76T,63,47,47,Amodiaquine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfcrt CIET,63,47,47,Amodiaquine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 1246D/Y,63,0,0,Amodiaquine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 1246Y,63,0,0,Amodiaquine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 184F,63,51,54,Lumefantrine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 184Y/F,63,3,3,Lumefantrine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 86N/Y,63,3,3,Amodiaquine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 86Y,63,35,38,Amodiaquine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
23870667,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Gadalla NB,2013,Sudan,Kassala City,36.4,15.45,2012,2012,pfmdr1 copy number >1,63,0,0,Lumefantrine,0,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication
1OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267505/#DKU358C16,Gadalla,2015,Sudan,"Gedarif, New Halfa",35.3686,14.0243,2006,2006,pfcrt 76T,23,19,19,,,,added by HYE (study not identified in WWARN PDMS)
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Sudan,,,,2012,2015,pfcrt 76T,9,3,3,Amodiaquine,1,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Sudan,,,,2012,2015,pfcrt CIET,9,3,3,Amodiaquine,1,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sudan,,,,2011,2014,pfcrt 76K/T,9,0,0,,16,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sudan,,,,2011,2014,pfcrt 76T,9,2,2,,16,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sudan,,,,2011,2014,pfcrt CIET,9,2,2,,16,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Sudan,,,,2011,2014,pfcrt CMNK,9,7,7,,16,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
SR1SUD,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958312.1/,Mohammed A,2018,Sudan,Khartoum,32.5599,15.5007,2015,2016,pfcrt 76T,20,16,16,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Sudan,,,,2012,2016,pfmdr1 86Y,7,1,1,,1,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Kwamasimba,34.8539,-6.3069,2004,2004,pfcrt 76K/T,40,15,15,Amodiaquine,4,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Kwamasimba,34.8539,-6.3069,2004,2004,pfcrt 76T,40,22,37,Amodiaquine,4,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Kwamasimba,34.8539,-6.3069,2004,2004,pfcrt CIET,40,16,16,Amodiaquine,4,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Kwamasimba,34.8539,-6.3069,2004,2004,pfcrt SMNT,40,3,3,Amodiaquine,4,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Mkokola,32.7953,-5.01667,2004,2004,pfcrt 76K/T,123,40,40,Amodiaquine,2,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Mkokola,32.7953,-5.01667,2004,2004,pfcrt 76T,123,80,120,Amodiaquine,2,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Mkokola,32.7953,-5.01667,2004,2004,pfcrt CIET,123,62,62,Amodiaquine,2,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
16703518,http://www.ncbi.nlm.nih.gov/pubmed/16703518,Alifrangis M,2006,Tanzania,Mkokola,32.7953,-5.01667,2004,2004,pfcrt SMNT,123,3,3,Amodiaquine,2,Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.,
SR1TAN,https://malariajournal.biomedcentral.com/track/pdf/10.1186/1475-2875-6-153,Enevold,2007,Tanzania,Chamwino,36.0431,-6.0986,2005,2005,pfcrt 76K/T,50,1,1,,,,added by HYE (study not identified in WWARN PDMS)
SR1TAN,https://malariajournal.biomedcentral.com/track/pdf/10.1186/1475-2875-6-153,Enevold,2007,Tanzania,Chamwino,36.0431,-6.0986,2005,2005,pfcrt 76T,50,34,35,,,,added by HYE (study not identified in WWARN PDMS)
17224049,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1781949&tool=pmcentrez&rendertype=abstract,Schönfeld M,2007,Tanzania,"Mbeya, Matema",33.45,-8.9,2004,2005,pfcrt 76K/T,86,6,6,Amodiaquine,0,Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.,
17224049,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1781949&tool=pmcentrez&rendertype=abstract,Schönfeld M,2007,Tanzania,"Mbeya, Matema",33.45,-8.9,2004,2005,pfcrt 76T,86,37,43,Amodiaquine,0,Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.,
17224049,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1781949&tool=pmcentrez&rendertype=abstract,Schönfeld M,2007,Tanzania,"Mbeya, Matema",33.45,-8.9,2004,2005,pfmdr1 86N/Y,85,6,6,Amodiaquine,0,Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.,
17224049,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1781949&tool=pmcentrez&rendertype=abstract,Schönfeld M,2007,Tanzania,"Mbeya, Matema",33.45,-8.9,2004,2005,pfmdr1 86Y,85,38,44,Amodiaquine,0,Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.,
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfcrt 76K/T,236,28,28,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfcrt 76T,236,203,231,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfcrt CIET,236,203,203,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfmdr1 1246D/Y,222,42,42,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfmdr1 1246Y,222,138,180,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfmdr1 184F,187,11,22,Lumefantrine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfmdr1 184Y/F,187,11,11,Lumefantrine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfmdr1 86N/Y,190,19,19,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17194834,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1803116&tool=pmcentrez&rendertype=abstract,Humphreys GS,2007,Tanzania,Muheza,38.7918,-5.17594,2002,2004,pfmdr1 86Y,190,158,177,Amodiaquine,0,Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.,"Clinical AQ, AQ+SP, ASAQ, AL data and post-tr"
17467344,http://www.ncbi.nlm.nih.gov/pubmed/17467344,Holmgren G,2007,Tanzania,Zanzibar,39.1989,-6.1652,2005,2005,pfcrt 76T,177,170,170,Amodiaquine,3,Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.,Clinical ASAQ data and post-treatment genotyp
17467344,http://www.ncbi.nlm.nih.gov/pubmed/17467344,Holmgren G,2007,Tanzania,Zanzibar,39.1989,-6.1652,2005,2005,pfmdr1 1246Y,193,42,42,Amodiaquine,3,Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.,Clinical ASAQ data and post-treatment genotyp
17467344,http://www.ncbi.nlm.nih.gov/pubmed/17467344,Holmgren G,2007,Tanzania,Zanzibar,39.1989,-6.1652,2005,2005,pfmdr1 184F,208,52,52,Lumefantrine,3,Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.,Clinical ASAQ data and post-treatment genotyp
17467344,http://www.ncbi.nlm.nih.gov/pubmed/17467344,Holmgren G,2007,Tanzania,Zanzibar,39.1989,-6.1652,2005,2005,pfmdr1 86Y,193,149,149,Amodiaquine,3,Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.,Clinical ASAQ data and post-treatment genotyp
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfcrt 76K/T,102,23,23,Amodiaquine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfcrt 76T,102,53,53,Amodiaquine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfmdr1 1246D/Y,98,24,24,Amodiaquine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfmdr1 1246Y,98,24,24,Amodiaquine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfmdr1 184F,100,0,25,Lumefantrine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfmdr1 184Y/F,100,25,25,Lumefantrine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfmdr1 86N/Y,102,30,30,Amodiaquine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19210165,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718568&tool=pmcentrez&rendertype=abstract,Sisowath C,2009,Tanzania,Fukayosi,38.6667,-6.4,2004,2004,pfmdr1 86Y,102,45,45,Amodiaquine,0,In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.,Clinical data AL. Post-treatment genotypes av
19624477,http://www.ncbi.nlm.nih.gov/pubmed/19624477,Bridges DJ,2009,Tanzania,Karonga,33.9248,-9.9525,2007,2007,pfcrt 76T,183,16,16,Amodiaquine,1,Low level genotypic chloroquine resistance near Malawi's northern border with Tanzania.,
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2004,2004,pfcrt 76K/T,163,55,55,Amodiaquine,2,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2006,2006,pfcrt 76K/T,74,21,21,Amodiaquine,3,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2007,2007,pfcrt 76K/T,73,24,24,Amodiaquine,4,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2004,2004,pfcrt 76T,163,103,158,Amodiaquine,2,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2006,2006,pfcrt 76T,74,51,72,Amodiaquine,3,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2007,2007,pfcrt 76T,73,36,60,Amodiaquine,4,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2004,2004,pfcrt CIET,163,80,80,Amodiaquine,2,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2006,2006,pfcrt CIET,74,51,51,Amodiaquine,3,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2007,2007,pfcrt CIET,73,36,36,Amodiaquine,4,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2004,2004,pfcrt SMNT,163,6,6,Amodiaquine,2,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2006,2006,pfcrt SMNT,74,0,0,Amodiaquine,3,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
19346369,http://www.ajtmh.org/content/80/4/523.long,Alifrangis M,2009,Tanzania,"Mkokola, Kwamasimba",32.7953,-5.01667,2007,2007,pfcrt SMNT,73,0,0,Amodiaquine,4,"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.",
21427394,http://www.ncbi.nlm.nih.gov/pubmed/21427394,Ngasala BE,2011,Tanzania,Bagamoyo District,38.9067,-6.43725,2007,2008,pfcrt 76K/T,357,52,52,Amodiaquine,0,Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.,Clinical AL data and post-treatment genotypes
21427394,http://www.ncbi.nlm.nih.gov/pubmed/21427394,Ngasala BE,2011,Tanzania,Bagamoyo District,38.9067,-6.43725,2007,2008,pfcrt 76T,357,66,118,Amodiaquine,0,Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.,Clinical AL data and post-treatment genotypes
21427394,http://www.ncbi.nlm.nih.gov/pubmed/21427394,Ngasala BE,2011,Tanzania,Bagamoyo District,38.9067,-6.43725,2007,2008,pfmdr1 86N/Y,357,84,84,Amodiaquine,0,Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.,Clinical AL data and post-treatment genotypes
21427394,http://www.ncbi.nlm.nih.gov/pubmed/21427394,Ngasala BE,2011,Tanzania,Bagamoyo District,38.9067,-6.43725,2007,2008,pfmdr1 86Y,357,118,202,Amodiaquine,0,Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.,Clinical AL data and post-treatment genotypes
21410954,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3065443&tool=pmcentrez&rendertype=abstract,Ngasala B,2011,Tanzania,Kibaha District,38.9929,-6.78132,2007,2007,pfcrt 76K/T,232,41,41,Amodiaquine,0,Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.,Clinical AL data and post-treatment genotypes
21410954,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3065443&tool=pmcentrez&rendertype=abstract,Ngasala B,2011,Tanzania,Kibaha District,38.9929,-6.78132,2007,2007,pfcrt 76T,232,39,80,Amodiaquine,0,Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.,Clinical AL data and post-treatment genotypes
21410954,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3065443&tool=pmcentrez&rendertype=abstract,Ngasala B,2011,Tanzania,Kibaha District,38.9929,-6.78132,2007,2007,pfmdr1 86N/Y,234,56,56,Amodiaquine,0,Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.,Clinical AL data and post-treatment genotypes
21410954,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3065443&tool=pmcentrez&rendertype=abstract,Ngasala B,2011,Tanzania,Kibaha District,38.9929,-6.78132,2007,2007,pfmdr1 86Y,234,63,119,Amodiaquine,0,Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.,Clinical AL data and post-treatment genotypes
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2004,2004,pfmdr1 1246D/Y,268,70,70,Amodiaquine,2,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2006,2006,pfmdr1 1246D/Y,76,23,23,Amodiaquine,3,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2007,2007,pfmdr1 1246D/Y,79,8,8,Amodiaquine,4,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2008,2008,pfmdr1 1246D/Y,33,3,3,Amodiaquine,5,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2010,2010,pfmdr1 1246D/Y,14,3,3,Amodiaquine,7,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2004,2004,pfmdr1 1246Y,268,177,247,Amodiaquine,2,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2006,2006,pfmdr1 1246Y,76,44,67,Amodiaquine,3,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2007,2007,pfmdr1 1246Y,79,43,51,Amodiaquine,4,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2008,2008,pfmdr1 1246Y,33,21,24,Amodiaquine,5,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2009,2009,pfmdr1 1246Y,12,7,7,Amodiaquine,6,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2010,2010,pfmdr1 1246Y,14,7,10,Amodiaquine,7,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2004,2004,pfmdr1 184F,288,12,29,Lumefantrine,2,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2006,2006,pfmdr1 184F,73,4,8,Lumefantrine,3,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2007,2007,pfmdr1 184F,106,10,15,Lumefantrine,4,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2008,2008,pfmdr1 184F,36,4,5,Lumefantrine,5,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2010,2010,pfmdr1 184F,17,4,7,Lumefantrine,7,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2009,2009,pfmdr1 184F,12,0,0,Lumefantrine,6,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2004,2004,pfmdr1 184Y/F,288,17,17,Lumefantrine,2,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2006,2006,pfmdr1 184Y/F,73,4,4,Lumefantrine,3,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2007,2007,pfmdr1 184Y/F,106,5,5,Lumefantrine,4,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2008,2008,pfmdr1 184Y/F,36,1,1,Lumefantrine,5,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2009,2009,pfmdr1 184Y/F,12,2,2,Lumefantrine,6,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2010,2010,pfmdr1 184Y/F,17,3,3,Lumefantrine,7,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2004,2004,pfmdr1 86N/Y,293,59,59,Amodiaquine,2,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2006,2006,pfmdr1 86N/Y,76,15,15,Amodiaquine,3,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2007,2007,pfmdr1 86N/Y,111,14,14,Amodiaquine,4,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2008,2008,pfmdr1 86N/Y,37,3,3,Amodiaquine,5,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2009,2009,pfmdr1 86N/Y,13,4,4,Amodiaquine,6,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2010,2010,pfmdr1 86N/Y,17,4,4,Amodiaquine,7,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2004,2004,pfmdr1 86Y,293,205,264,Amodiaquine,2,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2006,2006,pfmdr1 86Y,76,55,70,Amodiaquine,3,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2007,2007,pfmdr1 86Y,111,83,97,Amodiaquine,4,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2008,2008,pfmdr1 86Y,37,29,32,Amodiaquine,5,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2009,2009,pfmdr1 86Y,13,6,10,Amodiaquine,6,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22144430,http://www.ncbi.nlm.nih.gov/pubmed/?term=22144430,"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M",2011,Tanzania,Korogwe,38.4404,-5.16156,2010,2010,pfmdr1 86Y,17,7,11,Amodiaquine,7,Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.,CROSS-SECTIONAL STUDY
22369089,http://www.malariajournal.com/content/11/1/58,Kamugisha E,2012,Tanzania,Igombe health centre,32.9462,-2.41012,2010,2011,pfcrt 76T,90,10,10,Amodiaquine,0,"Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.",Clinical AL data and post-treatment genotypes
22369089,http://www.malariajournal.com/content/11/1/58,Kamugisha E,2012,Tanzania,Igombe health centre,32.9462,-2.41012,2010,2011,pfmdr1 86N/Y,95,4,4,Amodiaquine,0,"Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.",Clinical AL data and post-treatment genotypes
22369089,http://www.malariajournal.com/content/11/1/58,Kamugisha E,2012,Tanzania,Igombe health centre,32.9462,-2.41012,2010,2011,pfmdr1 86Y,95,6,10,Amodiaquine,0,"Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.",Clinical AL data and post-treatment genotypes
22966778,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3468380&tool=pmcentrez&rendertype=abstract,Fröberg G,2012,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfcrt 76T,117,76,76,Amodiaquine,0,Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.,In this publication a mixed infection was con
22966778,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3468380&tool=pmcentrez&rendertype=abstract,Fröberg G,2012,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 1246Y,113,18,18,Amodiaquine,0,Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.,In this publication a mixed infection was con
22966778,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3468380&tool=pmcentrez&rendertype=abstract,Fröberg G,2012,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 184F,117,28,28,Lumefantrine,0,Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.,In this publication a mixed infection was con
22966778,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3468380&tool=pmcentrez&rendertype=abstract,Fröberg G,2012,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 86Y,117,64,64,Amodiaquine,0,Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.,In this publication a mixed infection was con
22118982,http://www.ncbi.nlm.nih.gov/pubmed/22118982,Kamugisha E,2012,Tanzania,Mwanza,32.9,-2.5,2009,2010,pfcrt 76T,84,34,34,Amodiaquine,1,"Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?",
22118982,http://www.ncbi.nlm.nih.gov/pubmed/22118982,Kamugisha E,2012,Tanzania,Mwanza,32.9,-2.5,2009,2010,pfmdr1 86Y,77,13,13,Amodiaquine,1,"Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Coastal Region (Kibiti-Rufiji),38.9356,-7.7253,2010,2011,pfcrt 76K/T,139,0,0,Amodiaquine,5,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Coastal Region (Kibiti-Rufiji),38.9356,-7.7253,2010,2011,pfcrt 76T,139,9,9,Amodiaquine,5,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfcrt 76K/T,187,28,28,Amodiaquine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfcrt 76K/T,31,2,2,Amodiaquine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfcrt 76K/T,123,5,5,Amodiaquine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfcrt 76T,187,31,59,Amodiaquine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfcrt 76T,31,6,8,Amodiaquine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfcrt 76T,123,14,19,Amodiaquine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfmdr1 1246D/Y,184,15,15,Amodiaquine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfmdr1 1246D/Y,125,14,14,Amodiaquine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfmdr1 1246D/Y,32,4,4,Amodiaquine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfmdr1 1246Y,184,11,26,Amodiaquine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfmdr1 1246Y,32,1,5,Amodiaquine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfmdr1 1246Y,125,5,19,Amodiaquine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfmdr1 184F,186,46,69,Lumefantrine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfmdr1 184F,126,44,59,Lumefantrine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfmdr1 184F,31,10,18,Lumefantrine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfmdr1 184Y/F,126,15,15,Lumefantrine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfmdr1 184Y/F,186,23,23,Lumefantrine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfmdr1 184Y/F,31,8,8,Lumefantrine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfmdr1 86N/Y,188,27,27,Amodiaquine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfmdr1 86N/Y,124,20,20,Amodiaquine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfmdr1 86N/Y,31,3,3,Amodiaquine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2011,2011,pfmdr1 86Y,124,28,48,Amodiaquine,3,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2010,2010,pfmdr1 86Y,31,5,8,Amodiaquine,2,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
23506218,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3732084&tool=pmcentrez&rendertype=abstract,Malmberg M,2013,Tanzania,Fukayosi,38.6667,-6.4,2008,2008,pfmdr1 86Y,188,46,73,Amodiaquine,1,"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.",Studies 1 -3 includes data from previous publ
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Kagera (Muleba district),31.6606,-1.84916,2010,2011,pfcrt 76K/T,97,8,8,Amodiaquine,2,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Kagera (Muleba district),31.6606,-1.84916,2010,2011,pfcrt 76T,97,7,15,Amodiaquine,2,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Mbeya (Kyela and Rungwe districts),33.45,-8.9,2010,2011,pfcrt 76K/T,147,4,4,Amodiaquine,6,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Mbeya (Kyela and Rungwe districts),33.45,-8.9,2010,2011,pfcrt 76T,147,7,11,Amodiaquine,6,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfcrt 76K/T,121,17,17,Amodiaquine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfcrt 76T,121,70,87,Amodiaquine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 1246D/Y,121,14,14,Amodiaquine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 1246Y,121,13,27,Amodiaquine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 184F,121,24,39,Lumefantrine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 184Y/F,121,15,15,Lumefantrine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 86N/Y,121,12,12,Amodiaquine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
23510231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3605315&tool=pmcentrez&rendertype=abstract,Morris U,2013,Tanzania,"Micheweni, North A",39.2026,-6.16592,2010,2010,pfmdr1 86Y,121,61,73,Amodiaquine,0,Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.,Genotype frequencies from Pf DNA extracted fr
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Mtwara (Tandahimba and Mtwara-Urban),39.6227,-10.7528,2010,2011,pfcrt 76K/T,71,3,3,Amodiaquine,4,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Mtwara (Tandahimba and Mtwara-Urban),39.6227,-10.7528,2010,2011,pfcrt 76T,71,2,5,Amodiaquine,4,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Mwanza (Misungwi district),32.9,-2.51667,2010,2011,pfcrt 76K/T,171,10,10,Amodiaquine,1,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Mwanza (Misungwi district),32.9,-2.51667,2010,2011,pfcrt 76T,171,11,21,Amodiaquine,1,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Tanga (Bondo village),38.5833,-5.38333,2010,2011,pfcrt 76K/T,116,2,2,Amodiaquine,3,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
24225406,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3830541&tool=pmcentrez&rendertype=abstract,Mohammed A,2013,Tanzania,Tanga (Bondo village),38.5833,-5.38333,2010,2011,pfcrt 76T,116,6,8,Amodiaquine,3,"Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.",
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,"Coastal, Kibiti",38.9359,-7.72411,2010,2011,pfmdr1 1246D/Y,143,2,2,Amodiaquine,2,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,Pregnant women
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,"Coastal, Kibiti",38.9359,-7.72411,2010,2011,pfmdr1 1246Y,143,7,9,Amodiaquine,2,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,Pregnant women
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,"Coastal, Kibiti",38.9359,-7.72411,2010,2011,pfmdr1 184F,135,50,50,Lumefantrine,2,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,Pregnant women
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,"Coastal, Kibiti",38.9359,-7.72411,2010,2011,pfmdr1 184Y/F,135,0,0,Lumefantrine,2,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,Pregnant women
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,"Coastal, Kibiti",38.9359,-7.72411,2010,2011,pfmdr1 86N/Y,129,3,3,Amodiaquine,2,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,Pregnant women
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,"Coastal, Kibiti",38.9359,-7.72411,2010,2011,pfmdr1 86Y,129,33,36,Amodiaquine,2,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,Pregnant women
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Kagera,31.6606,-1.84916,2010,2011,pfmdr1 1246D/Y,127,2,2,Amodiaquine,5,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Kagera,31.6606,-1.84916,2010,2011,pfmdr1 1246Y,127,13,15,Amodiaquine,5,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Kagera,31.6606,-1.84916,2010,2011,pfmdr1 184F,121,38,39,Lumefantrine,5,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Kagera,31.6606,-1.84916,2010,2011,pfmdr1 184Y/F,121,1,1,Lumefantrine,5,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Kagera,31.6606,-1.84916,2010,2011,pfmdr1 86N/Y,125,4,4,Amodiaquine,5,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Kagera,31.6606,-1.84916,2010,2011,pfmdr1 86Y,125,31,35,Amodiaquine,5,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mbeya,33.45,-8.9,2010,2011,pfmdr1 1246D/Y,133,1,1,Amodiaquine,4,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mbeya,33.45,-8.9,2010,2011,pfmdr1 1246Y,133,13,14,Amodiaquine,4,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mbeya,33.45,-8.9,2010,2011,pfmdr1 184F,126,13,15,Lumefantrine,4,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mbeya,33.45,-8.9,2010,2011,pfmdr1 184Y/F,126,2,2,Lumefantrine,4,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mbeya,33.45,-8.9,2010,2011,pfmdr1 86N/Y,135,2,2,Amodiaquine,4,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mbeya,33.45,-8.9,2010,2011,pfmdr1 86Y,135,4,6,Amodiaquine,4,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mtwara,39.6227,-10.7528,2010,2011,pfmdr1 1246D/Y,70,0,0,Amodiaquine,3,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mtwara,39.6227,-10.7528,2010,2011,pfmdr1 1246Y,70,15,15,Amodiaquine,3,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mtwara,39.6227,-10.7528,2010,2011,pfmdr1 184F,67,23,24,Lumefantrine,3,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mtwara,39.6227,-10.7528,2010,2011,pfmdr1 184Y/F,67,1,1,Lumefantrine,3,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mtwara,39.6227,-10.7528,2010,2011,pfmdr1 86N/Y,66,1,1,Amodiaquine,3,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mtwara,39.6227,-10.7528,2010,2011,pfmdr1 86Y,66,16,17,Amodiaquine,3,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mwanza,32.9,-2.5,2010,2011,pfmdr1 1246D/Y,88,0,0,Amodiaquine,6,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mwanza,32.9,-2.5,2010,2011,pfmdr1 1246Y,88,15,15,Amodiaquine,6,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mwanza,32.9,-2.5,2010,2011,pfmdr1 184F,100,35,36,Lumefantrine,6,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mwanza,32.9,-2.5,2010,2011,pfmdr1 184Y/F,100,1,1,Lumefantrine,6,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mwanza,32.9,-2.5,2010,2011,pfmdr1 86N/Y,95,0,0,Amodiaquine,6,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Mwanza,32.9,-2.5,2010,2011,pfmdr1 86Y,95,23,23,Amodiaquine,6,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
1TAN,https://www.researchgate.net/publication/274378506_High_prevalence_of_Plasmodium_falciparum_pfcrt_K76T_mutation_in_children_with_sickle_cell_disease_at_a_tertiary_hospital_in_north-western_Tanzania,Mongella,2014,Tanzania,Mwanza,32.9,-2.5,2012,2012,pfcrt 76T,16,13,13,,,,added by HYE (study not identified in WWARN PDMS)
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Tanga,38.5833,-5.38333,2010,2011,pfmdr1 1246D/Y,85,1,1,Amodiaquine,1,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,pfcrt and pfmdr1 flanking microsatellites
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Tanga,38.5833,-5.38333,2010,2011,pfmdr1 1246Y,85,39,40,Amodiaquine,1,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Tanga,38.5833,-5.38333,2010,2011,pfmdr1 184F,92,60,60,Lumefantrine,1,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Tanga,38.5833,-5.38333,2010,2011,pfmdr1 184Y/F,92,0,0,Lumefantrine,1,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Tanga,38.5833,-5.38333,2010,2011,pfmdr1 86N/Y,94,2,2,Amodiaquine,1,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
25007802,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4099215&tool=pmcentrez&rendertype=abstract,Kavishe RA,2014,Tanzania,Tanga,38.5833,-5.38333,2010,2011,pfmdr1 86Y,94,56,58,Amodiaquine,1,Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Tanzania,,,,2008,2008,pfcrt 76T,50,17,17,Amodiaquine,4,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Tanzania,,,,2008,2008,pfcrt CIET,50,17,17,Amodiaquine,4,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Tanzania,,,,2008,2008,pfcrt CMNT,50,0,0,Amodiaquine,4,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Tanzania,,,,2008,2008,pfcrt SMNT,50,0,0,Amodiaquine,4,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Tanzania,,,,2008,2008,pfmdr1 86Y,50,16,16,Amodiaquine,4,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
24657918,http://www.ncbi.nlm.nih.gov/pubmed/24657918,Jovel IT,2014,Tanzania,,,,2008,2008,pfmdr1 copy number >1,46,0,0,Lumefantrine,4,Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms.,
1OTH,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267505/#DKU358C16,Gadalla,2015,Tanzania,Fukayosi,38.6667,-6.4,2006,2006,pfcrt 76T,13,3,3,,,,added by HYE (study not identified in WWARN PDMS)
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfcrt 76K/T,119,14,14,Amodiaquine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfcrt 76K/T,44,1,1,Amodiaquine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfcrt 76K/T,41,6,6,Amodiaquine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfcrt 76K/T,94,4,4,Amodiaquine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfcrt 76K/T,34,5,5,Amodiaquine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfcrt 76T,119,105,119,Amodiaquine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfcrt 76T,44,37,38,Amodiaquine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfcrt 76T,41,32,38,Amodiaquine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfcrt 76T,94,38,42,Amodiaquine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfcrt 76T,34,17,22,Amodiaquine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfmdr1 1246D/Y,114,34,34,Amodiaquine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfmdr1 1246D/Y,50,11,11,Amodiaquine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfmdr1 1246D/Y,42,6,6,Amodiaquine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 1246D/Y,22,4,4,Amodiaquine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 1246D/Y,94,2,2,Amodiaquine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfmdr1 1246Y,114,17,51,Amodiaquine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfmdr1 1246Y,50,6,17,Amodiaquine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfmdr1 1246Y,42,6,12,Amodiaquine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 1246Y,22,6,10,Amodiaquine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 1246Y,94,7,9,Amodiaquine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfmdr1 184F,114,11,28,Lumefantrine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfmdr1 184F,50,11,16,Lumefantrine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfmdr1 184F,43,10,14,Lumefantrine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 184F,26,6,9,Lumefantrine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 184F,94,30,56,Lumefantrine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfmdr1 184Y/F,114,17,17,Lumefantrine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfmdr1 184Y/F,50,5,5,Lumefantrine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfmdr1 184Y/F,43,4,4,Lumefantrine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 184Y/F,26,3,3,Lumefantrine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 184Y/F,94,26,26,Lumefantrine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfmdr1 86N/Y,119,14,14,Amodiaquine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfmdr1 86N/Y,47,11,11,Amodiaquine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfmdr1 86N/Y,41,9,9,Amodiaquine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 86N/Y,27,3,3,Amodiaquine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 86N/Y,98,7,7,Amodiaquine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2005,2005,pfmdr1 86Y,119,77,91,Amodiaquine,1,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2009,2009,pfmdr1 86Y,47,31,42,Amodiaquine,2,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2011,2011,pfmdr1 86Y,41,9,18,Amodiaquine,3,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 86Y,27,15,18,Amodiaquine,4,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",Asymptomatic
25917493,http://www.ncbi.nlm.nih.gov/pubmed/25917493,Morris U,2015,Tanzania,"Micheweni, North A",39.2026,-6.16592,2013,2013,pfmdr1 86Y,98,37,44,Amodiaquine,5,"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Mkuzi,38.3438,-4.75269,2012,2014,pfcrt 76T,20,3,3,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Mkuzi,38.3438,-4.75269,2012,2014,pfmdr1 86Y,20,9,9,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2004,2004,pfcrt 76K/T,117,2,2,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2005,2005,pfcrt 76K/T,76,2,2,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfcrt 76K/T,9,0,0,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2004,2004,pfcrt 76T,117,111,113,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2005,2005,pfcrt 76T,76,68,70,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfcrt 76T,9,9,9,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2004,2004,pfcrt CIET,117,111,113,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2005,2005,pfcrt CIET,76,68,70,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfcrt CIET,9,9,9,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2004,2004,pfcrt SMNT,117,0,0,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2005,2005,pfcrt SMNT,76,0,0,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfcrt SMNT,9,0,0,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfmdr1 1246Y,178,146,146,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfmdr1 184F,178,174,174,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
25890383,http://www.ncbi.nlm.nih.gov/pubmed/25890383,Gadalla N,2015,Tanzania,Muheza,38.7918,-5.17594,2006,2006,pfmdr1 86Y,178,163,163,Amodiaquine,3,"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Muleba,31.537,-2.1649,2012,2014,pfcrt 76T,27,4,4,Amodiaquine,1,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Muleba,31.537,-2.1649,2012,2014,pfmdr1 86Y,22,4,4,Amodiaquine,1,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Mwanza,32.9,-2.5,2012,2014,pfcrt 76T,20,0,0,Amodiaquine,1,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Mwanza,32.9,-2.5,2012,2014,pfmdr1 86Y,8,1,1,Amodiaquine,1,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Nachingwea,38.7159,-10.3318,2012,2014,pfcrt 76T,31,0,0,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
26152336,http://www.ncbi.nlm.nih.gov/pubmed/26152336,Golassa L,2015,Tanzania,Nachingwea,38.7159,-10.3318,2012,2014,pfmdr1 86Y,27,0,0,Amodiaquine,2,"Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.",
481,http://www.ncbi.nlm.nih.gov/pubmed/?term=27565897,"Mwaiswelo R, Ngasala B, Jovel I, Aydin-Schmidt B, Gosling R, Premji Z, Mmbando B, Björkman A, Mårtensson A",2016,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfcrt 76K/T,205,6,6,Amodiaquine,1,"Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.",
481,http://www.ncbi.nlm.nih.gov/pubmed/?term=27565897,"Mwaiswelo R, Ngasala B, Jovel I, Aydin-Schmidt B, Gosling R, Premji Z, Mmbando B, Björkman A, Mårtensson A",2016,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfcrt 76T,205,1,6,Amodiaquine,1,"Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.",
481,http://www.ncbi.nlm.nih.gov/pubmed/?term=27565897,"Mwaiswelo R, Ngasala B, Jovel I, Aydin-Schmidt B, Gosling R, Premji Z, Mmbando B, Björkman A, Mårtensson A",2016,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfmdr1 86N/Y,213,11,11,Amodiaquine,1,"Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.",
481,http://www.ncbi.nlm.nih.gov/pubmed/?term=27565897,"Mwaiswelo R, Ngasala B, Jovel I, Aydin-Schmidt B, Gosling R, Premji Z, Mmbando B, Björkman A, Mårtensson A",2016,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfmdr1 86Y,213,19,11,Amodiaquine,1,"Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.",
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Tanzania,,,,2012,2015,pfcrt 76T,10,3,1,Amodiaquine,5,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Tanzania,,,,2012,2015,pfcrt CIET,10,3,1,Amodiaquine,6,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2012,2013,pfcrt 76K/T,140,7,7,,3,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested Sample came from the number of patients in the study
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfcrt 76K/T,205,5,5,,4,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested number came from content.
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2012,2013,pfcrt 76T,140,14,21,,3,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested Sample came from the number of patients in the study
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfcrt 76T,205,2,7,,4,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested number came from content.
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2012,2013,pfmdr1 86N/Y,140,28,28,,3,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested Sample came from the number of patients in the study
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfmdr1 86N/Y,213,10,10,,4,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested number came from content.
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2012,2013,pfmdr1 86Y,140,11,39,,3,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested Sample came from the number of patients in the study
624,https://www.ncbi.nlm.nih.gov/pubmed/28829723,Richard Mwaiswelo,2017,Tanzania,Bagamoyo District,38.9067,-6.43725,2014,2014,pfmdr1 86Y,213,20,30,,4,"Sustained High Cure Rate of Artemether-Lumefantrine Against Uncomplicated Plasmodium falciparum Malaria After 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.",The total tested number came from content.
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Tanzania,,,,2014,2014,pfcrt 76K/T,6,0,0,,4,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Tanzania,,,,2014,2014,pfcrt 76T,6,0,0,,4,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Tanzania,,,,2014,2014,pfcrt CIET,6,0,0,,4,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Tanzania,,,,2014,2014,pfcrt CMNK,6,6,6,,4,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Tanzania,,,,2012,2016,pfmdr1 86Y,12,2,2,,11,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Kibaha District,38.9929,-6.78132,2016,2016,pfmdr1 1246Y,80,0,0,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Kibaha District,38.9929,-6.78132,2016,2016,pfmdr1 184F,80,34,34,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Kibaha District,38.9929,-6.78132,2016,2016,pfmdr1 86Y,80,1,1,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Mkuzi ,38.3403,-4.7516,2016,2016,pfmdr1 1246Y,88,1,1,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Mkuzi ,38.3403,-4.7516,2016,2016,pfmdr1 184F,88,41,41,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Mkuzi ,38.3403,-4.7516,2016,2016,pfmdr1 86Y,88,1,1,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Mlimba ,35.8089,-8.7825,2016,2016,pfmdr1 1246Y,88,1,1,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Mlimba ,35.8089,-8.7825,2016,2016,pfmdr1 184F,88,30,30,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Mlimba ,35.8089,-8.7825,2016,2016,pfmdr1 86Y,88,1,1,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Ujiji ,29.6746,-4.9115,2016,2016,pfmdr1 1246Y,88,0,0,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Ujiji ,29.6746,-4.9115,2016,2016,pfmdr1 184F,88,32,32,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
727,https://www.ncbi.nlm.nih.gov/pubmed/?term=30898164,"Ishengoma DS1, Mandara CI2,3, Francis F2, Talundzic E4, Lucchi NW4, Ngasala B5,6, Kabanywanyi AM7, Mahende MK7, Kamugisha E8, Kavishe RA3, Muro F3, Mohamed A9, Mandike R9, Mkude S9, Chacky F9, Paxton L4, Greer G10, Kitojo CA10, Njau R11, Martin T12, Venkatesan M13, Warsame M14,15, Halsey ES4,16, Udhayakumar V4.",2019,Tanzania,Ujiji ,29.6746,-4.9115,2016,2016,pfmdr1 86Y,88,0,0,,1,Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.,
16569231,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448192&tool=pmcentrez&rendertype=abstract,Cojean S,2006,Togo,,,,1998,2004,pfcrt 76T,2,2,2,Amodiaquine,10,Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.,travelers
20404118,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897320&tool=pmcentrez&rendertype=abstract,Witkowski B,2010,Togo,,,,2005,2009,pfmdr1 copy number = 2,4,1,1,Lumefantrine,7,Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Togo,,,,2012,2015,pfcrt 76T,5,1,1,Amodiaquine,12,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Togo,,,,2012,2015,pfcrt CIET,5,1,1,Amodiaquine,21,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Togo,,,,2014,2014,pfcrt 76K/T,6,0,0,,13,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Togo,,,,2014,2014,pfcrt 76T,6,0,0,,13,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Togo,,,,2014,2014,pfcrt CIET,6,0,0,,13,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Togo,,,,2014,2014,pfcrt CMNK,6,6,6,,13,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Togo,,,,2012,2016,pfmdr1 86Y,5,2,2,,14,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Apac,32.5333,1.98333,2002,2004,pfcrt 76K/T,346,94,94,Amodiaquine,6,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Apac,32.5333,1.98333,2002,2004,pfcrt 76T,346,238,332,Amodiaquine,6,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Arua,30.91,3.03,2002,2004,pfcrt 76K/T,80,8,8,Amodiaquine,4,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Arua,30.91,3.03,2002,2004,pfcrt 76T,80,69,77,Amodiaquine,4,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Jinja,33.2042,0.424444,2002,2004,pfcrt 76K/T,80,1,1,Amodiaquine,3,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Jinja,33.2042,0.424444,2002,2004,pfcrt 76T,80,78,79,Amodiaquine,3,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Kanungu,29.7426,-0.819525,2002,2004,pfcrt 76K/T,80,5,5,Amodiaquine,1,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Kanungu,29.7426,-0.819525,2002,2004,pfcrt 76T,80,75,80,Amodiaquine,1,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Mubende,31.395,0.5575,2002,2004,pfcrt 76K/T,80,3,3,Amodiaquine,2,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Mubende,31.395,0.5575,2002,2004,pfcrt 76T,80,77,80,Amodiaquine,2,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Tororo,34.1811,0.692778,2002,2004,pfcrt 76K/T,80,1,1,Amodiaquine,5,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
16518760,http://www.ncbi.nlm.nih.gov/pubmed/16518760,Francis D,2006,Uganda,Tororo,34.1811,0.692778,2002,2004,pfcrt 76T,80,79,80,Amodiaquine,5,Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.,Publication compares efficacy by transmission
SR2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472234/,Dokomajilar,2006,Uganda,Tororo,34.1811,0.692778,2004,2005,pfmdr1 1246Y,97,85,85,,,,added by HYE (study not identified in WWARN PDMS)
SR2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472234/,Dokomajilar,2006,Uganda,Tororo,34.1811,0.692778,2004,2005,pfmdr1 184F,97,10,10,,,,added by HYE (study not identified in WWARN PDMS)
SR2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472234/,Dokomajilar,2006,Uganda,Tororo,34.1811,0.692778,2004,2005,pfmdr1 86Y,97,89,89,,,,added by HYE (study not identified in WWARN PDMS)
SR2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472234/,Dokomajilar,2006,Uganda,Tororo,34.1811,0.692778,2004,2005,pfmdr1 copy number >1,97,0,0,,,,added by HYE (study not identified in WWARN PDMS)
17609321,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2045286&tool=pmcentrez&rendertype=abstract,Keen J,2007,Uganda,"Kampala, Kakira",32.5811,0.313611,2004,2006,pfcrt 76K/T,46,0,0,Amodiaquine,1,Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.,
17609321,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2045286&tool=pmcentrez&rendertype=abstract,Keen J,2007,Uganda,"Kampala, Kakira",32.5811,0.313611,2004,2006,pfcrt 76T,46,45,45,Amodiaquine,1,Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.,
17609321,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2045286&tool=pmcentrez&rendertype=abstract,Keen J,2007,Uganda,"Kampala, Kakira",32.5811,0.313611,2004,2006,pfcrt CIET,46,45,45,Amodiaquine,1,Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.,
17609321,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2045286&tool=pmcentrez&rendertype=abstract,Keen J,2007,Uganda,"Kampala, Kakira",32.5811,0.313611,2004,2006,pfcrt SMNT,46,0,0,Amodiaquine,1,Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.,
17562798,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1932488&tool=pmcentrez&rendertype=abstract,Nsobya SL,2007,Uganda,Tororo,34.1811,0.692778,2004,2004,pfcrt 76T,180,180,180,Amodiaquine,0,Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.,Clinical ASAQ data and post-treatment genotyp
17562798,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1932488&tool=pmcentrez&rendertype=abstract,Nsobya SL,2007,Uganda,Tororo,34.1811,0.692778,2004,2004,pfcrt CIET,180,180,180,Amodiaquine,0,Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.,Clinical ASAQ data and post-treatment genotyp
17562798,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1932488&tool=pmcentrez&rendertype=abstract,Nsobya SL,2007,Uganda,Tororo,34.1811,0.692778,2004,2004,pfmdr1 1246Y,201,167,167,Amodiaquine,0,Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.,
17562798,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1932488&tool=pmcentrez&rendertype=abstract,Nsobya SL,2007,Uganda,Tororo,34.1811,0.692778,2004,2004,pfmdr1 184F,201,30,30,Lumefantrine,0,Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.,
17562798,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1932488&tool=pmcentrez&rendertype=abstract,Nsobya SL,2007,Uganda,Tororo,34.1811,0.692778,2004,2004,pfmdr1 86Y,201,182,182,Amodiaquine,0,Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.,
SR3UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782860/,Nawaz,2008,Uganda,Kampala,32.5811,0.313611,2006,2007,pfcrt 76T,61,61,61,,,,added by HYE (study not identified in WWARN PDMS)
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfcrt 76T,40,40,40,Amodiaquine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfmdr1 1246D/Y,40,13,13,Amodiaquine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfmdr1 1246Y,40,18,31,Amodiaquine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfmdr1 184F,40,4,5,Lumefantrine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfmdr1 184Y/F,40,1,1,Lumefantrine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfmdr1 86N/Y,40,6,6,Amodiaquine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
20065051,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825959&tool=pmcentrez&rendertype=abstract,Nsobya SL,2010,Uganda,Kampala,32.5811,0.313611,2006,2008,pfmdr1 86Y,40,29,35,Amodiaquine,0,In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.,
21078941,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3028814&tool=pmcentrez&rendertype=abstract,Baliraine FN,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfcrt 76T,169,168,168,Amodiaquine,0,"Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.",In vitro quinine
21078941,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3028814&tool=pmcentrez&rendertype=abstract,Baliraine FN,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 1246Y,170,133,133,Amodiaquine,0,"Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.",In vitro quinine
21078941,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3028814&tool=pmcentrez&rendertype=abstract,Baliraine FN,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 184F,164,21,21,Lumefantrine,0,"Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.",In vitro quinine
21078941,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3028814&tool=pmcentrez&rendertype=abstract,Baliraine FN,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 86Y,167,143,143,Amodiaquine,0,"Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.",In vitro quinine
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfcrt 76K/T,93,0,0,Amodiaquine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfcrt 76T,93,92,92,Amodiaquine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 1246D/Y,194,49,49,Amodiaquine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,"Post-treatment (AL) genotype data available, "
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 1246Y,194,115,164,Amodiaquine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,"Post-treatment (AL) genotype data available, "
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 184F,194,18,43,Lumefantrine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,"Post-treatment (AL) genotype data available, "
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 184Y/F,194,25,25,Lumefantrine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,"Post-treatment (AL) genotype data available, "
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 86N/Y,194,32,32,Amodiaquine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,"Post-treatment (AL) genotype data available, "
21881128,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3164433&tool=pmcentrez&rendertype=abstract,Baliraine F,2011,Uganda,Kampala,32.5811,0.313611,2004,2008,pfmdr1 86Y,194,146,178,Amodiaquine,0,Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.,"Post-treatment (AL) genotype data available, "
22118982,http://www.ncbi.nlm.nih.gov/pubmed/22118982,Kamugisha E,2012,Uganda,Iganga,33,0.616667,2009,2010,pfcrt 76T,100,100,100,Amodiaquine,2,"Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?",
22118982,http://www.ncbi.nlm.nih.gov/pubmed/22118982,Kamugisha E,2012,Uganda,Iganga,33,0.616667,2009,2010,pfmdr1 86Y,81,63,63,Amodiaquine,2,"Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?",
23220229,http://www.ncbi.nlm.nih.gov/pubmed/23220229,Kiwuwa MS,2013,Uganda,Kampala Wakiso,32.5833,0.316667,2007,2008,pfcrt 76T,150,149,149,Amodiaquine,0,Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.,Presented as frequencies in mild and severe m
23220229,http://www.ncbi.nlm.nih.gov/pubmed/23220229,Kiwuwa MS,2013,Uganda,Kampala Wakiso,32.5833,0.316667,2007,2008,pfmdr1 1246D/Y,154,32,32,Amodiaquine,0,Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.,Presented as frequencies in mild and severe m
23220229,http://www.ncbi.nlm.nih.gov/pubmed/23220229,Kiwuwa MS,2013,Uganda,Kampala Wakiso,32.5833,0.316667,2007,2008,pfmdr1 1246Y,154,114,146,Amodiaquine,0,Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.,Presented as frequencies in mild and severe m
23220229,http://www.ncbi.nlm.nih.gov/pubmed/23220229,Kiwuwa MS,2013,Uganda,Kampala Wakiso,32.5833,0.316667,2007,2008,pfmdr1 86N/Y,156,108,108,Amodiaquine,0,Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.,Presented as frequencies in mild and severe m
23220229,http://www.ncbi.nlm.nih.gov/pubmed/23220229,Kiwuwa MS,2013,Uganda,Kampala Wakiso,32.5833,0.316667,2007,2008,pfmdr1 86Y,156,2,110,Amodiaquine,0,Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.,Presented as frequencies in mild and severe m
23220229,http://www.ncbi.nlm.nih.gov/pubmed/23220229,Kiwuwa MS,2013,Uganda,Kampala Wakiso,32.5833,0.316667,2007,2008,pfmdr1 copy number >1,7,0,0,Lumefantrine,0,Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.,Presented as frequencies in mild and severe m
597,http://www.ncbi.nlm.nih.gov/pubmed/?term=25183026,"Paganotti GM, Cosentino V, Russo G, Tabacchi F, Gramolelli S, Coluzzi M, Romano R",2014,Uganda,Karamoja,34.1532,2.83087,2007,2007,pfmdr1 86N/Y,55,24,24,Amodiaquine,1,Absence of the human CYP2C8*3 allele in Ugandan children exposed to Plasmodium falciparum malaria.,
597,http://www.ncbi.nlm.nih.gov/pubmed/?term=25183026,"Paganotti GM, Cosentino V, Russo G, Tabacchi F, Gramolelli S, Coluzzi M, Romano R",2014,Uganda,Karamoja,34.1532,2.83087,2007,2007,pfmdr1 86Y,55,18,42,Amodiaquine,1,Absence of the human CYP2C8*3 allele in Ugandan children exposed to Plasmodium falciparum malaria.,
597,http://www.ncbi.nlm.nih.gov/pubmed/?term=25183026,"Paganotti GM, Cosentino V, Russo G, Tabacchi F, Gramolelli S, Coluzzi M, Romano R",2014,Uganda,Makindye,32.5853,0.278169,2007,2007,pfmdr1 86N/Y,41,7,7,Amodiaquine,2,Absence of the human CYP2C8*3 allele in Ugandan children exposed to Plasmodium falciparum malaria.,
597,http://www.ncbi.nlm.nih.gov/pubmed/?term=25183026,"Paganotti GM, Cosentino V, Russo G, Tabacchi F, Gramolelli S, Coluzzi M, Romano R",2014,Uganda,Makindye,32.5853,0.278169,2007,2007,pfmdr1 86Y,41,29,36,Amodiaquine,2,Absence of the human CYP2C8*3 allele in Ugandan children exposed to Plasmodium falciparum malaria.,
24446524,http://www.ncbi.nlm.nih.gov/pubmed/24446524,Tukwasibwe S,2014,Uganda,Tororo,34.1811,0.692778,2010,2011,pfcrt 76K/T,454,24,24,Amodiaquine,0,Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda.,
24446524,http://www.ncbi.nlm.nih.gov/pubmed/24446524,Tukwasibwe S,2014,Uganda,Tororo,34.1811,0.692778,2010,2011,pfcrt 76T,454,430,454,Amodiaquine,0,Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda.,
24446524,http://www.ncbi.nlm.nih.gov/pubmed/24446524,Tukwasibwe S,2014,Uganda,Tororo,34.1811,0.692778,2010,2011,pfmdr1 1246D/Y,438,249,249,Amodiaquine,0,Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda.,Clinical data available. RFLP data presented 
24446524,http://www.ncbi.nlm.nih.gov/pubmed/24446524,Tukwasibwe S,2014,Uganda,Tororo,34.1811,0.692778,2010,2011,pfmdr1 1246Y,438,158,407,Amodiaquine,0,Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda.,Clinical data available. RFLP data presented 
24446524,http://www.ncbi.nlm.nih.gov/pubmed/24446524,Tukwasibwe S,2014,Uganda,Tororo,34.1811,0.692778,2010,2011,pfmdr1 86N/Y,472,206,206,Amodiaquine,0,Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda.,Clinical data available. RFLP data presented 
24446524,http://www.ncbi.nlm.nih.gov/pubmed/24446524,Tukwasibwe S,2014,Uganda,Tororo,34.1811,0.692778,2010,2011,pfmdr1 86Y,472,104,310,Amodiaquine,0,Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda.,Clinical data available. RFLP data presented 
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfcrt 76K/T,100,5,5,Amodiaquine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,Longitudinal study 2007-2012. Patients are ra
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfcrt 76T,100,93,98,Amodiaquine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,Longitudinal study 2007-2012. Patients are ra
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfmdr1 1246D/Y,97,14,14,Amodiaquine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfmdr1 1246Y,97,36,50,Amodiaquine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,Clinical ASAQ data and post-treatment genotyp
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfmdr1 184F,100,9,67,Lumefantrine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,Clinical ASAQ data and post-treatment genotyp
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfmdr1 184Y/F,100,58,58,Lumefantrine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfmdr1 86N/Y,100,26,26,Amodiaquine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,
24610872,http://www.ncbi.nlm.nih.gov/pubmed/24610872,Conrad,2014,Uganda,Tororo,34.1811,0.692778,2007,2008,pfmdr1 86Y,100,51,77,Amodiaquine,1,Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children.,Clinical ASAQ data and post-treatment genotyp
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfcrt 76K/T,223,12,12,Amodiaquine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Clinical data available. RFLP data presented 
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfcrt 76T,223,194,206,Amodiaquine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Clinical data available. RFLP data presented 
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfmdr1 1246D/Y,223,47,47,Amodiaquine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Longitudinal study 2007-2012. Patients are ra
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfmdr1 1246Y,223,82,129,Amodiaquine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Longitudinal study 2007-2012. Patients are ra
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfmdr1 184F,223,42,80,Lumefantrine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Longitudinal study 2007-2012. Patients are ra
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfmdr1 184Y/F,223,38,38,Lumefantrine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Longitudinal study 2007-2012. Patients are ra
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfmdr1 86N/Y,223,83,83,Amodiaquine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Longitudinal study 2007-2012. Patients are ra
24629020,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4004386&tool=pmcentrez&rendertype=abstract,Nankoberanyi S,2014,Uganda,Tororo,34.1811,0.692778,2007,2012,pfmdr1 86Y,223,64,147,Amodiaquine,0,Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.,Longitudinal study 2007-2012. Patients are ra
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfcrt 76K/T,38,0,0,Amodiaquine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfcrt 76K/T,147,3,3,Amodiaquine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfcrt 76K/T,93,2,2,Amodiaquine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfcrt 76K/T,108,4,4,Amodiaquine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfcrt 76K/T,111,9,9,Amodiaquine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfcrt 76K/T,77,12,12,Amodiaquine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfcrt 76T,38,38,38,Amodiaquine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfcrt 76T,147,144,147,Amodiaquine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfcrt 76T,93,87,89,Amodiaquine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfcrt 76T,108,104,108,Amodiaquine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfcrt 76T,111,102,111,Amodiaquine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfcrt 76T,77,52,64,Amodiaquine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfmdr1 1246D/Y,39,12,12,Amodiaquine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Prevalence in febrile vs. Asymptomatic subjec
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 1246D/Y,79,27,27,Amodiaquine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 1246D/Y,111,55,55,Amodiaquine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfmdr1 1246D/Y,92,22,22,Amodiaquine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 1246D/Y,110,53,53,Amodiaquine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfmdr1 1246D/Y,146,50,50,Amodiaquine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfmdr1 1246Y,39,18,30,Amodiaquine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Prevalence in febrile vs. Asymptomatic subjec
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 1246Y,79,10,37,Amodiaquine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 1246Y,111,34,89,Amodiaquine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfmdr1 1246Y,92,58,80,Amodiaquine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 1246Y,110,35,88,Amodiaquine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfmdr1 1246Y,146,61,111,Amodiaquine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfmdr1 184F,37,5,12,Lumefantrine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Clinical data available. RFLP data presented 
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 184F,73,19,23,Lumefantrine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 184F,111,25,70,Lumefantrine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfmdr1 184F,90,9,15,Lumefantrine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 184F,106,36,43,Lumefantrine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfmdr1 184F,145,20,42,Lumefantrine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfmdr1 184Y/F,37,7,7,Lumefantrine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Clinical data available. RFLP data presented 
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 184Y/F,73,4,4,Lumefantrine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 184Y/F,111,45,45,Lumefantrine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfmdr1 184Y/F,90,6,6,Lumefantrine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 184Y/F,106,7,7,Lumefantrine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfmdr1 184Y/F,145,22,22,Lumefantrine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfmdr1 86N/Y,37,7,7,Amodiaquine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Prevalence in febrile vs. Asymptomatic subjec
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 86N/Y,78,32,32,Amodiaquine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 86N/Y,109,41,41,Amodiaquine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfmdr1 86N/Y,89,27,27,Amodiaquine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 86N/Y,111,41,41,Amodiaquine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfmdr1 86N/Y,144,88,88,Amodiaquine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2007,2007,pfmdr1 86Y,37,18,25,Amodiaquine,2,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Prevalence in febrile vs. Asymptomatic subjec
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 86Y,78,6,38,Amodiaquine,7,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 86Y,109,21,62,Amodiaquine,5,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2009,2009,pfmdr1 86Y,89,39,66,Amodiaquine,4,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 86Y,111,18,59,Amodiaquine,6,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
24799371,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Mbogo GW,2014,Uganda,Tororo,34.1811,0.692778,2008,2008,pfmdr1 86Y,144,25,113,Amodiaquine,3,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Uganda,,,,2004,2006,pfcrt 76K/T,50,0,0,Amodiaquine,3,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Uganda,,,,2004,2006,pfcrt 76T,50,49,49,Amodiaquine,3,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfcrt 76K/T,73,9,9,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfcrt 76K/T,331,34,34,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfcrt 76K/T,271,66,66,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfcrt 76T,73,63,72,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfcrt 76T,331,280,314,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfcrt 76T,271,179,245,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 1246D/Y,72,15,15,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 1246D/Y,320,72,72,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 1246D/Y,258,59,59,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 1246Y,72,16,31,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 1246Y,320,64,136,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 1246Y,258,34,93,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 184F,74,15,56,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 184F,335,60,204,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 184F,268,32,184,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 184Y/F,74,41,41,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 184Y/F,335,144,144,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 184Y/F,268,152,152,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 86N/Y,73,22,22,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 86N/Y,321,92,92,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 86N/Y,259,62,62,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2010,2010,pfmdr1 86Y,73,15,37,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2011,2011,pfmdr1 86Y,321,61,153,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
2UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432194/,Tumwebaze,2015,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 86Y,259,10,72,,,,added by HYE (study not identified in WWARN PDMS); extracted from barplot and supplement
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfcrt 76K/T,599,118,118,Amodiaquine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfcrt 76T,599,351,469,Amodiaquine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfmdr1 1246D/Y,596,95,95,Amodiaquine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfmdr1 1246Y,596,48,143,Amodiaquine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfmdr1 184F,599,119,359,Lumefantrine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfmdr1 184Y/F,599,240,240,Lumefantrine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfmdr1 86N/Y,594,6,6,Amodiaquine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
26597254,http://www.ncbi.nlm.nih.gov/pubmed/?term=26597254,"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, Belay K, Kapella BK, Chang MA, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ",2016,Uganda,"Apac, Mubende, Kanungu",,,2013,2014,pfmdr1 86Y,594,47,53,Amodiaquine,1,Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.,AL ASAQ clinical data
513,http://www.ncbi.nlm.nih.gov/pubmed/?term=27401569,"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ",2016,Uganda,Tororo,34.1811,0.692778,2011,2012,pfcrt 76K/T,635,79,79,Amodiaquine,1,Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.,Children treated with IPT DP more than 60 days ago included in the prevalence
513,http://www.ncbi.nlm.nih.gov/pubmed/?term=27401569,"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ",2016,Uganda,Tororo,34.1811,0.692778,2011,2012,pfcrt 76T,635,547,626,Amodiaquine,1,Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.,Children treated with IPT DP more than 60 days ago included in the prevalence
513,http://www.ncbi.nlm.nih.gov/pubmed/?term=27401569,"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ",2016,Uganda,Tororo,34.1811,0.692778,2011,2012,pfmdr1 1246D/Y,616,292,292,Amodiaquine,1,Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.,Including pre-treatment genotypes + genotypes
513,http://www.ncbi.nlm.nih.gov/pubmed/?term=27401569,"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ",2016,Uganda,Tororo,34.1811,0.692778,2011,2012,pfmdr1 1246Y,616,63,355,Amodiaquine,1,Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.,Including pre-treatment genotypes + genotypes
513,http://www.ncbi.nlm.nih.gov/pubmed/?term=27401569,"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ",2016,Uganda,Tororo,34.1811,0.692778,2011,2012,pfmdr1 86N/Y,630,389,389,Amodiaquine,1,Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.,Including pre-treatment genotypes + genotypes
513,http://www.ncbi.nlm.nih.gov/pubmed/?term=27401569,"Nankabirwa JI, Conrad MD, Legac J, Tukwasibwe S, Tumwebaze P, Wandera B, Brooker SJ, Staedke SG, Kamya MR, Nsobya SL, Dorsey G, Rosenthal PJ",2016,Uganda,Tororo,34.1811,0.692778,2011,2012,pfmdr1 86Y,630,52,441,Amodiaquine,1,Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.,Including pre-treatment genotypes + genotypes
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Uganda,,,,2012,2015,pfcrt 76T,6,3,3,Amodiaquine,6,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Uganda,,,,2012,2015,pfcrt CIET,6,3,3,Amodiaquine,12,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
493,http://www.ncbi.nlm.nih.gov/pubmed/?term=28068997,"Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T",2017,Uganda,Gulu,32.2881,2.7724,2014,2014,pfcrt 76K/T,144,4,4,Amodiaquine,1,Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.,
493,http://www.ncbi.nlm.nih.gov/pubmed/?term=28068997,"Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T",2017,Uganda,Gulu,32.2881,2.7724,2014,2014,pfcrt 76T,144,42,46,Amodiaquine,1,Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.,
493,http://www.ncbi.nlm.nih.gov/pubmed/?term=28068997,"Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T",2017,Uganda,Gulu,32.2881,2.7724,2014,2014,pfmdr1 1246Y,143,9,9,Amodiaquine,1,Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.,
493,http://www.ncbi.nlm.nih.gov/pubmed/?term=28068997,"Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T",2017,Uganda,Gulu,32.2881,2.7724,2014,2014,pfmdr1 184F,143,14,28,Lumefantrine,1,Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.,
493,http://www.ncbi.nlm.nih.gov/pubmed/?term=28068997,"Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T",2017,Uganda,Gulu,32.2881,2.7724,2014,2014,pfmdr1 184Y/F,143,14,14,Lumefantrine,1,Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.,
493,http://www.ncbi.nlm.nih.gov/pubmed/?term=28068997,"Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T",2017,Uganda,Gulu,32.2881,2.7724,2014,2014,pfmdr1 86Y,144,3,3,Amodiaquine,1,Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfcrt 76K/T,70,0,0,Amodiaquine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfcrt 76K/T,50,8,8,Amodiaquine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfcrt 76K/T,35,8,8,Amodiaquine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfcrt 76T,70,68,68,Amodiaquine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfcrt 76T,50,40,48,Amodiaquine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfcrt 76T,35,22,30,Amodiaquine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfmdr1 1246D/Y,62,24,24,Amodiaquine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfmdr1 1246D/Y,45,9,9,Amodiaquine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfmdr1 1246D/Y,35,7,7,Amodiaquine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfmdr1 1246Y,62,12,36,Amodiaquine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfmdr1 1246Y,45,2,11,Amodiaquine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfmdr1 1246Y,35,0,7,Amodiaquine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfmdr1 184F,64,10,23,Lumefantrine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfmdr1 184F,47,6,29,Lumefantrine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfmdr1 184F,32,8,23,Lumefantrine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfmdr1 184Y/F,64,13,13,Lumefantrine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfmdr1 184Y/F,47,23,23,Lumefantrine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfmdr1 184Y/F,32,15,15,Lumefantrine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfmdr1 86N/Y,61,25,25,Amodiaquine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfmdr1 86N/Y,45,14,14,Amodiaquine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfmdr1 86N/Y,36,5,5,Amodiaquine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2012,2012,pfmdr1 86Y,61,23,48,Amodiaquine,1,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2013,2013,pfmdr1 86Y,45,0,14,Amodiaquine,2,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Jinja,33.2042,0.424444,2015,2015,pfmdr1 86Y,36,0,5,Amodiaquine,3,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfcrt 76K/T,86,0,0,Amodiaquine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfcrt 76K/T,66,15,15,Amodiaquine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfcrt 76K/T,117,18,18,Amodiaquine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfcrt 76T,86,84,84,Amodiaquine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfcrt 76T,66,40,55,Amodiaquine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfcrt 76T,117,64,82,Amodiaquine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfmdr1 1246D/Y,79,34,34,Amodiaquine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfmdr1 1246D/Y,61,3,3,Amodiaquine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfmdr1 1246D/Y,116,20,20,Amodiaquine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfmdr1 1246Y,79,16,50,Amodiaquine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfmdr1 1246Y,61,3,6,Amodiaquine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfmdr1 1246Y,116,3,23,Amodiaquine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfmdr1 184F,80,16,42,Lumefantrine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfmdr1 184F,59,9,32,Lumefantrine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfmdr1 184F,109,25,66,Lumefantrine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfmdr1 184Y/F,80,26,26,Lumefantrine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfmdr1 184Y/F,59,23,23,Lumefantrine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfmdr1 184Y/F,109,41,41,Lumefantrine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfmdr1 86N/Y,77,35,35,Amodiaquine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfmdr1 86N/Y,60,18,18,Amodiaquine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfmdr1 86N/Y,114,6,6,Amodiaquine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2012,2012,pfmdr1 86Y,77,27,62,Amodiaquine,4,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2013,2013,pfmdr1 86Y,60,6,24,Amodiaquine,5,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Kanungu,29.7426,-0.819525,2015,2015,pfmdr1 86Y,114,0,6,Amodiaquine,6,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
573,http://www.ncbi.nlm.nih.gov/pubmed/?term=28968782,"Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfcrt 76T,216,160,160,Amodiaquine,1,Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.,
573,http://www.ncbi.nlm.nih.gov/pubmed/?term=28968782,"Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 1246Y,207,55,55,Amodiaquine,1,Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.,Children treated with IPT DP more than 60 days ago included in the prevalence
573,http://www.ncbi.nlm.nih.gov/pubmed/?term=28968782,"Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 184F,214,142,142,Lumefantrine,1,Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.,Including pre-treatment genotypes + genotypes
573,http://www.ncbi.nlm.nih.gov/pubmed/?term=28968782,"Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 86Y,213,46,46,Amodiaquine,1,Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.,Children treated with IPT DP more than 60 days ago included in the prevalence
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfcrt 76K/T,342,62,62,Amodiaquine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfcrt 76K/T,378,57,57,Amodiaquine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfcrt 76K/T,285,57,57,Amodiaquine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfcrt 76T,342,274,336,Amodiaquine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfcrt 76T,378,284,341,Amodiaquine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfcrt 76T,285,138,195,Amodiaquine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfmdr1 1246D/Y,362,108,108,Amodiaquine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 1246D/Y,286,63,63,Amodiaquine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 1246D/Y,300,105,105,Amodiaquine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfmdr1 1246Y,362,18,126,Amodiaquine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 1246Y,286,11,74,Amodiaquine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 1246Y,300,45,150,Amodiaquine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfmdr1 184F,361,54,162,Lumefantrine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 184F,274,69,179,Lumefantrine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 184F,316,63,205,Lumefantrine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfmdr1 184Y/F,361,108,108,Lumefantrine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 184Y/F,274,110,110,Lumefantrine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 184Y/F,316,142,142,Lumefantrine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfmdr1 86N/Y,363,145,145,Amodiaquine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 86N/Y,282,46,46,Amodiaquine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 86N/Y,317,167,167,Amodiaquine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2013,2013,pfmdr1 86Y,363,26,171,Amodiaquine,8,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2015,2015,pfmdr1 86Y,282,0,46,Amodiaquine,9,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
591,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,Uganda,Tororo,34.1811,0.692778,2012,2012,pfmdr1 86Y,317,16,183,Amodiaquine,7,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfcrt 76K/T,675,101,101,Amodiaquine,1,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfcrt 76K/T,29,1,1,Amodiaquine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfcrt 76T,675,540,641,Amodiaquine,1,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfcrt 76T,29,6,7,Amodiaquine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfmdr1 1246D/Y,650,162,162,Amodiaquine,1,Changing Antimalarial Drug Sensitivities in Uganda.,Children treated with IPT DP more than 60 days ago included in the prevalence
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfmdr1 1246D/Y,29,6,6,Amodiaquine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfmdr1 1246Y,650,130,292,Amodiaquine,1,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfmdr1 1246Y,29,1,7,Amodiaquine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfmdr1 184F,677,135,474,Lumefantrine,1,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfmdr1 184F,29,9,15,Lumefantrine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfmdr1 184Y/F,677,339,339,Lumefantrine,1,Changing Antimalarial Drug Sensitivities in Uganda.,Including pre-treatment genotypes + genotypes
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfmdr1 184Y/F,29,6,6,Lumefantrine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfmdr1 86N/Y,653,196,196,Amodiaquine,1,Changing Antimalarial Drug Sensitivities in Uganda.,Children treated with IPT DP more than 60 days ago included in the prevalence
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfmdr1 86N/Y,29,1,1,Amodiaquine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2010,2013,pfmdr1 86Y,653,65,261,Amodiaquine,1,Changing Antimalarial Drug Sensitivities in Uganda.,
611,http://www.ncbi.nlm.nih.gov/pubmed/?term=28923866,"Rasmussen SA, Ceja FG, Conrad MD, Tumwebaze PK, Byaruhanga O, Katairo T, Nsobya SL, Rosenthal PJ, Cooper RA",2017,Uganda,Tororo,34.1811,0.692778,2016,2016,pfmdr1 86Y,29,0,1,Amodiaquine,2,Changing Antimalarial Drug Sensitivities in Uganda.,
1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361791/pdf/12936_2017_Article_1777.pdf,Tukwasibwe,2017,Uganda,Tororo,34.1811,0.692778,2011,2014,pfcrt 76K/T,215,8,8,,,,added by HYE (study not identified in WWARN PDMS)
1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361791/pdf/12936_2017_Article_1777.pdf,Tukwasibwe,2017,Uganda,Tororo,34.1811,0.692778,2011,2014,pfcrt 76T,215,193,201,,,,added by HYE (study not identified in WWARN PDMS)
1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361791/pdf/12936_2017_Article_1777.pdf,Tukwasibwe,2017,Uganda,Tororo,34.1811,0.692778,2011,2014,pfmdr1 86Y,220,17,80,,,,added by HYE (study not identified in WWARN PDMS)
SR1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817777/,Conrad,2017,Uganda,Tororo,34.1811,0.692778,2011,2015,pfcrt 76T,150,99,99,,,,added by HYE (study not identified in WWARN PDMS)
SR1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817777/,Conrad,2017,Uganda,Tororo,34.1811,0.692778,2011,2015,pfmdr1 1246Y,181,16,16,,,,added by HYE (study not identified in WWARN PDMS)
SR1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817777/,Conrad,2017,Uganda,Tororo,34.1811,0.692778,2011,2015,pfmdr1 184F,146,38,38,,,,added by HYE (study not identified in WWARN PDMS)
SR1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817777/,Conrad,2017,Uganda,Tororo,34.1811,0.692778,2011,2015,pfmdr1 86Y,146,0,0,,,,added by HYE (study not identified in WWARN PDMS)
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Uganda,,,,2014,2014,pfcrt 76K/T,3,0,0,,5,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Uganda,,,,2014,2014,pfcrt 76T,3,2,2,,5,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Uganda,,,,2014,2014,pfcrt CIET,3,2,2,,5,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Uganda,,,,2014,2014,pfcrt CMNK,3,1,1,,5,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfcrt 76K/T,226,22,22,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfcrt 76T,226,9,31,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfmdr1 1246D/Y,226,15,15,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfmdr1 1246Y,226,3,18,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfmdr1 184F,226,59,160,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfmdr1 184Y/F,226,101,101,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfmdr1 86N/Y,226,0,0,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
714,https://www.ncbi.nlm.nih.gov/pubmed/?term=30418593,"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, Kyambadde P, Opigo J, Kalyesubula S, Senzoga J, Vinden J, Conrad M, Rosenthal PJ.",2018,Uganda,"Arua, Gulu, Mbale",,,2015,2016,pfmdr1 86Y,226,2,2,,1,Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Uganda,Mbarara,30.6545,-0.6072,2012,2014,pfmdr1 1246D/Y,134,7,7,Amodiaquine,2,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Uganda,Mbarara,30.6545,-0.6072,2012,2014,pfmdr1 1246Y,134,28,35,Amodiaquine,2,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Uganda,Mbarara,30.6545,-0.6072,2012,2014,pfmdr1 184F,134,37,44,Lumefantrine,2,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Uganda,Mbarara,30.6545,-0.6072,2012,2014,pfmdr1 184Y/F,134,7,7,Lumefantrine,2,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Uganda,Mbarara,30.6545,-0.6072,2012,2014,pfmdr1 86N/Y,134,2,2,Amodiaquine,2,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
602,http://www.ncbi.nlm.nih.gov/pubmed/?term=29390014,"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP",2018,Uganda,Mbarara,30.6545,-0.6072,2012,2014,pfmdr1 86Y,134,2,4,Amodiaquine,2,Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.,
1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361791/pdf/12936_2017_Article_1777.pdf,Tukwasibwe,2018,Uganda,Tororo,34.1811,0.692778,2011,2014,pfmdr1 86N/Y,220,63,63,,,,added by HYE (study not identified in WWARN PDMS)
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Uganda,,,,2012,2016,pfmdr1 86Y,13,2,2,,10,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361791/pdf/12936_2017_Article_1777.pdf,Tukwasibwe,2019,Uganda,Tororo,34.1811,0.692778,2011,2014,pfmdr1 1246Y,215,48,117,,,,added by HYE (study not identified in WWARN PDMS)
1UGA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361791/pdf/12936_2017_Article_1777.pdf,Tukwasibwe,2020,Uganda,Tororo,34.1811,0.692778,2011,2014,pfmdr1 1246D/Y,215,69,69,,,,added by HYE (study not identified in WWARN PDMS)
24354640,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3878239&tool=pmcentrez&rendertype=abstract,Mharakurwa S,2013,Zambia,Macha,26.783,-16.4235,2006,2006,pfcrt 76K/T,128,2,2,Amodiaquine,0,Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia.,Pf genotypes in mosquitoes available.
24354640,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3878239&tool=pmcentrez&rendertype=abstract,Mharakurwa S,2013,Zambia,Macha,26.783,-16.4235,2006,2006,pfcrt 76T,128,111,113,Amodiaquine,0,Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia.,Pf genotypes in mosquitoes available.
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Zambia,,,,2004,2006,pfcrt 76K/T,116,5,5,Amodiaquine,4,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Zambia,,,,2006,2007,pfcrt 76K/T,77,3,3,Amodiaquine,5,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Zambia,,,,2004,2006,pfcrt 76T,116,26,31,Amodiaquine,4,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
25425434,http://www.ncbi.nlm.nih.gov/pubmed/?term=25425434,"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW",2014,Zambia,,,,2006,2007,pfcrt 76T,77,13,16,Amodiaquine,5,Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.,
498,http://www.ncbi.nlm.nih.gov/pubmed/?term=27919256,"Mwanza S, Joshi S, Nambozi M, Chileshe J, Malunga P, Kabuya JB, Hachizovu S, Manyando C, Mulenga M, Laufer M",2016,Zambia,Nchelenge,28.7285,-9.35348,2010,2013,pfcrt 76T,302,0,0,Amodiaquine,1,The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia.,
498,http://www.ncbi.nlm.nih.gov/pubmed/?term=27919256,"Mwanza S, Joshi S, Nambozi M, Chileshe J, Malunga P, Kabuya JB, Hachizovu S, Manyando C, Mulenga M, Laufer M",2016,Zambia,Nchelenge,28.7285,-9.35348,2010,2013,pfcrt CIET,302,0,0,Amodiaquine,1,The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia.,
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Zambia,,,,2012,2015,pfcrt 76T,20,1,1,Amodiaquine,10,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Zambia,,,,2012,2015,pfcrt CIET,20,1,1,Amodiaquine,9,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Zambia,,,,2014,2014,pfcrt 76K/T,8,0,0,,6,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Zambia,,,,2014,2014,pfcrt 76T,8,1,1,,6,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Zambia,,,,2014,2014,pfcrt CIET,8,1,1,,6,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
625,https://www.ncbi.nlm.nih.gov/pubmed/28747223,Feng Lu,2017,Zambia,,,,2014,2014,pfcrt CMNK,8,7,7,,6,Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Zambia,,,,2012,2016,pfmdr1 86Y,21,3,3,,4,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Zimbabwe,,,,2012,2015,pfcrt 76T,1,0,0,Amodiaquine,8,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
423,http://www.ncbi.nlm.nih.gov/pubmed/?term=27160572,"Zhou RM, Zhang HW, Yang CY, Liu Y, Zhao YL, Li SH, Qian D, Xu BL",2016,Zimbabwe,,,,2012,2015,pfcrt CIET,1,0,0,Amodiaquine,23,Molecular mutation profile of pfcrt in Plasmodium falciparum isolates imported from Africa in Henan province.,travelers
721,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/BABD196AA81AEE51DC2038A0388C76C6/S0031182018001609a.pdf/molecular_investigation_of_the_pfmdr1_gene_of_plasmodium_falciparum_isolates_in_henan_province_imported_from_africa.pdf,,2018,Zimbabwe,,,,2012,2016,pfmdr1 86Y,1,0,0,,6,Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa.,travelers